SEC Info - Walgreens Boots Alliance, Inc. - ‘10-Q’ for 11/30/19

SEC Info℠

Home

Help

Please Sign In

Walgreens Boots Alliance, Inc. – ‘10-Q’ for 11/30/19 – ‘JSON’

On: Wednesday, 1/8/20, at 4:14pm ET · For: 11/30/19 · Accession #: 1618921-20-8 · File #: 1-36759

  As Of               Filer                 Filing    For·On·As Docs:Size

 1/08/20  Walgreens Boots Alliance, Inc.    10-Q       11/30/19   89:10M

Quarterly Report — Form 10-Q — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.06M 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     30K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     30K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     25K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     25K 
45: R1          Cover Page                                          HTML     88K 
74: R2          Consolidated Condensed Balance Sheets               HTML    140K 
62: R3          Consolidated Condensed Balance Sheets               HTML     41K 
                (Parenthetical)                                                  
18: R4          Consolidated Condensed Statements of Equity         HTML     70K 
43: R5          Consolidated Condensed Statements of Earnings       HTML     92K 
73: R6          Consolidated Condensed Statements of Comprehensive  HTML     59K 
                Income                                                           
61: R7          Consolidated Condensed Statements of Cash Flows     HTML    119K 
                (Unaudited)                                                      
14: R8          Accounting policies                                 HTML     29K 
47: R9          Acquisitions                                        HTML     28K 
24: R10         Exit and disposal activities                        HTML    138K 
33: R11         Leases                                              HTML    151K 
85: R12         Equity method investments                           HTML     45K 
55: R13         Goodwill and other intangible assets                HTML     92K 
23: R14         Debt                                                HTML     93K 
32: R15         Financial instruments                               HTML     73K 
84: R16         Fair value measurements                             HTML     84K 
54: R17         Commitments and contingencies                       HTML     43K 
25: R18         Income taxes                                        HTML     27K 
31: R19         Retirement benefits                                 HTML     44K 
80: R20         Accumulated other comprehensive income (Loss)       HTML    107K 
69: R21         Segment reporting                                   HTML     77K 
22: R22         Sales                                               HTML     52K 
50: R23         Related parties                                     HTML     35K 
79: R24         New accounting pronouncements                       HTML    102K 
68: R25         Supplemental information                            HTML     54K 
21: R26         Accounting policies (Policies)                      HTML    107K 
49: R27         Exit and disposal activities (Tables)               HTML    137K 
78: R28         Leases (Tables)                                     HTML    112K 
70: R29         Equity method investments (Tables)                  HTML     40K 
52: R30         Goodwill and other intangible assets (Tables)       HTML     94K 
81: R31         Debt (Tables)                                       HTML    138K 
34: R32         Financial instruments (Tables)                      HTML     72K 
26: R33         Fair value measurements (Tables)                    HTML     80K 
53: R34         Retirement benefits (Tables)                        HTML     39K 
82: R35         Accumulated other comprehensive income (Loss)       HTML    107K 
                (Tables)                                                         
36: R36         Segment reporting (Tables)                          HTML     73K 
27: R37         Sales (Tables)                                      HTML     50K 
51: R38         Related parties (Tables)                            HTML     34K 
83: R39         New accounting pronouncements New accounting        HTML     78K 
                pronouncements (Tables)                                          
66: R40         Supplemental information (Tables)                   HTML     65K 
75: R41         Acquisitions (Details)                              HTML     33K 
41: R42         Exit and disposal activities - Narrative (Details)  HTML     84K 
11: R43         Exit and disposal activities - Restructuring Costs  HTML     64K 
                (Details)                                                        
67: R44         Exit and disposal activities - Restructuring        HTML     65K 
                Reserve Activity (Details)                                       
76: R45         Leases - Narrative (Details)                        HTML     30K 
42: R46         Leases - Supplemental Balance Sheet Information     HTML     44K 
                (Details)                                                        
12: R47         Leases - Components of Lease Cost (Details)         HTML     38K 
65: R48         Leases - Supplemental Cash Flow Information         HTML     41K 
                (Details)                                                        
77: R49         Leases - Average Lease Terms And Discounts          HTML     35K 
                (Details)                                                        
89: R50         Leases - Future Lease Payments for Operating and    HTML     67K 
                Finance Leases (Details)                                         
59: R51         Equity method investments - Schedule of Equity      HTML     42K 
                Method Investments (Details)                                     
29: R52         Equity method investments - Narrative (Details)     HTML     46K 
38: R53         Goodwill and other intangible assets - Schedule of  HTML     41K 
                Goodwill (Details)                                               
88: R54         Goodwill and other intangible assets - Schedule of  HTML     51K 
                Finite-Lived Intangible Assets by Major Class                    
                (Details)                                                        
58: R55         Goodwill and other intangible assets - Narrative    HTML     31K 
                (Details)                                                        
28: R56         Goodwill and other intangible assets - Schedule of  HTML     36K 
                Finite-Lived Intangible Assets, Future                           
                Amortization Expense (Details)                                   
37: R57         Debt - Short and Long-Term Debt (Details)           HTML     77K 
87: R58         Debt - Note Issuances (Details)                     HTML     45K 
60: R59         Debt - Additional Information (Details)             HTML     76K 
16: R60         Financial instruments (Details)                     HTML     57K 
48: R61         Fair value measurements (Details)                   HTML     59K 
72: R62         Commitments and contingencies (Details)             HTML     26K 
64: R63         Income taxes (Details)                              HTML     29K 
15: R64         Retirement benefits (Details)                       HTML     52K 
46: R65         Accumulated other comprehensive income (Loss)       HTML     63K 
                (Details)                                                        
71: R66         Segment reporting (Details)                         HTML     62K 
63: R67         Sales (Details)                                     HTML     43K 
17: R68         Related parties (Details)                           HTML     30K 
44: R69         New accounting pronouncements - Narrative           HTML     52K 
                (Details)                                                        
39: R70         New accounting pronouncements - Effect of Lease     HTML     89K 
                842 Adoption (Details)                                           
30: R71         Supplemental information - Narrative (Details)      HTML     44K 
56: R72         Supplemental information - Depreciation and         HTML     33K 
                Amortization Expense (Details)                                   
86: R73         Supplemental information - Summary of Cash, Cash    HTML     36K 
                Equivalents and Restricted Cash (Details)                        
40: R74         Supplemental information - Summary of Dividends     HTML     26K 
                per Share (Details)                                              
35: XML         IDEA XML File -- Filing Summary                      XML    160K 
20: XML         XBRL Instance -- wba-20191130_htm                    XML   3.08M 
13: EXCEL       IDEA Workbook of Financial Reports                  XLSX     91K 
 7: EX-101.CAL  XBRL Calculations -- wba-20191130_cal                XML    262K 
 8: EX-101.DEF  XBRL Definitions -- wba-20191130_def                 XML    680K 
 9: EX-101.LAB  XBRL Labels -- wba-20191130_lab                      XML   1.64M 
10: EX-101.PRE  XBRL Presentations -- wba-20191130_pre               XML   1.02M 
 6: EX-101.SCH  XBRL Schema -- wba-20191130                          XSD    170K 
57: JSON        XBRL Instance as JSON Data -- MetaLinks              370±   549K 
19: ZIP         XBRL Zipped Folder -- 0001618921-20-000008-xbrl      Zip    328K

‘JSON’ — XBRL Instance as JSON Data — MetaLinks

This File is an XBRL Instance as JavaScript Object Notation (JSON) Data.

{
"instance":  {
    "wba-20191130.htm":  {
        "axisCustom":  0,
        "axisStandard":  28,
        "contextCount":  322,
        "dts":  {
            "calculationLink":  {
                "local":  [
                    "wba-20191130_cal.xml"
                    ]
                },
            "definitionLink":  {
                "local":  [
                    "wba-20191130_def.xml"
                    ],
                "remote":  [
                    "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml",
                    "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml"
                    ]
                },
            "inline":  {
                "local":  [
                    "wba-20191130.htm"
                    ]
                },
            "labelLink":  {
                "local":  [
                    "wba-20191130_lab.xml"
                    ],
                "remote":  [
                    "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml",
                    "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-doc-2019-01-31.xml"
                    ]
                },
            "presentationLink":  {
                "local":  [
                    "wba-20191130_pre.xml"
                    ]
                },
            "referenceLink":  {
                "remote":  [
                    "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml",
                    "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-ref-2019-01-31.xml"
                    ]
                },
            "schema":  {
                "local":  [
                    "wba-20191130.xsd"
                    ],
                "remote":  [
                    "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd",
                    "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
                    "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
                    "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
                    "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
                    "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
                    "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
                    "http://www.xbrl.org/2005/xbrldt-2005.xsd",
                    "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
                    "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd",
                    "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd",
                    "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd",
                    "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd",
                    "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd",
                    "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd",
                    "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
                    "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
                    "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
                    "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
                    "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
                    "http://xbrl.fasb.org/us-gaap/2019/elts/us-parts-codification-2019-01-31.xsd"
                    ]
                }
            },
        "elementCount":  560,
        "entityCount":  1,
        "hidden":  {
            "http://fasb.org/us-gaap/2019-01-31":  19,
            "http://walgreensbootsalliance.com/20191130":  1,
            "http://xbrl.sec.gov/dei/2019-01-31":  6,
            "total":  26
            },
        "keyCustom":  27,
        "keyStandard":  352,
        "memberCustom":  50,
        "memberStandard":  42,
        "nsprefix":  "wba",
        "nsuri":  "http://walgreensbootsalliance.com/20191130",
        "report":  {
            "R1":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "dei:DocumentType",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "document",
                "isDefault":  "true",
                "longName":  "0001001 - Document - Cover Page",
                "role":  "http://walgreensbootsalliance.com/role/CoverPage",
                "shortName":  "Cover Page",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "dei:DocumentType",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R10":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2105103 - Disclosure - Exit and disposal activities",
                "role":  "http://walgreensbootsalliance.com/role/Exitanddisposalactivities",
                "shortName":  "Exit and disposal activities",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R11":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "us-gaap:LesseeFinanceLeasesTextBlock",
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:LesseeOperatingLeasesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2110104 - Disclosure - Leases",
                "role":  "http://walgreensbootsalliance.com/role/Leases",
                "shortName":  "Leases",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "us-gaap:LesseeFinanceLeasesTextBlock",
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:LesseeOperatingLeasesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R12":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2118105 - Disclosure - Equity method investments",
                "role":  "http://walgreensbootsalliance.com/role/Equitymethodinvestments",
                "shortName":  "Equity method investments",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R13":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2122106 - Disclosure - Goodwill and other intangible assets",
                "role":  "http://walgreensbootsalliance.com/role/Goodwillandotherintangibleassets",
                "shortName":  "Goodwill and other intangible assets",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R14":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DebtDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2128107 - Disclosure - Debt",
                "role":  "http://walgreensbootsalliance.com/role/Debt",
                "shortName":  "Debt",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DebtDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R15":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2133108 - Disclosure - Financial instruments",
                "role":  "http://walgreensbootsalliance.com/role/Financialinstruments",
                "shortName":  "Financial instruments",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R16":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FairValueDisclosuresTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2136109 - Disclosure - Fair value measurements",
                "role":  "http://walgreensbootsalliance.com/role/Fairvaluemeasurements",
                "shortName":  "Fair value measurements",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FairValueDisclosuresTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R17":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2139110 - Disclosure - Commitments and contingencies",
                "role":  "http://walgreensbootsalliance.com/role/Commitmentsandcontingencies",
                "shortName":  "Commitments and contingencies",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R18":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:IncomeTaxDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2141111 - Disclosure - Income taxes",
                "role":  "http://walgreensbootsalliance.com/role/Incometaxes",
                "shortName":  "Income taxes",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:IncomeTaxDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R19":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:PostemploymentBenefitsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2143112 - Disclosure - Retirement benefits",
                "role":  "http://walgreensbootsalliance.com/role/Retirementbenefits",
                "shortName":  "Retirement benefits",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:PostemploymentBenefitsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R2":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i1f1b97c60a2e470196477e925efb794c_I20191130",
                    "decimals":  "-6",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:CashAndCashEquivalentsAtCarryingValue",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "1001002 - Statement - CONSOLIDATED CONDENSED BALANCE SHEETS",
                "role":  "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS",
                "shortName":  "CONSOLIDATED CONDENSED BALANCE SHEETS",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i1f1b97c60a2e470196477e925efb794c_I20191130",
                    "decimals":  "-6",
                    "lang":  null,
                    "name":  "us-gaap:AccountsReceivableNetCurrent",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R20":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ComprehensiveIncomeNoteTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2146113 - Disclosure - Accumulated other comprehensive income (loss)",
                "role":  "http://walgreensbootsalliance.com/role/Accumulatedothercomprehensiveincomeloss",
                "shortName":  "Accumulated other comprehensive income (loss)",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ComprehensiveIncomeNoteTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R21":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SegmentReportingDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2149114 - Disclosure - Segment reporting",
                "role":  "http://walgreensbootsalliance.com/role/Segmentreporting",
                "shortName":  "Segment reporting",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SegmentReportingDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R22":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:RevenueFromContractWithCustomerTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2152115 - Disclosure - Sales",
                "role":  "http://walgreensbootsalliance.com/role/Sales",
                "shortName":  "Sales",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:RevenueFromContractWithCustomerTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R23":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2155116 - Disclosure - Related parties",
                "role":  "http://walgreensbootsalliance.com/role/Relatedparties",
                "shortName":  "Related parties",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R24":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DescriptionOfNewAccountingPronouncementsNotYetAdopted",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2158117 - Disclosure - New accounting pronouncements",
                "role":  "http://walgreensbootsalliance.com/role/Newaccountingpronouncements",
                "shortName":  "New accounting pronouncements",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DescriptionOfNewAccountingPronouncementsNotYetAdopted",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R25":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2162118 - Disclosure - Supplemental information",
                "role":  "http://walgreensbootsalliance.com/role/Supplementalinformation",
                "shortName":  "Supplemental information",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R26":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2202201 - Disclosure - Accounting policies (Policies)",
                "role":  "http://walgreensbootsalliance.com/role/AccountingpoliciesPolicies",
                "shortName":  "Accounting policies (Policies)",
                "subGroupType":  "policies",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R27":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i4de0b787c7a349c890bf65f3e980f78c_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2306301 - Disclosure - Exit and disposal activities (Tables)",
                "role":  "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesTables",
                "shortName":  "Exit and disposal activities (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i4de0b787c7a349c890bf65f3e980f78c_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R28":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "wba:AssetsAndLiabilitiesLesseeTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2311302 - Disclosure - Leases (Tables)",
                "role":  "http://walgreensbootsalliance.com/role/LeasesTables",
                "shortName":  "Leases (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "wba:AssetsAndLiabilitiesLesseeTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R29":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:EquityMethodInvestmentsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2319303 - Disclosure - Equity method investments (Tables)",
                "role":  "http://walgreensbootsalliance.com/role/EquitymethodinvestmentsTables",
                "shortName":  "Equity method investments (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:EquityMethodInvestmentsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R3":  {
                "firstAnchor":  null,
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "1002003 - Statement - CONSOLIDATED CONDENSED BALANCE SHEETS (Parenthetical)",
                "role":  "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical",
                "shortName":  "CONSOLIDATED CONDENSED BALANCE SHEETS (Parenthetical)",
                "subGroupType":  "parenthetical",
                "uniqueAnchor":  null
                },
            "R30":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfGoodwillTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2323304 - Disclosure - Goodwill and other intangible assets (Tables)",
                "role":  "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsTables",
                "shortName":  "Goodwill and other intangible assets (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfGoodwillTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R31":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfShortTermDebtTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2329305 - Disclosure - Debt (Tables)",
                "role":  "http://walgreensbootsalliance.com/role/DebtTables",
                "shortName":  "Debt (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfShortTermDebtTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R32":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2334306 - Disclosure - Financial instruments (Tables)",
                "role":  "http://walgreensbootsalliance.com/role/FinancialinstrumentsTables",
                "shortName":  "Financial instruments (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R33":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2337307 - Disclosure - Fair value measurements (Tables)",
                "role":  "http://walgreensbootsalliance.com/role/FairvaluemeasurementsTables",
                "shortName":  "Fair value measurements (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R34":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2344308 - Disclosure - Retirement benefits (Tables)",
                "role":  "http://walgreensbootsalliance.com/role/RetirementbenefitsTables",
                "shortName":  "Retirement benefits (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R35":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2347309 - Disclosure - Accumulated other comprehensive income (loss) (Tables)",
                "role":  "http://walgreensbootsalliance.com/role/AccumulatedothercomprehensiveincomelossTables",
                "shortName":  "Accumulated other comprehensive income (loss) (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R36":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2350310 - Disclosure - Segment reporting (Tables)",
                "role":  "http://walgreensbootsalliance.com/role/SegmentreportingTables",
                "shortName":  "Segment reporting (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R37":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DisaggregationOfRevenueTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2353311 - Disclosure - Sales (Tables)",
                "role":  "http://walgreensbootsalliance.com/role/SalesTables",
                "shortName":  "Sales (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DisaggregationOfRevenueTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R38":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2356312 - Disclosure - Related parties (Tables)",
                "role":  "http://walgreensbootsalliance.com/role/RelatedpartiesTables",
                "shortName":  "Related parties (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R39":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2359313 - Disclosure - New accounting pronouncements New accounting pronouncements (Tables)",
                "role":  "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsNewaccountingpronouncementsTables",
                "shortName":  "New accounting pronouncements New accounting pronouncements (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R4":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "ia7a94161382042a093a0c1c80ccab600_I20180831",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:CommonStockSharesOutstanding",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "1003004 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF EQUITY",
                "role":  "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEQUITY",
                "shortName":  "CONSOLIDATED CONDENSED STATEMENTS OF EQUITY",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "ia7a94161382042a093a0c1c80ccab600_I20180831",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:CommonStockSharesOutstanding",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    }
                },
            "R40":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "wba:ScheduleofDepreciationandAmortizationExpenseTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2363314 - Disclosure - Supplemental information (Tables)",
                "role":  "http://walgreensbootsalliance.com/role/SupplementalinformationTables",
                "shortName":  "Supplemental information (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "wba:ScheduleofDepreciationandAmortizationExpenseTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R41":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  "-6",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:PaymentsToAcquireBusinessesGross",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2404401 - Disclosure - Acquisitions (Details)",
                "role":  "http://walgreensbootsalliance.com/role/AcquisitionsDetails",
                "shortName":  "Acquisitions (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  "-6",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:PaymentsToAcquireBusinessesGross",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R42":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i082dbdb917014a78b0ef5af67fde4318_D20171024-20171024",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "wba:RestructuringAndRelatedCostNumberOfStoresExpectedToClose",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "store",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2407402 - Disclosure - Exit and disposal activities - Narrative (Details)",
                "role":  "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesNarrativeDetails",
                "shortName":  "Exit and disposal activities - Narrative (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i082dbdb917014a78b0ef5af67fde4318_D20171024-20171024",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "wba:RestructuringAndRelatedCostNumberOfStoresExpectedToClose",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "store",
                    "xsiNil":  "false"
                    }
                },
            "R43":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i4de0b787c7a349c890bf65f3e980f78c_D20190901-20191130",
                    "decimals":  "-6",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:RestructuringCosts",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2408403 - Disclosure - Exit and disposal activities - Restructuring Costs (Details)",
                "role":  "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringCostsDetails",
                "shortName":  "Exit and disposal activities - Restructuring Costs (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i4de0b787c7a349c890bf65f3e980f78c_D20190901-20191130",
                    "decimals":  "-6",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:RestructuringCosts",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R44":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i3e268e645aa940ae9c3fe4e46d3f1387_I20190831",
                    "decimals":  "-6",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:RestructuringReserve",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2409404 - Disclosure - Exit and disposal activities - Restructuring Reserve Activity (Details)",
                "role":  "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringReserveActivityDetails",
                "shortName":  "Exit and disposal activities - Restructuring Reserve Activity (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i3e268e645aa940ae9c3fe4e46d3f1387_I20190831",
                    "decimals":  "-6",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:RestructuringReserve",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R45":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i50ba2dcf4f5845289876f461eacb89e9_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "wba:LesseeLeaseTermOfContract",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2412405 - Disclosure - Leases - Narrative (Details)",
                "role":  "http://walgreensbootsalliance.com/role/LeasesNarrativeDetails",
                "shortName":  "Leases - Narrative (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i50ba2dcf4f5845289876f461eacb89e9_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "wba:LesseeLeaseTermOfContract",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R46":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i1f1b97c60a2e470196477e925efb794c_I20191130",
                    "decimals":  "-6",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:OperatingLeaseRightOfUseAsset",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2413406 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)",
                "role":  "http://walgreensbootsalliance.com/role/LeasesSupplementalBalanceSheetInformationDetails",
                "shortName":  "Leases - Supplemental Balance Sheet Information (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "wba:AssetsAndLiabilitiesLesseeTableTextBlock",
                        "ix:continuation",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i1f1b97c60a2e470196477e925efb794c_I20191130",
                    "decimals":  "-6",
                    "lang":  null,
                    "name":  "us-gaap:FinanceLeaseRightOfUseAsset",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R47":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:LeaseCostTableTextBlock",
                        "ix:continuation",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  "-6",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:OperatingLeaseCost",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2414407 - Disclosure - Leases - Components of Lease Cost (Details)",
                "role":  "http://walgreensbootsalliance.com/role/LeasesComponentsofLeaseCostDetails",
                "shortName":  "Leases - Components of Lease Cost (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:LeaseCostTableTextBlock",
                        "ix:continuation",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  "-6",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:OperatingLeaseCost",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R48":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:LeaseCostTableTextBlock",
                        "ix:continuation",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  "-6",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:SaleAndLeasebackTransactionGainLossNet",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2415408 - Disclosure - Leases - Supplemental Cash Flow Information (Details)",
                "role":  "http://walgreensbootsalliance.com/role/LeasesSupplementalCashFlowInformationDetails",
                "shortName":  "Leases - Supplemental Cash Flow Information (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:LeaseCostTableTextBlock",
                        "ix:continuation",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  "-6",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:SaleAndLeasebackTransactionGainLossNet",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R49":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "ix:continuation",
                        "ix:continuation",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i1f1b97c60a2e470196477e925efb794c_I20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2416409 - Disclosure - Leases - Average Lease Terms And Discounts (Details)",
                "role":  "http://walgreensbootsalliance.com/role/LeasesAverageLeaseTermsAndDiscountsDetails",
                "shortName":  "Leases - Average Lease Terms And Discounts (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "ix:continuation",
                        "ix:continuation",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i1f1b97c60a2e470196477e925efb794c_I20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R5":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:DisaggregationOfRevenueTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  "-6",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "1004005 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF EARNINGS",
                "role":  "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEARNINGS",
                "shortName":  "CONSOLIDATED CONDENSED STATEMENTS OF EARNINGS",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  "-6",
                    "lang":  null,
                    "name":  "us-gaap:CostOfGoodsAndServicesSold",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R50":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
                        "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
                        "ix:continuation",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i1f1b97c60a2e470196477e925efb794c_I20191130",
                    "decimals":  "-6",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2417410 - Disclosure - Leases - Future Lease Payments for Operating and Finance Leases (Details)",
                "role":  "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails",
                "shortName":  "Leases - Future Lease Payments for Operating and Finance Leases (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
                        "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
                        "ix:continuation",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i1f1b97c60a2e470196477e925efb794c_I20191130",
                    "decimals":  "-6",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R51":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i1f1b97c60a2e470196477e925efb794c_I20191130",
                    "decimals":  "-6",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:EquityMethodInvestments",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2420411 - Disclosure - Equity method investments - Schedule of Equity Method Investments (Details)",
                "role":  "http://walgreensbootsalliance.com/role/EquitymethodinvestmentsScheduleofEquityMethodInvestmentsDetails",
                "shortName":  "Equity method investments - Schedule of Equity Method Investments (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:EquityMethodInvestmentsTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "if88ae65350f14e2b81beecd8fee48509_I20191130",
                    "decimals":  "-6",
                    "lang":  null,
                    "name":  "us-gaap:EquityMethodInvestments",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R52":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  "-6",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:IncomeLossFromEquityMethodInvestments",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2421412 - Disclosure - Equity method investments - Narrative (Details)",
                "role":  "http://walgreensbootsalliance.com/role/EquitymethodinvestmentsNarrativeDetails",
                "shortName":  "Equity method investments - Narrative (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "us-gaap:InvestmentsInAndAdvancesToAffiliatesBalanceShares",
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "if88ae65350f14e2b81beecd8fee48509_I20191130",
                    "decimals":  "INF",
                    "lang":  null,
                    "name":  "us-gaap:InvestmentsInAndAdvancesToAffiliatesBalanceShares",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    }
                },
            "R53":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfGoodwillTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "ibb20f1a01afd499ebd2a820069c62231_I20190831",
                    "decimals":  "-6",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:Goodwill",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2424413 - Disclosure - Goodwill and other intangible assets - Schedule of Goodwill (Details)",
                "role":  "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofGoodwillDetails",
                "shortName":  "Goodwill and other intangible assets - Schedule of Goodwill (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfGoodwillTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  "-6",
                    "lang":  null,
                    "name":  "us-gaap:GoodwillAcquiredDuringPeriod",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R54":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "ix:continuation",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i1f1b97c60a2e470196477e925efb794c_I20191130",
                    "decimals":  "-6",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:FiniteLivedIntangibleAssetsGross",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2425414 - Disclosure - Goodwill and other intangible assets - Schedule of Finite-Lived Intangible Assets by Major Class (Details)",
                "role":  "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofFiniteLivedIntangibleAssetsbyMajorClassDetails",
                "shortName":  "Goodwill and other intangible assets - Schedule of Finite-Lived Intangible Assets by Major Class (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "ix:continuation",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i1f1b97c60a2e470196477e925efb794c_I20191130",
                    "decimals":  "-6",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:FiniteLivedIntangibleAssetsGross",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R55":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "wba:ScheduleofDepreciationandAmortizationExpenseTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  "-6",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:AmortizationOfIntangibleAssets",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2426415 - Disclosure - Goodwill and other intangible assets - Narrative (Details)",
                "role":  "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsNarrativeDetails",
                "shortName":  "Goodwill and other intangible assets - Narrative (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i7eb9c9f4e04f45f5a08a80b9dfae4521_I20191130",
                    "decimals":  "2",
                    "lang":  null,
                    "name":  "us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "number",
                    "xsiNil":  "false"
                    }
                },
            "R56":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i1f1b97c60a2e470196477e925efb794c_I20191130",
                    "decimals":  "-6",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2427416 - Disclosure - Goodwill and other intangible assets - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details)",
                "role":  "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails",
                "shortName":  "Goodwill and other intangible assets - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i1f1b97c60a2e470196477e925efb794c_I20191130",
                    "decimals":  "-6",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R57":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
                        "us-gaap:ScheduleOfShortTermDebtTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i1f1b97c60a2e470196477e925efb794c_I20191130",
                    "decimals":  "-6",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ShortTermBorrowings",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2430417 - Disclosure - Debt - Short and Long-Term Debt (Details)",
                "role":  "http://walgreensbootsalliance.com/role/DebtShortandLongTermDebtDetails",
                "shortName":  "Debt - Short and Long-Term Debt (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
                        "us-gaap:ScheduleOfShortTermDebtTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i516f97805823434299bc6c8690ebd937_I20191130",
                    "decimals":  "-6",
                    "lang":  null,
                    "name":  "us-gaap:OtherLongTermDebt",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R58":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
                        "us-gaap:ScheduleOfShortTermDebtTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i5574dcd69c9d4bd9af3ccb775bff09b1_I20191130",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:DebtInstrumentFaceAmount",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2431418 - Disclosure - Debt - Note Issuances (Details)",
                "role":  "http://walgreensbootsalliance.com/role/DebtNoteIssuancesDetails",
                "shortName":  "Debt - Note Issuances (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
                        "us-gaap:ScheduleOfShortTermDebtTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i5574dcd69c9d4bd9af3ccb775bff09b1_I20191130",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:DebtInstrumentFaceAmount",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R59":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  "-6",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:InterestPaidNet",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2432419 - Disclosure - Debt - Additional Information (Details)",
                "role":  "http://walgreensbootsalliance.com/role/DebtAdditionalInformationDetails",
                "shortName":  "Debt - Additional Information (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  "-6",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:InterestPaidNet",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R6":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  "-6",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ProfitLoss",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "1005006 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME",
                "role":  "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME",
                "shortName":  "CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  "-6",
                    "lang":  null,
                    "name":  "us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R60":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "ix:continuation",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i5aefa7645d35434a995e5f7bad21ca6f_D20190901-20191130",
                    "decimals":  "-6",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2435420 - Disclosure - Financial instruments (Details)",
                "role":  "http://walgreensbootsalliance.com/role/FinancialinstrumentsDetails",
                "shortName":  "Financial instruments (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "ix:continuation",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i5aefa7645d35434a995e5f7bad21ca6f_D20190901-20191130",
                    "decimals":  "-6",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R61":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i1f1b97c60a2e470196477e925efb794c_I20191130",
                    "decimals":  "-6",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2438421 - Disclosure - Fair value measurements (Details)",
                "role":  "http://walgreensbootsalliance.com/role/FairvaluemeasurementsDetails",
                "shortName":  "Fair value measurements (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i1f1b97c60a2e470196477e925efb794c_I20191130",
                    "decimals":  "-6",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R62":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i8f0761bd66a94dfca0b2d2066e25e57d_D20190122-20190122",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:PaymentsForLegalSettlements",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2440422 - Disclosure - Commitments and contingencies (Details)",
                "role":  "http://walgreensbootsalliance.com/role/CommitmentsandcontingenciesDetails",
                "shortName":  "Commitments and contingencies (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i8f0761bd66a94dfca0b2d2066e25e57d_D20190122-20190122",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:PaymentsForLegalSettlements",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R63":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "number",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2442423 - Disclosure - Income taxes (Details)",
                "role":  "http://walgreensbootsalliance.com/role/IncometaxesDetails",
                "shortName":  "Income taxes (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "number",
                    "xsiNil":  "false"
                    }
                },
            "R64":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  "-6",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2445424 - Disclosure - Retirement benefits (Details)",
                "role":  "http://walgreensbootsalliance.com/role/RetirementbenefitsDetails",
                "shortName":  "Retirement benefits (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  "-6",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R65":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "ibb20f1a01afd499ebd2a820069c62231_I20190831",
                    "decimals":  "-6",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2448425 - Disclosure - Accumulated other comprehensive income (loss) (Details)",
                "role":  "http://walgreensbootsalliance.com/role/AccumulatedothercomprehensiveincomelossDetails",
                "shortName":  "Accumulated other comprehensive income (loss) (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i4d7bba4b00424695b752cba2a8d60285_I20190831",
                    "decimals":  "-6",
                    "lang":  null,
                    "name":  "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R66":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:NumberOfReportableSegments",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "segment",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2451426 - Disclosure - Segment reporting (Details)",
                "role":  "http://walgreensbootsalliance.com/role/SegmentreportingDetails",
                "shortName":  "Segment reporting (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:NumberOfReportableSegments",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "segment",
                    "xsiNil":  "false"
                    }
                },
            "R67":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:DisaggregationOfRevenueTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  "-6",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2454427 - Disclosure - Sales (Details)",
                "role":  "http://walgreensbootsalliance.com/role/SalesDetails",
                "shortName":  "Sales (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:DisaggregationOfRevenueTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "ie4bfeccfd94946d1b0fe05c5637e02be_D20190901-20191130",
                    "decimals":  "-6",
                    "lang":  null,
                    "name":  "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R68":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  "-6",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2457428 - Disclosure - Related parties (Details)",
                "role":  "http://walgreensbootsalliance.com/role/RelatedpartiesDetails",
                "shortName":  "Related parties (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  "-6",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R69":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "wba:AssetsAndLiabilitiesLesseeTableTextBlock",
                        "ix:continuation",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i1f1b97c60a2e470196477e925efb794c_I20191130",
                    "decimals":  "-6",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:OperatingLeaseLiability",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2460429 - Disclosure - New accounting pronouncements - Narrative (Details)",
                "role":  "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsNarrativeDetails",
                "shortName":  "New accounting pronouncements - Narrative (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "icad5c86cbc054fab976b896fee20754b_I20190901",
                    "decimals":  "-9",
                    "lang":  null,
                    "name":  "us-gaap:OperatingLeaseLiability",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R7":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  "-6",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ProfitLoss",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "1006007 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED)",
                "role":  "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED",
                "shortName":  "CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED)",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  "-6",
                    "lang":  null,
                    "name":  "us-gaap:DeferredIncomeTaxExpenseBenefit",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R70":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i1f1b97c60a2e470196477e925efb794c_I20191130",
                    "decimals":  "-6",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:OtherAssetsCurrent",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2461430 - Disclosure - New accounting pronouncements - Effect of Lease 842 Adoption (Details)",
                "role":  "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsEffectofLease842AdoptionDetails",
                "shortName":  "New accounting pronouncements - Effect of Lease 842 Adoption (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "ix:continuation",
                        "div",
                        "ix:continuation",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "ia3b775ef506b4bdd80e20c03d9f34ee6_I20190901",
                    "decimals":  "-6",
                    "lang":  null,
                    "name":  "us-gaap:OtherAssetsCurrent",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R71":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i1f1b97c60a2e470196477e925efb794c_I20191130",
                    "decimals":  "-8",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:AccountsReceivableRelatedParties",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2464431 - Disclosure - Supplemental information - Narrative (Details)",
                "role":  "http://walgreensbootsalliance.com/role/SupplementalinformationNarrativeDetails",
                "shortName":  "Supplemental information - Narrative (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i1f1b97c60a2e470196477e925efb794c_I20191130",
                    "decimals":  "-8",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:AccountsReceivableRelatedParties",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R72":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "wba:ScheduleofDepreciationandAmortizationExpenseTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  "-6",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:Depreciation",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2465432 - Disclosure - Supplemental information - Depreciation and Amortization Expense (Details)",
                "role":  "http://walgreensbootsalliance.com/role/SupplementalinformationDepreciationandAmortizationExpenseDetails",
                "shortName":  "Supplemental information - Depreciation and Amortization Expense (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "wba:ScheduleofDepreciationandAmortizationExpenseTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  "-6",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:Depreciation",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R73":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i1f1b97c60a2e470196477e925efb794c_I20191130",
                    "decimals":  "-6",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:CashAndCashEquivalentsAtCarryingValue",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2466433 - Disclosure - Supplemental information - Summary of Cash, Cash Equivalents and Restricted Cash (Details)",
                "role":  "http://walgreensbootsalliance.com/role/SupplementalinformationSummaryofCashCashEquivalentsandRestrictedCashDetails",
                "shortName":  "Supplemental information - Summary of Cash, Cash Equivalents and Restricted Cash (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  null
                },
            "R74":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfDividendsPayableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  "4",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:CommonStockDividendsPerShareDeclared",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usdPerShare",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2467434 - Disclosure - Supplemental information - Summary of Dividends per Share (Details)",
                "role":  "http://walgreensbootsalliance.com/role/SupplementalinformationSummaryofDividendsperShareDetails",
                "shortName":  "Supplemental information - Summary of Dividends per Share (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfDividendsPayableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  "4",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:CommonStockDividendsPerShareDeclared",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usdPerShare",
                    "xsiNil":  "false"
                    }
                },
            "R8":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SignificantAccountingPoliciesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2101101 - Disclosure - Accounting policies",
                "role":  "http://walgreensbootsalliance.com/role/Accountingpolicies",
                "shortName":  "Accounting policies",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SignificantAccountingPoliciesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R9":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:BusinessCombinationDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "2103102 - Disclosure - Acquisitions",
                "role":  "http://walgreensbootsalliance.com/role/Acquisitions",
                "shortName":  "Acquisitions",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "wba-20191130.htm",
                    "contextRef":  "i586e414b08f24747895bbf59b1ffd985_D20190901-20191130",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:BusinessCombinationDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                }
            },
        "segmentCount":  101,
        "tag":  {
            "country_GB":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "UNITED KINGDOM",
                            "terseLabel":  "UNITED KINGDOM"
                            }
                        }
                    },
                "localname":  "GB",
                "nsuri":  "http://xbrl.sec.gov/country/2017-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "country_US":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "UNITED STATES",
                            "terseLabel":  "UNITED STATES"
                            }
                        }
                    },
                "localname":  "US",
                "nsuri":  "http://xbrl.sec.gov/country/2017-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesNarrativeDetails",
                    "http://walgreensbootsalliance.com/role/RetirementbenefitsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "dei_AmendmentFlag":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
                            "label":  "Amendment Flag",
                            "terseLabel":  "Amendment Flag"
                            }
                        }
                    },
                "localname":  "AmendmentFlag",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CoverPage"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_CityAreaCode":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Area code of city",
                            "label":  "City Area Code",
                            "terseLabel":  "City Area Code"
                            }
                        }
                    },
                "localname":  "CityAreaCode",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CoverPage"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_CoverAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Cover page.",
                            "label":  "Cover page."
                            }
                        }
                    },
                "localname":  "CoverAbstract",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "xbrltype":  "stringItemType"
                },
            "dei_CurrentFiscalYearEndDate":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "End date of current fiscal year in the format --MM-DD.",
                            "label":  "Current Fiscal Year End Date",
                            "terseLabel":  "Current Fiscal Year End Date"
                            }
                        }
                    },
                "localname":  "CurrentFiscalYearEndDate",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CoverPage"
                    ],
                "xbrltype":  "gMonthDayItemType"
                },
            "dei_DocumentFiscalPeriodFocus":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Fiscal period values are FY, Q1, Q2, and Q3.   1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
                            "label":  "Document Fiscal Period Focus",
                            "terseLabel":  "Document Fiscal Period Focus"
                            }
                        }
                    },
                "localname":  "DocumentFiscalPeriodFocus",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CoverPage"
                    ],
                "xbrltype":  "fiscalPeriodItemType"
                },
            "dei_DocumentFiscalYearFocus":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "This is focus fiscal year of the document report in CCYY format.  For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus.  Example: 2006.",
                            "label":  "Document Fiscal Year Focus",
                            "terseLabel":  "Document Fiscal Year Focus"
                            }
                        }
                    },
                "localname":  "DocumentFiscalYearFocus",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CoverPage"
                    ],
                "xbrltype":  "gYearItemType"
                },
            "dei_DocumentInformationLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Document Information [Line Items]",
                            "terseLabel":  "Document Information [Line Items]"
                            }
                        }
                    },
                "localname":  "DocumentInformationLineItems",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CoverPage"
                    ],
                "xbrltype":  "stringItemType"
                },
            "dei_DocumentInformationTable":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
                            "label":  "Document Information [Table]",
                            "terseLabel":  "Document Information [Table]"
                            }
                        }
                    },
                "localname":  "DocumentInformationTable",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CoverPage"
                    ],
                "xbrltype":  "stringItemType"
                },
            "dei_DocumentPeriodEndDate":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The end date of the period reflected on the cover page if a periodic report.  For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date.  The format of the date is CCYY-MM-DD.",
                            "label":  "Document Period End Date",
                            "terseLabel":  "Document Period End Date"
                            }
                        }
                    },
                "localname":  "DocumentPeriodEndDate",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CoverPage"
                    ],
                "xbrltype":  "dateItemType"
                },
            "dei_DocumentQuarterlyReport":  {
                "auth_ref":  [
                    "r414"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true only for a form used as an quarterly report.",
                            "label":  "Document Quarterly Report",
                            "terseLabel":  "Document Quarterly Report"
                            }
                        }
                    },
                "localname":  "DocumentQuarterlyReport",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CoverPage"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_DocumentTransitionReport":  {
                "auth_ref":  [
                    "r415"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true only for a form used as a transition report.",
                            "label":  "Document Transition Report",
                            "terseLabel":  "Document Transition Report"
                            }
                        }
                    },
                "localname":  "DocumentTransitionReport",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CoverPage"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_DocumentType":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc).  The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
                            "label":  "Document Type",
                            "terseLabel":  "Document Type"
                            }
                        }
                    },
                "localname":  "DocumentType",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CoverPage"
                    ],
                "xbrltype":  "submissionTypeItemType"
                },
            "dei_EntityAddressAddressLine1":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Address Line 1 such as Attn, Building Name, Street Name",
                            "label":  "Entity Address, Address Line One",
                            "terseLabel":  "Entity Address, Address Line One"
                            }
                        }
                    },
                "localname":  "EntityAddressAddressLine1",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CoverPage"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityAddressCityOrTown":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Name of the City or Town",
                            "label":  "Entity Address, City or Town",
                            "terseLabel":  "Entity Address, City or Town"
                            }
                        }
                    },
                "localname":  "EntityAddressCityOrTown",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CoverPage"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityAddressPostalZipCode":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Code for the postal or zip code",
                            "label":  "Entity Address, Postal Zip Code",
                            "terseLabel":  "Entity Address, Postal Zip Code"
                            }
                        }
                    },
                "localname":  "EntityAddressPostalZipCode",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CoverPage"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityAddressStateOrProvince":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Name of the state or province.",
                            "label":  "Entity Address, State or Province",
                            "terseLabel":  "Entity Address, State or Province"
                            }
                        }
                    },
                "localname":  "EntityAddressStateOrProvince",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CoverPage"
                    ],
                "xbrltype":  "stateOrProvinceItemType"
                },
            "dei_EntityCentralIndexKey":  {
                "auth_ref":  [
                    "r416"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC.  It is commonly abbreviated as CIK.",
                            "label":  "Entity Central Index Key",
                            "terseLabel":  "Entity Central Index Key"
                            }
                        }
                    },
                "localname":  "EntityCentralIndexKey",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CoverPage"
                    ],
                "xbrltype":  "centralIndexKeyItemType"
                },
            "dei_EntityCommonStockSharesOutstanding":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report.  Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
                            "label":  "Entity Common Stock, Shares Outstanding",
                            "terseLabel":  "Entity Common Stock, Shares Outstanding (in shares)"
                            }
                        }
                    },
                "localname":  "EntityCommonStockSharesOutstanding",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CoverPage"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "dei_EntityCurrentReportingStatus":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days.  This information should be based on the registrant's current or most recent filing containing the related disclosure.",
                            "label":  "Entity Current Reporting Status",
                            "terseLabel":  "Entity Current Reporting Status"
                            }
                        }
                    },
                "localname":  "EntityCurrentReportingStatus",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CoverPage"
                    ],
                "xbrltype":  "yesNoItemType"
                },
            "dei_EntityEmergingGrowthCompany":  {
                "auth_ref":  [
                    "r416"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Indicate if registrant meets the emerging growth company criteria.",
                            "label":  "Entity Emerging Growth Company",
                            "terseLabel":  "Entity Emerging Growth Company"
                            }
                        }
                    },
                "localname":  "EntityEmergingGrowthCompany",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CoverPage"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_EntityFileNumber":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Commission file number.  The field allows up to 17 characters.  The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
                            "label":  "Entity File Number",
                            "terseLabel":  "Entity File Number"
                            }
                        }
                    },
                "localname":  "EntityFileNumber",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CoverPage"
                    ],
                "xbrltype":  "fileNumberItemType"
                },
            "dei_EntityFilerCategory":  {
                "auth_ref":  [
                    "r416"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Indicate whether the registrant is one of the following:  Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer.  Definitions of these categories are stated in Rule 12b-2 of the Exchange Act.  This information should be based on the registrant's current or most recent filing containing the related disclosure.",
                            "label":  "Entity Filer Category",
                            "terseLabel":  "Entity Filer Category"
                            }
                        }
                    },
                "localname":  "EntityFilerCategory",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CoverPage"
                    ],
                "xbrltype":  "filerCategoryItemType"
                },
            "dei_EntityIncorporationStateCountryCode":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Two-character EDGAR code representing the state or country of incorporation.",
                            "label":  "Entity Incorporation, State or Country Code",
                            "terseLabel":  "Entity Incorporation, State or Country Code"
                            }
                        }
                    },
                "localname":  "EntityIncorporationStateCountryCode",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CoverPage"
                    ],
                "xbrltype":  "edgarStateCountryItemType"
                },
            "dei_EntityInteractiveDataCurrent":  {
                "auth_ref":  [
                    "r417"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
                            "label":  "Entity Interactive Data Current",
                            "terseLabel":  "Entity Interactive Data Current"
                            }
                        }
                    },
                "localname":  "EntityInteractiveDataCurrent",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CoverPage"
                    ],
                "xbrltype":  "yesNoItemType"
                },
            "dei_EntityRegistrantName":  {
                "auth_ref":  [
                    "r416"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
                            "label":  "Entity Registrant Name",
                            "terseLabel":  "Entity Registrant Name"
                            }
                        }
                    },
                "localname":  "EntityRegistrantName",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CoverPage"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityShellCompany":  {
                "auth_ref":  [
                    "r416"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
                            "label":  "Entity Shell Company",
                            "terseLabel":  "Entity Shell Company"
                            }
                        }
                    },
                "localname":  "EntityShellCompany",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CoverPage"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_EntitySmallBusiness":  {
                "auth_ref":  [
                    "r416"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Indicates that the company is a Smaller Reporting Company (SRC).",
                            "label":  "Entity Small Business",
                            "terseLabel":  "Entity Small Business"
                            }
                        }
                    },
                "localname":  "EntitySmallBusiness",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CoverPage"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_EntityTaxIdentificationNumber":  {
                "auth_ref":  [
                    "r416"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
                            "label":  "Entity Tax Identification Number",
                            "terseLabel":  "Entity Tax Identification Number"
                            }
                        }
                    },
                "localname":  "EntityTaxIdentificationNumber",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CoverPage"
                    ],
                "xbrltype":  "employerIdItemType"
                },
            "dei_LocalPhoneNumber":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Local phone number for entity.",
                            "label":  "Local Phone Number",
                            "terseLabel":  "Local Phone Number"
                            }
                        }
                    },
                "localname":  "LocalPhoneNumber",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CoverPage"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_Security12bTitle":  {
                "auth_ref":  [
                    "r412"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Title of a 12(b) registered security.",
                            "label":  "Title of 12(b) Security",
                            "terseLabel":  "Title of 12(b) Security"
                            }
                        }
                    },
                "localname":  "Security12bTitle",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CoverPage"
                    ],
                "xbrltype":  "securityTitleItemType"
                },
            "dei_SecurityExchangeName":  {
                "auth_ref":  [
                    "r413"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Name of the Exchange on which a security is registered.",
                            "label":  "Security Exchange Name",
                            "terseLabel":  "Security Exchange Name"
                            }
                        }
                    },
                "localname":  "SecurityExchangeName",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CoverPage"
                    ],
                "xbrltype":  "edgarExchangeCodeItemType"
                },
            "dei_TradingSymbol":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Trading symbol of an instrument as listed on an exchange.",
                            "label":  "Trading Symbol",
                            "terseLabel":  "Trading Symbol"
                            }
                        }
                    },
                "localname":  "TradingSymbol",
                "nsuri":  "http://xbrl.sec.gov/dei/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CoverPage"
                    ],
                "xbrltype":  "tradingSymbolItemType"
                },
            "srt_ConsolidationItemsAxis":  {
                "auth_ref":  [
                    "r146",
                    "r157"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Consolidation Items [Axis]",
                            "terseLabel":  "Consolidation Items [Axis]"
                            }
                        }
                    },
                "localname":  "ConsolidationItemsAxis",
                "nsuri":  "http://fasb.org/srt/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringCostsDetails",
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofGoodwillDetails",
                    "http://walgreensbootsalliance.com/role/SalesDetails",
                    "http://walgreensbootsalliance.com/role/SegmentreportingDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_ConsolidationItemsDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Consolidation Items [Domain]",
                            "terseLabel":  "Consolidation Items [Domain]"
                            }
                        }
                    },
                "localname":  "ConsolidationItemsDomain",
                "nsuri":  "http://fasb.org/srt/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringCostsDetails",
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofGoodwillDetails",
                    "http://walgreensbootsalliance.com/role/SalesDetails",
                    "http://walgreensbootsalliance.com/role/SegmentreportingDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_EquityMethodInvesteeNameDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Investment, Name [Domain]",
                            "terseLabel":  "Investment, Name [Domain]"
                            }
                        }
                    },
                "localname":  "EquityMethodInvesteeNameDomain",
                "nsuri":  "http://fasb.org/srt/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/EquitymethodinvestmentsNarrativeDetails",
                    "http://walgreensbootsalliance.com/role/EquitymethodinvestmentsScheduleofEquityMethodInvestmentsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_MaximumMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Maximum [Member]",
                            "terseLabel":  "Maximum"
                            }
                        }
                    },
                "localname":  "MaximumMember",
                "nsuri":  "http://fasb.org/srt/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtAdditionalInformationDetails",
                    "http://walgreensbootsalliance.com/role/EquitymethodinvestmentsScheduleofEquityMethodInvestmentsDetails",
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesNarrativeDetails",
                    "http://walgreensbootsalliance.com/role/LeasesNarrativeDetails",
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_MinimumMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Minimum [Member]",
                            "terseLabel":  "Minimum"
                            }
                        }
                    },
                "localname":  "MinimumMember",
                "nsuri":  "http://fasb.org/srt/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/EquitymethodinvestmentsScheduleofEquityMethodInvestmentsDetails",
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesNarrativeDetails",
                    "http://walgreensbootsalliance.com/role/LeasesNarrativeDetails",
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_ProductOrServiceAxis":  {
                "auth_ref":  [
                    "r159",
                    "r232",
                    "r234",
                    "r405",
                    "r406"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Product and Service [Axis]",
                            "terseLabel":  "Product and Service [Axis]"
                            }
                        }
                    },
                "localname":  "ProductOrServiceAxis",
                "nsuri":  "http://fasb.org/srt/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/SalesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_ProductsAndServicesDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Product and Service [Domain]",
                            "terseLabel":  "Product and Service [Domain]"
                            }
                        }
                    },
                "localname":  "ProductsAndServicesDomain",
                "nsuri":  "http://fasb.org/srt/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/SalesDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_RangeAxis":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Statistical Measurement [Axis]",
                            "terseLabel":  "Range [Axis]"
                            }
                        }
                    },
                "localname":  "RangeAxis",
                "nsuri":  "http://fasb.org/srt/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtAdditionalInformationDetails",
                    "http://walgreensbootsalliance.com/role/EquitymethodinvestmentsScheduleofEquityMethodInvestmentsDetails",
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesNarrativeDetails",
                    "http://walgreensbootsalliance.com/role/LeasesNarrativeDetails",
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_RangeMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Statistical Measurement [Domain]",
                            "terseLabel":  "Range [Domain]"
                            }
                        }
                    },
                "localname":  "RangeMember",
                "nsuri":  "http://fasb.org/srt/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtAdditionalInformationDetails",
                    "http://walgreensbootsalliance.com/role/EquitymethodinvestmentsScheduleofEquityMethodInvestmentsDetails",
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesNarrativeDetails",
                    "http://walgreensbootsalliance.com/role/LeasesNarrativeDetails",
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_RestatementAdjustmentMember":  {
                "auth_ref":  [
                    "r128",
                    "r130",
                    "r131",
                    "r132"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Restatement Adjustment [Member]",
                            "terseLabel":  "Adjustments"
                            }
                        }
                    },
                "localname":  "RestatementAdjustmentMember",
                "nsuri":  "http://fasb.org/srt/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsEffectofLease842AdoptionDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_RestatementAxis":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Restatement [Axis]",
                            "terseLabel":  "Restatement [Axis]"
                            }
                        }
                    },
                "localname":  "RestatementAxis",
                "nsuri":  "http://fasb.org/srt/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsEffectofLease842AdoptionDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_RestatementDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Restatement [Domain]",
                            "terseLabel":  "Restatement [Domain]"
                            }
                        }
                    },
                "localname":  "RestatementDomain",
                "nsuri":  "http://fasb.org/srt/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsEffectofLease842AdoptionDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_ScenarioPreviouslyReportedMember":  {
                "auth_ref":  [
                    "r130",
                    "r131",
                    "r132"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Previously Reported [Member]",
                            "terseLabel":  "Previously Reported"
                            }
                        }
                    },
                "localname":  "ScenarioPreviouslyReportedMember",
                "nsuri":  "http://fasb.org/srt/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsEffectofLease842AdoptionDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis":  {
                "auth_ref":  [
                    "r167"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Investment, Name [Axis]",
                            "terseLabel":  "Investment, Name [Axis]",
                            "verboseLabel":  "Investment, Name [Axis]"
                            }
                        }
                    },
                "localname":  "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
                "nsuri":  "http://fasb.org/srt/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/EquitymethodinvestmentsNarrativeDetails",
                    "http://walgreensbootsalliance.com/role/EquitymethodinvestmentsScheduleofEquityMethodInvestmentsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_SegmentGeographicalDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Geographical [Domain]",
                            "terseLabel":  "Geographical [Domain]"
                            }
                        }
                    },
                "localname":  "SegmentGeographicalDomain",
                "nsuri":  "http://fasb.org/srt/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_StatementGeographicalAxis":  {
                "auth_ref":  [
                    "r160",
                    "r232",
                    "r235",
                    "r407",
                    "r409",
                    "r411"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Geographical [Axis]",
                            "terseLabel":  "Geographical [Axis]"
                            }
                        }
                    },
                "localname":  "StatementGeographicalAxis",
                "nsuri":  "http://fasb.org/srt/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AOCIAttributableToParentNetOfTaxRollForward":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
                            "label":  "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
                            "terseLabel":  "AOCI Attributable to Parent, Net of Tax [Roll Forward]"
                            }
                        }
                    },
                "localname":  "AOCIAttributableToParentNetOfTaxRollForward",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/AccumulatedothercomprehensiveincomelossDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AccountingPoliciesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Accounting Policies [Abstract]",
                            "terseLabel":  "Accounting Policies [Abstract]"
                            }
                        }
                    },
                "localname":  "AccountingPoliciesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AccountingStandardsUpdate201602Member":  {
                "auth_ref":  [
                    "r335"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Accounting Standards Update 2016-02 Leases (Topic 842).",
                            "label":  "Accounting Standards Update 2016-02 [Member]",
                            "terseLabel":  "Accounting Standards Update 2016-02"
                            }
                        }
                    },
                "localname":  "AccountingStandardsUpdate201602Member",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsEffectofLease842AdoptionDetails",
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_AccountsNotesAndLoansReceivableLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Accounts, Notes, Loans and Financing Receivable [Line Items]",
                            "terseLabel":  "Accounts, Notes, Loans and Financing Receivable [Line Items]"
                            }
                        }
                    },
                "localname":  "AccountsNotesAndLoansReceivableLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/SupplementalinformationNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis":  {
                "auth_ref":  [
                    "r49"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by type of receivable.",
                            "label":  "Receivable Type [Axis]",
                            "terseLabel":  "Receivable Type [Axis]"
                            }
                        }
                    },
                "localname":  "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/SupplementalinformationNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AccountsPayableCurrent":  {
                "auth_ref":  [
                    "r37"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Accounts Payable, Current",
                            "terseLabel":  "Trade accounts payable (see note 16)"
                            }
                        }
                    },
                "localname":  "AccountsPayableCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent":  {
                "auth_ref":  [
                    "r123",
                    "r358",
                    "r376",
                    "r399"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount for accounts payable to related parties.",
                            "label":  "Accounts Payable, Related Parties",
                            "terseLabel":  "Trade accounts payable, net"
                            }
                        }
                    },
                "localname":  "AccountsPayableRelatedPartiesCurrentAndNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/RelatedpartiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccountsReceivableNet":  {
                "auth_ref":  [
                    "r27",
                    "r387"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.",
                            "label":  "Accounts Receivable, after Allowance for Credit Loss",
                            "terseLabel":  "Trade receivables"
                            }
                        }
                    },
                "localname":  "AccountsReceivableNet",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/SupplementalinformationNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccountsReceivableNetCurrent":  {
                "auth_ref":  [
                    "r3",
                    "r27",
                    "r162",
                    "r163",
                    "r233"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
                            "label":  "Accounts Receivable, after Allowance for Credit Loss, Current",
                            "terseLabel":  "Accounts receivable, net"
                            }
                        }
                    },
                "localname":  "AccountsReceivableNetCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccountsReceivableRelatedParties":  {
                "auth_ref":  [
                    "r26",
                    "r119",
                    "r358",
                    "r359",
                    "r360",
                    "r396"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "For an unclassified balance sheet, amount of receivables arising from transactions with related parties.",
                            "label":  "Accounts Receivable, Related Parties",
                            "terseLabel":  "Accounts receivable from related party"
                            }
                        }
                    },
                "localname":  "AccountsReceivableRelatedParties",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/SupplementalinformationNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccruedIncomeTaxesCurrent":  {
                "auth_ref":  [
                    "r20",
                    "r372",
                    "r389"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
                            "label":  "Accrued Income Taxes, Current",
                            "terseLabel":  "Income taxes"
                            }
                        }
                    },
                "localname":  "AccruedIncomeTaxesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccruedLiabilitiesCurrent":  {
                "auth_ref":  [
                    "r40"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.  Examples include taxes, interest, rent and utilities.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Accrued Liabilities, Current",
                            "terseLabel":  "Accrued expenses and other liabilities"
                            }
                        }
                    },
                "localname":  "AccruedLiabilitiesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS",
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsEffectofLease842AdoptionDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember":  {
                "auth_ref":  [
                    "r65",
                    "r71",
                    "r73",
                    "r246",
                    "r288"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
                            "label":  "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
                            "terseLabel":  "Pension/ post-retirement obligations"
                            }
                        }
                    },
                "localname":  "AccumulatedDefinedBenefitPlansAdjustmentMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/AccumulatedothercomprehensiveincomelossDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment":  {
                "auth_ref":  [
                    "r35",
                    "r197"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
                            "label":  "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
                            "terseLabel":  "Accumulated depreciation and amortization on property, plant, and equipment"
                            }
                        }
                    },
                "localname":  "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/SupplementalinformationNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember":  {
                "auth_ref":  [
                    "r71",
                    "r80",
                    "r287"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
                            "label":  "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
                            "terseLabel":  "Unrealized gain (loss) on cash flow hedges"
                            }
                        }
                    },
                "localname":  "AccumulatedGainLossNetCashFlowHedgeParentMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/AccumulatedothercomprehensiveincomelossDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Accumulated Other Comprehensive Income (Loss) [Line Items]",
                            "terseLabel":  "Accumulated Other Comprehensive Income (Loss) [Line Items]"
                            }
                        }
                    },
                "localname":  "AccumulatedOtherComprehensiveIncomeLossLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/AccumulatedothercomprehensiveincomelossDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax":  {
                "auth_ref":  [
                    "r68",
                    "r70",
                    "r71"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end.  Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.  Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
                            "label":  "Accumulated Other Comprehensive Income (Loss), Net of Tax",
                            "verboseLabel":  "Accumulated other comprehensive loss"
                            }
                        }
                    },
                "localname":  "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]",
                            "terseLabel":  "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]"
                            }
                        }
                    },
                "localname":  "AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Disclosure of information about components of accumulated other comprehensive income (loss).",
                            "label":  "Accumulated Other Comprehensive Income (Loss) [Table]",
                            "terseLabel":  "Accumulated Other Comprehensive Income (Loss) [Table]"
                            }
                        }
                    },
                "localname":  "AccumulatedOtherComprehensiveIncomeLossTable",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/AccumulatedothercomprehensiveincomelossDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AccumulatedOtherComprehensiveIncomeMember":  {
                "auth_ref":  [
                    "r67",
                    "r71",
                    "r73",
                    "r288"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent.  Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
                            "label":  "AOCI Attributable to Parent [Member]",
                            "terseLabel":  "Accumulated other comprehensive income (loss)"
                            }
                        }
                    },
                "localname":  "AccumulatedOtherComprehensiveIncomeMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/AccumulatedothercomprehensiveincomelossDetails",
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEQUITY"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_AccumulatedTranslationAdjustmentMember":  {
                "auth_ref":  [
                    "r63",
                    "r71",
                    "r73",
                    "r288"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
                            "label":  "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
                            "terseLabel":  "Cumulative translation adjustments"
                            }
                        }
                    },
                "localname":  "AccumulatedTranslationAdjustmentMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/AccumulatedothercomprehensiveincomelossDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_AdditionalPaidInCapital":  {
                "auth_ref":  [
                    "r28"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.  Includes adjustments to additional paid in capital.  Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees.  Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock.  For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock.  For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
                            "label":  "Additional Paid in Capital",
                            "terseLabel":  "Paid-in capital"
                            }
                        }
                    },
                "localname":  "AdditionalPaidInCapital",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AdditionalPaidInCapitalMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
                            "label":  "Additional Paid-in Capital [Member]",
                            "terseLabel":  "Paid-in capital"
                            }
                        }
                    },
                "localname":  "AdditionalPaidInCapitalMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEQUITY"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis":  {
                "auth_ref":  [
                    "r127"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by type of change in accounting principle.  Does not include error corrections.",
                            "label":  "Adjustments for Change in Accounting Principle [Axis]",
                            "terseLabel":  "Adjustments for Change in Accounting Principle [Axis]"
                            }
                        }
                    },
                "localname":  "AdjustmentsForChangeInAccountingPrincipleAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsEffectofLease842AdoptionDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis":  {
                "auth_ref":  [
                    "r127"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by new accounting pronouncement.",
                            "label":  "Adjustments for New Accounting Pronouncements [Axis]",
                            "terseLabel":  "Adjustments for New Accounting Pronouncements [Axis]"
                            }
                        }
                    },
                "localname":  "AdjustmentsForNewAccountingPronouncementsAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
                            "terseLabel":  "Adjustments to reconcile net earnings to net cash provided by operating activities:"
                            }
                        }
                    },
                "localname":  "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue":  {
                "auth_ref":  [
                    "r258",
                    "r259",
                    "r262",
                    "r263"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
                            "label":  "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
                            "terseLabel":  "Stock-based compensation"
                            }
                        }
                    },
                "localname":  "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEQUITY"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AmortizationOfAcquisitionCosts":  {
                "auth_ref":  [
                    "r112",
                    "r183"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/SegmentreportingDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_OperatingIncomeLoss",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The amount of expense recognized in the current period that reflects the allocation of capitalized costs associated with acquisition of business.  As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
                            "label":  "Amortization of Acquisition Costs",
                            "negatedLabel":  "Acquisition-related amortization and impairment"
                            }
                        }
                    },
                "localname":  "AmortizationOfAcquisitionCosts",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/SegmentreportingDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AmortizationOfIntangibleAssets":  {
                "auth_ref":  [
                    "r112",
                    "r183",
                    "r190"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/SupplementalinformationDepreciationandAmortizationExpenseDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_DepreciationDepletionAndAmortization",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets.  As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
                            "label":  "Amortization of Intangible Assets",
                            "terseLabel":  "Amortization of intangible assets",
                            "verboseLabel":  "Intangible asset and other amortization"
                            }
                        }
                    },
                "localname":  "AmortizationOfIntangibleAssets",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsNarrativeDetails",
                    "http://walgreensbootsalliance.com/role/SupplementalinformationDepreciationandAmortizationExpenseDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount":  {
                "auth_ref":  [
                    "r140"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
                            "label":  "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
                            "terseLabel":  "Antidilutive securities excluded from EPS calculations (in shares)"
                            }
                        }
                    },
                "localname":  "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/SupplementalinformationNarrativeDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_Assets":  {
                "auth_ref":  [
                    "r151",
                    "r370",
                    "r388"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized.  Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
                            "label":  "Assets",
                            "terseLabel":  "Total assets",
                            "totalLabel":  "Total assets"
                            }
                        }
                    },
                "localname":  "Assets",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS",
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsEffectofLease842AdoptionDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AssetsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Assets [Abstract]",
                            "terseLabel":  "Assets"
                            }
                        }
                    },
                "localname":  "AssetsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AssetsCurrent":  {
                "auth_ref":  [
                    "r4",
                    "r5",
                    "r56"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer).  Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
                            "label":  "Assets, Current",
                            "terseLabel":  "Total current assets",
                            "totalLabel":  "Total current assets"
                            }
                        }
                    },
                "localname":  "AssetsCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS",
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsEffectofLease842AdoptionDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AssetsCurrentAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Assets, Current [Abstract]",
                            "terseLabel":  "Current assets:"
                            }
                        }
                    },
                "localname":  "AssetsCurrentAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AssetsFairValueDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Assets, Fair Value Disclosure [Abstract]",
                            "verboseLabel":  "Assets [Abstract]"
                            }
                        }
                    },
                "localname":  "AssetsFairValueDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/FairvaluemeasurementsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AssetsNoncurrent":  {
                "auth_ref":  [
                    "r10",
                    "r11",
                    "r12",
                    "r13",
                    "r14",
                    "r15",
                    "r16",
                    "r17"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.",
                            "label":  "Assets, Noncurrent",
                            "totalLabel":  "Total non-current assets"
                            }
                        }
                    },
                "localname":  "AssetsNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AssetsNoncurrentAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Assets, Noncurrent [Abstract]",
                            "terseLabel":  "Non-current assets:"
                            }
                        }
                    },
                "localname":  "AssetsNoncurrentAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_BalanceSheetLocationAxis":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by location on balance sheet (statement of financial position).",
                            "label":  "Balance Sheet Location [Axis]",
                            "terseLabel":  "Balance Sheet Location [Axis]"
                            }
                        }
                    },
                "localname":  "BalanceSheetLocationAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/FinancialinstrumentsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_BalanceSheetLocationDomain":  {
                "auth_ref":  [
                    "r300",
                    "r305"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Location in the balance sheet (statement of financial position).",
                            "label":  "Balance Sheet Location [Domain]",
                            "terseLabel":  "Balance Sheet Location [Domain]"
                            }
                        }
                    },
                "localname":  "BalanceSheetLocationDomain",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/FinancialinstrumentsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_BasisOfAccountingPolicyPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
                            "label":  "Basis of Accounting, Policy [Policy Text Block]",
                            "terseLabel":  "Basis of Presentation"
                            }
                        }
                    },
                "localname":  "BasisOfAccountingPolicyPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/AccountingpoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_BusinessAcquisitionAcquireeDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
                            "label":  "Business Acquisition, Acquiree [Domain]",
                            "terseLabel":  "Business Acquisition, Acquiree [Domain]"
                            }
                        }
                    },
                "localname":  "BusinessAcquisitionAcquireeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/AcquisitionsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_BusinessAcquisitionAxis":  {
                "auth_ref":  [
                    "r274",
                    "r275"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by business combination or series of individually immaterial business combinations.",
                            "label":  "Business Acquisition [Axis]",
                            "terseLabel":  "Business Acquisition [Axis]"
                            }
                        }
                    },
                "localname":  "BusinessAcquisitionAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/AcquisitionsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_BusinessAcquisitionLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Business Acquisition [Line Items]",
                            "terseLabel":  "Business Acquisition [Line Items]"
                            }
                        }
                    },
                "localname":  "BusinessAcquisitionLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/AcquisitionsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_BusinessCombinationAcquisitionRelatedCosts":  {
                "auth_ref":  [
                    "r273"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/SegmentreportingDetails":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_OperatingIncomeLoss",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period.  Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
                            "label":  "Business Combination, Acquisition Related Costs",
                            "negatedLabel":  "Acquisition-related costs"
                            }
                        }
                    },
                "localname":  "BusinessCombinationAcquisitionRelatedCosts",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/SegmentreportingDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_BusinessCombinationDisclosureTextBlock":  {
                "auth_ref":  [
                    "r278"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.  The disclosure may include leverage buyout transactions (as applicable).",
                            "label":  "Business Combination Disclosure [Text Block]",
                            "terseLabel":  "Acquisitions"
                            }
                        }
                    },
                "localname":  "BusinessCombinationDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/Acquisitions"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_BusinessCombinationsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Business Combinations [Abstract]",
                            "terseLabel":  "Business Combinations [Abstract]"
                            }
                        }
                    },
                "localname":  "BusinessCombinationsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_CashAndCashEquivalentsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Cash and Cash Equivalents [Abstract]"
                            }
                        }
                    },
                "localname":  "CashAndCashEquivalentsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_CashAndCashEquivalentsAtCarryingValue":  {
                "auth_ref":  [
                    "r1",
                    "r33",
                    "r114"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        },
                    "http://walgreensbootsalliance.com/role/SupplementalinformationSummaryofCashCashEquivalentsandRestrictedCashDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of currency on hand as well as demand deposits with banks or financial institutions.  Includes other kinds of accounts that have the general characteristics of demand deposits.  Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.  Excludes cash and cash equivalents within disposal group and discontinued operation.",
                            "label":  "Cash and Cash Equivalents, at Carrying Value",
                            "terseLabel":  "Cash and cash equivalents"
                            }
                        }
                    },
                "localname":  "CashAndCashEquivalentsAtCarryingValue",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS",
                    "http://walgreensbootsalliance.com/role/SupplementalinformationSummaryofCashCashEquivalentsandRestrictedCashDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CashAndCashEquivalentsFairValueDisclosure":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions.  Includes other kinds of accounts that have the general characteristics of demand deposits.  Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
                            "label":  "Cash and Cash Equivalents, Fair Value Disclosure",
                            "terseLabel":  "Money market funds"
                            }
                        }
                    },
                "localname":  "CashAndCashEquivalentsFairValueDisclosure",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/FairvaluemeasurementsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents":  {
                "auth_ref":  [
                    "r106",
                    "r114",
                    "r117"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/SupplementalinformationSummaryofCashCashEquivalentsandRestrictedCashDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage.  Excludes amount for disposal group and discontinued operations.  Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.  Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
                            "label":  "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
                            "periodEndLabel":  "Cash, cash equivalents and restricted cash at end of period",
                            "periodStartLabel":  "Cash, cash equivalents and restricted cash at beginning of period",
                            "totalLabel":  "Cash, cash equivalents and restricted cash"
                            }
                        }
                    },
                "localname":  "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED",
                    "http://walgreensbootsalliance.com/role/SupplementalinformationSummaryofCashCashEquivalentsandRestrictedCashDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect":  {
                "auth_ref":  [
                    "r106",
                    "r324"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change.  Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.  Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
                            "label":  "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
                            "totalLabel":  "Net increase (decrease) in cash, cash equivalents, and restricted cash"
                            }
                        }
                    },
                "localname":  "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect [Abstract]",
                            "terseLabel":  "Changes in cash, cash equivalents and restricted cash:"
                            }
                        }
                    },
                "localname":  "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ChangeInAccountingPrincipleMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "A change from one generally accepted accounting principle to another generally accepted accounting principle when there are two or more generally accepted accounting principles that apply or when the accounting principle formerly used is no longer generally accepted.  A change in the method of applying an accounting principle that is not treated as a change in accounting estimate also is considered a change in accounting principle.",
                            "label":  "Adjustments for Change in Accounting Principle [Domain]",
                            "terseLabel":  "Adjustments for Change in Accounting Principle [Domain]"
                            }
                        }
                    },
                "localname":  "ChangeInAccountingPrincipleMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsEffectofLease842AdoptionDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1":  {
                "auth_ref":  [
                    "r314"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of gain (loss) from the increase (decrease) in fair value of derivative and nonderivative instruments designated as fair value hedging instruments recognized in the income statement.",
                            "label":  "Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments",
                            "terseLabel":  "Gains and (losses) due to changes in fair value of derivative instruments"
                            }
                        }
                    },
                "localname":  "ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/FinancialinstrumentsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ClassOfStockDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Share of stock differentiated by the voting rights the holder receives.  Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
                            "label":  "Class of Stock [Domain]",
                            "terseLabel":  "Class of Stock [Domain]"
                            }
                        }
                    },
                "localname":  "ClassOfStockDomain",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CoverPage"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_CommercialPaperMember":  {
                "auth_ref":  [
                    "r219"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
                            "label":  "Commercial Paper [Member]",
                            "terseLabel":  "Commercial Paper"
                            }
                        }
                    },
                "localname":  "CommercialPaperMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtAdditionalInformationDetails",
                    "http://walgreensbootsalliance.com/role/DebtShortandLongTermDebtDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_CommitmentsAndContingencies":  {
                "auth_ref":  [
                    "r45",
                    "r217",
                    "r377",
                    "r398"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_LiabilitiesAndStockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
                            "label":  "Commitments and Contingencies",
                            "terseLabel":  "Commitments and contingencies (see note 10)"
                            }
                        }
                    },
                "localname":  "CommitmentsAndContingencies",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CommitmentsAndContingenciesDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Commitments and Contingencies Disclosure [Abstract]",
                            "terseLabel":  "Commitments and Contingencies Disclosure [Abstract]"
                            }
                        }
                    },
                "localname":  "CommitmentsAndContingenciesDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock":  {
                "auth_ref":  [
                    "r216",
                    "r218"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The entire disclosure for commitments and contingencies.",
                            "label":  "Commitments and Contingencies Disclosure [Text Block]",
                            "terseLabel":  "Commitments and contingencies"
                            }
                        }
                    },
                "localname":  "CommitmentsAndContingenciesDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/Commitmentsandcontingencies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_CommonStockDividendsPerShareDeclared":  {
                "auth_ref":  [
                    "r228"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Aggregate dividends declared during the period for each share of common stock outstanding.",
                            "label":  "Common Stock, Dividends, Per Share, Declared",
                            "terseLabel":  "Cash dividends declared (in dollars per share)"
                            }
                        }
                    },
                "localname":  "CommonStockDividendsPerShareDeclared",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/SupplementalinformationSummaryofDividendsperShareDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_CommonStockMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Stock that is subordinate to all other stock of the issuer.",
                            "label":  "Common Stock [Member]",
                            "terseLabel":  "Common stock",
                            "verboseLabel":  "Common Stock, $0.01 par value"
                            }
                        }
                    },
                "localname":  "CommonStockMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEQUITY",
                    "http://walgreensbootsalliance.com/role/CoverPage"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_CommonStockParOrStatedValuePerShare":  {
                "auth_ref":  [
                    "r25"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Face amount or stated value per share of common stock.",
                            "label":  "Common Stock, Par or Stated Value Per Share",
                            "terseLabel":  "Common stock, par value (in dollars per share)"
                            }
                        }
                    },
                "localname":  "CommonStockParOrStatedValuePerShare",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_CommonStockSharesAuthorized":  {
                "auth_ref":  [
                    "r25"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
                            "label":  "Common Stock, Shares Authorized",
                            "terseLabel":  "Common stock, authorized shares (in shares)"
                            }
                        }
                    },
                "localname":  "CommonStockSharesAuthorized",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CommonStockSharesIssued":  {
                "auth_ref":  [
                    "r25"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury).  These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized.  Shares issued include shares outstanding and shares held in the treasury.",
                            "label":  "Common Stock, Shares, Issued",
                            "terseLabel":  "Common stock, issued (in shares)"
                            }
                        }
                    },
                "localname":  "CommonStockSharesIssued",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CommonStockSharesOutstanding":  {
                "auth_ref":  [
                    "r25",
                    "r223"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Number of shares of common stock outstanding.  Common stock represent the ownership interest in a corporation.",
                            "label":  "Common Stock, Shares, Outstanding",
                            "periodEndLabel":  "Ending Balance (in shares)",
                            "periodStartLabel":  "Beginning Balance (in shares)"
                            }
                        }
                    },
                "localname":  "CommonStockSharesOutstanding",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEQUITY"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CommonStockValue":  {
                "auth_ref":  [
                    "r25"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer).  This item includes treasury stock repurchased by the entity.  Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
                            "label":  "Common Stock, Value, Issued",
                            "terseLabel":  "Common stock $.01 par value; authorized 3.2 billion shares; issued 1,172,513,618 at November 30, 2019 and August 31, 2019"
                            }
                        }
                    },
                "localname":  "CommonStockValue",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CompensationAndRetirementDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Retirement Benefits [Abstract]",
                            "terseLabel":  "Retirement Benefits [Abstract]"
                            }
                        }
                    },
                "localname":  "CompensationAndRetirementDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ComprehensiveIncomeNetOfTax":  {
                "auth_ref":  [
                    "r76",
                    "r78",
                    "r79"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity.  Excludes changes in equity resulting from investments by owners and distributions to owners.",
                            "label":  "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
                            "totalLabel":  "Comprehensive income attributable to Walgreens Boots Alliance, Inc."
                            }
                        }
                    },
                "localname":  "ComprehensiveIncomeNetOfTax",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest":  {
                "auth_ref":  [
                    "r76",
                    "r78",
                    "r282",
                    "r283",
                    "r291"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_ComprehensiveIncomeNetOfTax",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests.  Excludes changes in equity resulting from investments by owners and distributions to owners.",
                            "label":  "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
                            "terseLabel":  "Comprehensive income (loss) attributable to noncontrolling interests"
                            }
                        }
                    },
                "localname":  "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest":  {
                "auth_ref":  [
                    "r76",
                    "r78",
                    "r281",
                    "r291"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_ComprehensiveIncomeNetOfTax",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income.  Excludes changes in equity resulting from investments by owners and distributions to owners.",
                            "label":  "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
                            "totalLabel":  "Total comprehensive income"
                            }
                        }
                    },
                "localname":  "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ComprehensiveIncomeNoteTextBlock":  {
                "auth_ref":  [
                    "r92"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
                            "label":  "Comprehensive Income (Loss) Note [Text Block]",
                            "terseLabel":  "Accumulated other comprehensive income (loss)"
                            }
                        }
                    },
                "localname":  "ComprehensiveIncomeNoteTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/Accumulatedothercomprehensiveincomeloss"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_CostOfGoodsAndServicesSold":  {
                "auth_ref":  [
                    "r88"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEARNINGS":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_GrossProfit",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period.  This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
                            "label":  "Cost of Goods and Services Sold",
                            "terseLabel":  "Cost of sales"
                            }
                        }
                    },
                "localname":  "CostOfGoodsAndServicesSold",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEARNINGS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CreditFacilityAxis":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by type of credit facility.  Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
                            "label":  "Credit Facility [Axis]",
                            "terseLabel":  "Credit Facility [Axis]"
                            }
                        }
                    },
                "localname":  "CreditFacilityAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtAdditionalInformationDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_CreditFacilityDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Type of credit facility.  Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
                            "label":  "Credit Facility [Domain]",
                            "terseLabel":  "Credit Facility [Domain]"
                            }
                        }
                    },
                "localname":  "CreditFacilityDomain",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_CrossCurrencyInterestRateContractMember":  {
                "auth_ref":  [
                    "r240",
                    "r308"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Derivative instrument whose primary underlying risk is tied to interest rates and foreign exchange rates.",
                            "label":  "Cross Currency Interest Rate Contract [Member]",
                            "terseLabel":  "Cross currency interest rate swaps"
                            }
                        }
                    },
                "localname":  "CrossCurrencyInterestRateContractMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/FairvaluemeasurementsDetails",
                    "http://walgreensbootsalliance.com/role/FinancialinstrumentsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount after tax of increase (decrease) to equity or (increase) decrease to net assets, resulting from the cumulative effect adjustment of a new accounting principle applied in the period of adoption.",
                            "label":  "Cumulative Effect of New Accounting Principle in Period of Adoption",
                            "terseLabel":  "Adoption of new accounting standards",
                            "verboseLabel":  "Cumulative effect of new accounting principle in period of adoption"
                            }
                        }
                    },
                "localname":  "CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEQUITY",
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesNarrativeDetails",
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DebtDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Debt Disclosure [Abstract]",
                            "terseLabel":  "Debt Disclosure [Abstract]"
                            }
                        }
                    },
                "localname":  "DebtDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DebtDisclosureTextBlock":  {
                "auth_ref":  [
                    "r222"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
                            "label":  "Debt Disclosure [Text Block]",
                            "terseLabel":  "Debt"
                            }
                        }
                    },
                "localname":  "DebtDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/Debt"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_DebtInstrumentAxis":  {
                "auth_ref":  [
                    "r19",
                    "r20",
                    "r21",
                    "r371",
                    "r373",
                    "r386"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
                            "label":  "Debt Instrument [Axis]",
                            "terseLabel":  "Debt Instrument [Axis]"
                            }
                        }
                    },
                "localname":  "DebtInstrumentAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtAdditionalInformationDetails",
                    "http://walgreensbootsalliance.com/role/DebtNoteIssuancesDetails",
                    "http://walgreensbootsalliance.com/role/DebtShortandLongTermDebtDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DebtInstrumentCarryingAmount":  {
                "auth_ref":  [
                    "r21",
                    "r221",
                    "r373",
                    "r386"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt.  Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
                            "label":  "Long-term Debt, Gross",
                            "terseLabel":  "Carrying value of the notes"
                            }
                        }
                    },
                "localname":  "DebtInstrumentCarryingAmount",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtNoteIssuancesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DebtInstrumentFaceAmount":  {
                "auth_ref":  [
                    "r328",
                    "r330"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Face (par) amount of debt instrument at time of issuance.",
                            "label":  "Debt Instrument, Face Amount",
                            "terseLabel":  "Face amount"
                            }
                        }
                    },
                "localname":  "DebtInstrumentFaceAmount",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtAdditionalInformationDetails",
                    "http://walgreensbootsalliance.com/role/DebtNoteIssuancesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DebtInstrumentFairValue":  {
                "auth_ref":  [
                    "r323"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
                            "label":  "Debt Instrument, Fair Value Disclosure",
                            "terseLabel":  "Fair value of the notes"
                            }
                        }
                    },
                "localname":  "DebtInstrumentFairValue",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtNoteIssuancesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DebtInstrumentInterestRateStatedPercentage":  {
                "auth_ref":  [
                    "r42"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Contractual interest rate for funds borrowed, under the debt agreement.",
                            "label":  "Debt Instrument, Interest Rate, Stated Percentage",
                            "terseLabel":  "Stated interest rate"
                            }
                        }
                    },
                "localname":  "DebtInstrumentInterestRateStatedPercentage",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtShortandLongTermDebtDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_DebtInstrumentLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Debt Instrument [Line Items]",
                            "terseLabel":  "Debt Instrument [Line Items]"
                            }
                        }
                    },
                "localname":  "DebtInstrumentLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtAdditionalInformationDetails",
                    "http://walgreensbootsalliance.com/role/DebtNoteIssuancesDetails",
                    "http://walgreensbootsalliance.com/role/DebtShortandLongTermDebtDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DebtInstrumentNameDomain":  {
                "auth_ref":  [
                    "r43"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
                            "label":  "Debt Instrument, Name [Domain]",
                            "terseLabel":  "Debt Instrument, Name [Domain]"
                            }
                        }
                    },
                "localname":  "DebtInstrumentNameDomain",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtAdditionalInformationDetails",
                    "http://walgreensbootsalliance.com/role/DebtNoteIssuancesDetails",
                    "http://walgreensbootsalliance.com/role/DebtShortandLongTermDebtDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_DebtInstrumentTable":  {
                "auth_ref":  [
                    "r43",
                    "r120",
                    "r224",
                    "r225",
                    "r226",
                    "r227",
                    "r327",
                    "r328",
                    "r330",
                    "r385"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation.  These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
                            "label":  "Schedule of Long-term Debt Instruments [Table]",
                            "terseLabel":  "Schedule of Long-term Debt Instruments [Table]"
                            }
                        }
                    },
                "localname":  "DebtInstrumentTable",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtAdditionalInformationDetails",
                    "http://walgreensbootsalliance.com/role/DebtNoteIssuancesDetails",
                    "http://walgreensbootsalliance.com/role/DebtShortandLongTermDebtDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DeferredIncomeTaxExpenseBenefit":  {
                "auth_ref":  [
                    "r112",
                    "r118",
                    "r268",
                    "r269"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
                            "label":  "Deferred Income Tax Expense (Benefit)",
                            "terseLabel":  "Deferred income taxes"
                            }
                        }
                    },
                "localname":  "DeferredIncomeTaxExpenseBenefit",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredIncomeTaxLiabilitiesNet":  {
                "auth_ref":  [
                    "r264",
                    "r267"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_LiabilitiesNoncurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
                            "label":  "Deferred Income Tax Liabilities, Net",
                            "terseLabel":  "Deferred income taxes"
                            }
                        }
                    },
                "localname":  "DeferredIncomeTaxLiabilitiesNet",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS",
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsEffectofLease842AdoptionDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DefinedBenefitPlanDisclosureLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Defined Benefit Plan Disclosure [Line Items]",
                            "terseLabel":  "Defined Benefit Plan Disclosure [Line Items]"
                            }
                        }
                    },
                "localname":  "DefinedBenefitPlanDisclosureLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/RetirementbenefitsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear":  {
                "auth_ref":  [
                    "r255"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of contributions expected to be received by defined benefit plan from employer in fiscal year.  Excludes contributions paid by employer in current fiscal year.",
                            "label":  "Defined Benefit Plan, Expected Future Employer Contributions, Remainder of Fiscal Year",
                            "terseLabel":  "Expected employer cash contributions to defined benefit plan in current fiscal year"
                            }
                        }
                    },
                "localname":  "DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/RetirementbenefitsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets":  {
                "auth_ref":  [
                    "r245",
                    "r254",
                    "r256"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/RetirementbenefitsDetails":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
                            "label":  "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
                            "negatedLabel":  "Expected returns on plan assets/other"
                            }
                        }
                    },
                "localname":  "DefinedBenefitPlanExpectedReturnOnPlanAssets",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/RetirementbenefitsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DefinedBenefitPlanInterestCost":  {
                "auth_ref":  [
                    "r239",
                    "r244",
                    "r253",
                    "r256"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/RetirementbenefitsDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of cost recognized for passage of time related to defined benefit plan.",
                            "label":  "Defined Benefit Plan, Interest Cost",
                            "terseLabel":  "Interest costs"
                            }
                        }
                    },
                "localname":  "DefinedBenefitPlanInterestCost",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/RetirementbenefitsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost":  {
                "auth_ref":  [
                    "r242",
                    "r251",
                    "r256"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/RetirementbenefitsDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of net periodic benefit cost (credit) for defined benefit plan.",
                            "label":  "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
                            "totalLabel":  "Total net periodic pension costs (income)"
                            }
                        }
                    },
                "localname":  "DefinedBenefitPlanNetPeriodicBenefitCost",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/RetirementbenefitsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]",
                            "terseLabel":  "Components of net periodic benefit costs [Abstract]"
                            }
                        }
                    },
                "localname":  "DefinedBenefitPlanNetPeriodicBenefitCostAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/RetirementbenefitsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DefinedBenefitPlanServiceCost":  {
                "auth_ref":  [
                    "r238",
                    "r243",
                    "r252",
                    "r256"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/RetirementbenefitsDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
                            "label":  "Defined Benefit Plan, Service Cost",
                            "terseLabel":  "Service costs"
                            }
                        }
                    },
                "localname":  "DefinedBenefitPlanServiceCost",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/RetirementbenefitsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DefinedContributionPlanCostRecognized":  {
                "auth_ref":  [
                    "r257"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of cost for defined contribution plan.",
                            "label":  "Defined Contribution Plan, Cost",
                            "terseLabel":  "Cost recognized in the consolidated condensed statements of earnings"
                            }
                        }
                    },
                "localname":  "DefinedContributionPlanCostRecognized",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/RetirementbenefitsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of discretionary contributions made by an employer to a defined contribution plan.",
                            "label":  "Defined Contribution Plan, Employer Discretionary Contribution Amount",
                            "terseLabel":  "Employer cash contributions to defined benefit pension plans"
                            }
                        }
                    },
                "localname":  "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/RetirementbenefitsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_Depreciation":  {
                "auth_ref":  [
                    "r112",
                    "r196"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/SupplementalinformationDepreciationandAmortizationExpenseDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_DepreciationDepletionAndAmortization",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives.  Includes production and non-production related depreciation.",
                            "label":  "Depreciation",
                            "terseLabel":  "Depreciation expense"
                            }
                        }
                    },
                "localname":  "Depreciation",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/SupplementalinformationDepreciationandAmortizationExpenseDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DepreciationDepletionAndAmortization":  {
                "auth_ref":  [
                    "r112",
                    "r148"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        },
                    "http://walgreensbootsalliance.com/role/SupplementalinformationDepreciationandAmortizationExpenseDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
                            "label":  "Depreciation, Depletion and Amortization",
                            "terseLabel":  "Depreciation and amortization",
                            "totalLabel":  "Total depreciation and amortization expense"
                            }
                        }
                    },
                "localname":  "DepreciationDepletionAndAmortization",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED",
                    "http://walgreensbootsalliance.com/role/SupplementalinformationDepreciationandAmortizationExpenseDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DerivativeAssetNotionalAmount":  {
                "auth_ref":  [
                    "r294",
                    "r295",
                    "r297"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Nominal or face amount used to calculate payments on the derivative asset.",
                            "label":  "Derivative Asset, Notional Amount",
                            "terseLabel":  "Notional"
                            }
                        }
                    },
                "localname":  "DerivativeAssetNotionalAmount",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/FinancialinstrumentsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DerivativeAssets":  {
                "auth_ref":  [
                    "r58",
                    "r59",
                    "r323"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.  Includes assets not subject to a master netting arrangement and not elected to be offset.",
                            "label":  "Derivative Asset",
                            "terseLabel":  "Derivative asset"
                            }
                        }
                    },
                "localname":  "DerivativeAssets",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/FairvaluemeasurementsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DerivativeContractTypeDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
                            "label":  "Derivative Contract [Domain]",
                            "terseLabel":  "Derivative Contract [Domain]"
                            }
                        }
                    },
                "localname":  "DerivativeContractTypeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/FairvaluemeasurementsDetails",
                    "http://walgreensbootsalliance.com/role/FinancialinstrumentsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_DerivativeFairValueOfDerivativeAsset":  {
                "auth_ref":  [
                    "r57",
                    "r60",
                    "r303",
                    "r366"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.  Includes assets elected not to be offset.  Excludes assets not subject to a master netting arrangement.",
                            "label":  "Derivative Asset, Fair Value, Gross Asset",
                            "terseLabel":  "Fair value"
                            }
                        }
                    },
                "localname":  "DerivativeFairValueOfDerivativeAsset",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/FinancialinstrumentsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DerivativeInstrumentRiskAxis":  {
                "auth_ref":  [
                    "r301",
                    "r304",
                    "r307",
                    "r309"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by type of derivative contract.",
                            "label":  "Derivative Instrument [Axis]",
                            "terseLabel":  "Derivative Instrument [Axis]"
                            }
                        }
                    },
                "localname":  "DerivativeInstrumentRiskAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/FairvaluemeasurementsDetails",
                    "http://walgreensbootsalliance.com/role/FinancialinstrumentsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
                            "terseLabel":  "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
                            }
                        }
                    },
                "localname":  "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock":  {
                "auth_ref":  [
                    "r316"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
                            "label":  "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
                            "terseLabel":  "Financial instruments"
                            }
                        }
                    },
                "localname":  "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/Financialinstruments"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_DerivativeLiabilities":  {
                "auth_ref":  [
                    "r58",
                    "r59",
                    "r323"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.  Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
                            "label":  "Derivative Liability",
                            "terseLabel":  "Derivative liability"
                            }
                        }
                    },
                "localname":  "DerivativeLiabilities",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/FairvaluemeasurementsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DerivativeLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Derivative [Line Items]",
                            "terseLabel":  "Derivative [Line Items]"
                            }
                        }
                    },
                "localname":  "DerivativeLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/FinancialinstrumentsTables"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DerivativeTable":  {
                "auth_ref":  [
                    "r124",
                    "r293",
                    "r296",
                    "r297",
                    "r298",
                    "r299",
                    "r306",
                    "r307",
                    "r311",
                    "r312",
                    "r315"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments.  May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
                            "label":  "Derivative [Table]",
                            "terseLabel":  "Derivative [Table]"
                            }
                        }
                    },
                "localname":  "DerivativeTable",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/FinancialinstrumentsTables"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DerivativesFairValueLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Derivatives, Fair Value [Line Items]",
                            "terseLabel":  "Derivatives, Fair Value [Line Items]"
                            }
                        }
                    },
                "localname":  "DerivativesFairValueLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/FinancialinstrumentsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted":  {
                "auth_ref":  [
                    "r133"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The entire disclosure for a new accounting pronouncement that has been issued but not yet adopted.",
                            "label":  "Description of New Accounting Pronouncements Not yet Adopted [Text Block]",
                            "terseLabel":  "New accounting pronouncements"
                            }
                        }
                    },
                "localname":  "DescriptionOfNewAccountingPronouncementsNotYetAdopted",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/Newaccountingpronouncements"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_DesignatedAsHedgingInstrumentMember":  {
                "auth_ref":  [
                    "r298"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
                            "label":  "Designated as Hedging Instrument [Member]",
                            "terseLabel":  "Designated as Hedging Instrument"
                            }
                        }
                    },
                "localname":  "DesignatedAsHedgingInstrumentMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/FinancialinstrumentsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_DisaggregationOfRevenueLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Disaggregation of Revenue [Line Items]",
                            "terseLabel":  "Disaggregation of Revenue [Line Items]"
                            }
                        }
                    },
                "localname":  "DisaggregationOfRevenueLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/SalesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DisaggregationOfRevenueTable":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
                            "label":  "Disaggregation of Revenue [Table]",
                            "terseLabel":  "Disaggregation of Revenue [Table]"
                            }
                        }
                    },
                "localname":  "DisaggregationOfRevenueTable",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/SalesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DisaggregationOfRevenueTableTextBlock":  {
                "auth_ref":  [
                    "r232"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
                            "label":  "Disaggregation of Revenue [Table Text Block]",
                            "terseLabel":  "Disaggregation of Revenue"
                            }
                        }
                    },
                "localname":  "DisaggregationOfRevenueTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/SalesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_DividendsCommonStockCash":  {
                "auth_ref":  [
                    "r228"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
                            "label":  "Dividends, Common Stock, Cash",
                            "negatedLabel":  "Dividends declared"
                            }
                        }
                    },
                "localname":  "DividendsCommonStockCash",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEQUITY"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DomesticPlanMember":  {
                "auth_ref":  [
                    "r248"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Location of employer sponsoring plan, designed to provide retirement benefits, determined as principal place of business.  Includes, but is not limited to, defined benefit and defined contribution plans.",
                            "label":  "Domestic Plan [Member]",
                            "terseLabel":  "Domestic Plan"
                            }
                        }
                    },
                "localname":  "DomesticPlanMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/RetirementbenefitsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_EarningsPerShareAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Earnings Per Share [Abstract]",
                            "terseLabel":  "Net earnings per common share:"
                            }
                        }
                    },
                "localname":  "EarningsPerShareAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEARNINGS"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract]",
                            "terseLabel":  "Weighted average common shares outstanding:"
                            }
                        }
                    },
                "localname":  "EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEARNINGS"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents":  {
                "auth_ref":  [
                    "r324"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies.  Excludes amounts for disposal group and discontinued operations.  Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.  Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
                            "label":  "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
                            "terseLabel":  "Effect of exchange rate changes on cash, cash equivalents and restricted cash"
                            }
                        }
                    },
                "localname":  "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_EffectiveIncomeTaxRateContinuingOperations":  {
                "auth_ref":  [
                    "r122",
                    "r265",
                    "r266"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
                            "label":  "Effective Income Tax Rate Reconciliation, Percent",
                            "terseLabel":  "Effective tax rate"
                            }
                        }
                    },
                "localname":  "EffectiveIncomeTaxRateContinuingOperations",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/IncometaxesDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_EquityComponentDomain":  {
                "auth_ref":  [
                    "r223"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
                            "label":  "Equity Component [Domain]",
                            "terseLabel":  "Equity Component [Domain]"
                            }
                        }
                    },
                "localname":  "EquityComponentDomain",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/AccumulatedothercomprehensiveincomelossDetails",
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEQUITY",
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesNarrativeDetails",
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_EquityMethodInvestmentOwnershipPercentage":  {
                "auth_ref":  [
                    "r167"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
                            "label":  "Equity Method Investment, Ownership Percentage",
                            "verboseLabel":  "Ownership percentage"
                            }
                        }
                    },
                "localname":  "EquityMethodInvestmentOwnershipPercentage",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/EquitymethodinvestmentsNarrativeDetails",
                    "http://walgreensbootsalliance.com/role/EquitymethodinvestmentsScheduleofEquityMethodInvestmentsDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_EquityMethodInvestments":  {
                "auth_ref":  [
                    "r34",
                    "r152",
                    "r166"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_AssetsNoncurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee.  This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
                            "label":  "Equity Method Investments",
                            "terseLabel":  "Equity method investments (see note 5)",
                            "verboseLabel":  "Carrying value"
                            }
                        }
                    },
                "localname":  "EquityMethodInvestments",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS",
                    "http://walgreensbootsalliance.com/role/EquitymethodinvestmentsScheduleofEquityMethodInvestmentsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Equity Method Investments and Joint Ventures [Abstract]",
                            "terseLabel":  "Equity Method Investments and Joint Ventures [Abstract]"
                            }
                        }
                    },
                "localname":  "EquityMethodInvestmentsAndJointVenturesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_EquityMethodInvestmentsDisclosureTextBlock":  {
                "auth_ref":  [
                    "r170",
                    "r292"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The entire disclosure for equity method investments and joint ventures.  Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee.  Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.",
                            "label":  "Equity Method Investments and Joint Ventures Disclosure [Text Block]",
                            "terseLabel":  "Equity method investments"
                            }
                        }
                    },
                "localname":  "EquityMethodInvestmentsDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/Equitymethodinvestments"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_EquityMethodInvestmentsFairValueDisclosure":  {
                "auth_ref":  [
                    "r165"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Fair value portion of investments accounted under the equity method.",
                            "label":  "Equity Method Investments, Fair Value Disclosure",
                            "terseLabel":  "Fair market value of equity investment"
                            }
                        }
                    },
                "localname":  "EquityMethodInvestmentsFairValueDisclosure",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/EquitymethodinvestmentsNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_EquityMethodInvestmentsTextBlock":  {
                "auth_ref":  [
                    "r169"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.",
                            "label":  "Equity Method Investments [Table Text Block]",
                            "terseLabel":  "Equity Method Investments"
                            }
                        }
                    },
                "localname":  "EquityMethodInvestmentsTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/EquitymethodinvestmentsTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_EquitySecuritiesFvNi":  {
                "auth_ref":  [
                    "r322"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
                            "label":  "Equity Securities, FV-NI",
                            "terseLabel":  "Investments in equity securities"
                            }
                        }
                    },
                "localname":  "EquitySecuritiesFvNi",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/FairvaluemeasurementsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]",
                            "terseLabel":  "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]"
                            }
                        }
                    },
                "localname":  "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/FairvaluemeasurementsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
                            "terseLabel":  "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
                            }
                        }
                    },
                "localname":  "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/FairvaluemeasurementsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable":  {
                "auth_ref":  [
                    "r317",
                    "r318",
                    "r319",
                    "r321"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
                            "label":  "Fair Value, Recurring and Nonrecurring [Table]",
                            "terseLabel":  "Fair Value Measurements, Recurring and Nonrecurring [Table]"
                            }
                        }
                    },
                "localname":  "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/FairvaluemeasurementsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FairValueByFairValueHierarchyLevelAxis":  {
                "auth_ref":  [
                    "r240",
                    "r241",
                    "r256",
                    "r318",
                    "r362"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
                            "label":  "Fair Value Hierarchy and NAV [Axis]",
                            "terseLabel":  "Fair Value Hierarchy and NAV [Axis]"
                            }
                        }
                    },
                "localname":  "FairValueByFairValueHierarchyLevelAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/EquitymethodinvestmentsNarrativeDetails",
                    "http://walgreensbootsalliance.com/role/FairvaluemeasurementsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FairValueDisclosuresAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Fair Value Disclosures [Abstract]",
                            "terseLabel":  "Fair Value Disclosures [Abstract]"
                            }
                        }
                    },
                "localname":  "FairValueDisclosuresAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FairValueDisclosuresTextBlock":  {
                "auth_ref":  [
                    "r320"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities.  Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
                            "label":  "Fair Value Disclosures [Text Block]",
                            "terseLabel":  "Fair value measurements"
                            }
                        }
                    },
                "localname":  "FairValueDisclosuresTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/Fairvaluemeasurements"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_FairValueInputsLevel1Member":  {
                "auth_ref":  [
                    "r240",
                    "r241",
                    "r256",
                    "r318",
                    "r363"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
                            "label":  "Fair Value, Inputs, Level 1 [Member]",
                            "terseLabel":  "Level 1"
                            }
                        }
                    },
                "localname":  "FairValueInputsLevel1Member",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/EquitymethodinvestmentsNarrativeDetails",
                    "http://walgreensbootsalliance.com/role/FairvaluemeasurementsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_FairValueInputsLevel2Member":  {
                "auth_ref":  [
                    "r240",
                    "r241",
                    "r256",
                    "r318",
                    "r364"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
                            "label":  "Fair Value, Inputs, Level 2 [Member]",
                            "terseLabel":  "Level 2"
                            }
                        }
                    },
                "localname":  "FairValueInputsLevel2Member",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/FairvaluemeasurementsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_FairValueInputsLevel3Member":  {
                "auth_ref":  [
                    "r240",
                    "r241",
                    "r256",
                    "r318",
                    "r365"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
                            "label":  "Fair Value, Inputs, Level 3 [Member]",
                            "terseLabel":  "Level 3"
                            }
                        }
                    },
                "localname":  "FairValueInputsLevel3Member",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/FairvaluemeasurementsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_FairValueMeasurementsFairValueHierarchyDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
                            "label":  "Fair Value Hierarchy and NAV [Domain]",
                            "terseLabel":  "Fair Value Hierarchy and NAV [Domain]"
                            }
                        }
                    },
                "localname":  "FairValueMeasurementsFairValueHierarchyDomain",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/EquitymethodinvestmentsNarrativeDetails",
                    "http://walgreensbootsalliance.com/role/FairvaluemeasurementsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable":  {
                "auth_ref":  [
                    "r300",
                    "r306",
                    "r313"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
                            "label":  "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
                            "terseLabel":  "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
                            }
                        }
                    },
                "localname":  "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/FinancialinstrumentsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FinanceLeaseInterestExpense":  {
                "auth_ref":  [
                    "r338",
                    "r344",
                    "r355"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of interest expense on finance lease liability.",
                            "label":  "Finance Lease, Interest Expense",
                            "terseLabel":  "Interest"
                            }
                        }
                    },
                "localname":  "FinanceLeaseInterestExpense",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesComponentsofLeaseCostDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinanceLeaseInterestPaymentOnLiability":  {
                "auth_ref":  [
                    "r340",
                    "r349"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/LeasesSupplementalCashFlowInformationDetails":  {
                        "order":  3.0,
                        "parentTag":  "wba_LeasesPayments",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of interest paid on finance lease liability.",
                            "label":  "Finance Lease, Interest Payment on Liability",
                            "terseLabel":  "Operating cash flows from finance leases"
                            }
                        }
                    },
                "localname":  "FinanceLeaseInterestPaymentOnLiability",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesSupplementalCashFlowInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Finance Lease, Liability, Payment, Due [Abstract]",
                            "terseLabel":  "Finance lease"
                            }
                        }
                    },
                "localname":  "FinanceLeaseLiabilitiesPaymentsDueAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FinanceLeaseLiability":  {
                "auth_ref":  [
                    "r337",
                    "r354"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_FinanceLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        },
                    "http://walgreensbootsalliance.com/role/LeasesSupplementalBalanceSheetInformationDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Present value of lessee's discounted obligation for lease payments from finance lease.",
                            "label":  "Finance Lease, Liability",
                            "terseLabel":  "Lease liability",
                            "totalLabel":  "Total finance lease obligations"
                            }
                        }
                    },
                "localname":  "FinanceLeaseLiability",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails",
                    "http://walgreensbootsalliance.com/role/LeasesSupplementalBalanceSheetInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinanceLeaseLiabilityCurrent":  {
                "auth_ref":  [
                    "r337"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/LeasesSupplementalBalanceSheetInformationDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_FinanceLeaseLiability",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
                            "label":  "Finance Lease, Liability, Current",
                            "terseLabel":  "Accrued expenses and other liabilities"
                            }
                        }
                    },
                "localname":  "FinanceLeaseLiabilityCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesSupplementalBalanceSheetInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock":  {
                "auth_ref":  [
                    "r354"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of undiscounted cash flows of finance lease liability.  Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.",
                            "label":  "Finance Lease, Liability, Maturity [Table Text Block]",
                            "terseLabel":  "Finance Lease, Liability, Maturity"
                            }
                        }
                    },
                "localname":  "FinanceLeaseLiabilityMaturityTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_FinanceLeaseLiabilityNoncurrent":  {
                "auth_ref":  [
                    "r337"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/LeasesSupplementalBalanceSheetInformationDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_FinanceLeaseLiability",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
                            "label":  "Finance Lease, Liability, Noncurrent",
                            "terseLabel":  "Other non-current liabilities"
                            }
                        }
                    },
                "localname":  "FinanceLeaseLiabilityNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesSupplementalBalanceSheetInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinanceLeaseLiabilityPaymentsDue":  {
                "auth_ref":  [
                    "r354"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        },
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails_1":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
                            "label":  "Finance Lease, Liability, Payment, Due",
                            "totalLabel":  "Total undiscounted minimum lease payments"
                            }
                        }
                    },
                "localname":  "FinanceLeaseLiabilityPaymentsDue",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive":  {
                "auth_ref":  [
                    "r354"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails_1":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_FinanceLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payments for finance lease, due in fifth fiscal year following latest fiscal year.",
                            "label":  "Finance Lease, Liability, Payments, Due Year Five",
                            "terseLabel":  "2024"
                            }
                        }
                    },
                "localname":  "FinanceLeaseLiabilityPaymentsDueYearFive",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour":  {
                "auth_ref":  [
                    "r354"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails_1":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_FinanceLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payments for finance lease, due in fourth fiscal year following latest fiscal year.",
                            "label":  "Finance Lease, Liability, Payments, Due Year Four",
                            "terseLabel":  "2023"
                            }
                        }
                    },
                "localname":  "FinanceLeaseLiabilityPaymentsDueYearFour",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree":  {
                "auth_ref":  [
                    "r354"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails_1":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_FinanceLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payments for finance lease, due in third fiscal year following latest fiscal year.",
                            "label":  "Finance Lease, Liability, Payments, Due Year Three",
                            "terseLabel":  "2022"
                            }
                        }
                    },
                "localname":  "FinanceLeaseLiabilityPaymentsDueYearThree",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo":  {
                "auth_ref":  [
                    "r354"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails_1":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_FinanceLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payments for finance lease, due in second fiscal year following latest fiscal year.",
                            "label":  "Finance Lease, Liability, Payments, Due Year Two",
                            "terseLabel":  "2021"
                            }
                        }
                    },
                "localname":  "FinanceLeaseLiabilityPaymentsDueYearTwo",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear":  {
                "auth_ref":  [
                    "r354"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails_1":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_FinanceLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payments for finance lease, due in remainder of fiscal year following latest fiscal year ended.",
                            "label":  "Finance Lease, Liability, Payments, Remainder of Fiscal Year",
                            "terseLabel":  "2020 (Remaining period)"
                            }
                        }
                    },
                "localname":  "FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount":  {
                "auth_ref":  [
                    "r354"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_FinanceLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
                            "label":  "Finance Lease, Liability, Undiscounted Excess Amount",
                            "negatedLabel":  "Less:  Present value discount"
                            }
                        }
                    },
                "localname":  "FinanceLeaseLiabilityUndiscountedExcessAmount",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinanceLeasePrincipalPayments":  {
                "auth_ref":  [
                    "r339",
                    "r349"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/LeasesSupplementalCashFlowInformationDetails":  {
                        "order":  2.0,
                        "parentTag":  "wba_LeasesPayments",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of cash outflow for principal payment on finance lease.",
                            "label":  "Finance Lease, Principal Payments",
                            "terseLabel":  "Financing cash flows from finance leases"
                            }
                        }
                    },
                "localname":  "FinanceLeasePrincipalPayments",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesSupplementalCashFlowInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinanceLeaseRightOfUseAsset":  {
                "auth_ref":  [
                    "r336"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of lessee's right to use underlying asset under finance lease.",
                            "label":  "Finance Lease, Right-of-Use Asset",
                            "terseLabel":  "Property, plant and equipment, net"
                            }
                        }
                    },
                "localname":  "FinanceLeaseRightOfUseAsset",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesSupplementalBalanceSheetInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinanceLeaseRightOfUseAssetAmortization":  {
                "auth_ref":  [
                    "r338",
                    "r344",
                    "r355"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of amortization expense attributable to right-of-use asset from finance lease.",
                            "label":  "Finance Lease, Right-of-Use Asset, Amortization",
                            "terseLabel":  "Amortization"
                            }
                        }
                    },
                "localname":  "FinanceLeaseRightOfUseAssetAmortization",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesComponentsofLeaseCostDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent":  {
                "auth_ref":  [
                    "r352",
                    "r355"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Weighted average discount rate for finance lease calculated at point in time.",
                            "label":  "Finance Lease, Weighted Average Discount Rate, Percent",
                            "terseLabel":  "Finance leases"
                            }
                        }
                    },
                "localname":  "FinanceLeaseWeightedAverageDiscountRatePercent",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesAverageLeaseTermsAndDiscountsDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1":  {
                "auth_ref":  [
                    "r351",
                    "r355"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
                            "label":  "Finance Lease, Weighted Average Remaining Lease Term",
                            "terseLabel":  "Finance leases"
                            }
                        }
                    },
                "localname":  "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesAverageLeaseTermsAndDiscountsDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization":  {
                "auth_ref":  [
                    "r189"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofFiniteLivedIntangibleAssetsbyMajorClassDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_FiniteLivedIntangibleAssetsNet",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
                            "label":  "Finite-Lived Intangible Assets, Accumulated Amortization",
                            "terseLabel":  "Accumulated amortization"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsAccumulatedAmortization",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofFiniteLivedIntangibleAssetsbyMajorClassDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable":  {
                "auth_ref":  [
                    "r184"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "A table containing detailed characteristics of finite-lived intangible assets acquired during a business combination.  Finite-lived intangible assets are assets that have no physical form, but have expected future economic benefit, and are expected to be used over a defined period.  Acquired finite-lived intangible assets are disclosed by major class (assets that can be grouped together because they are similar, either by their nature or by their use in operations of the Entity) and in total.  Additionally, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period are also disclosed.",
                            "label":  "Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]",
                            "terseLabel":  "Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofFiniteLivedIntangibleAssetsbyMajorClassDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the remainder of the fiscal year following the latest fiscal year.  Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
                            "label":  "Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year",
                            "verboseLabel":  "2021"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive":  {
                "auth_ref":  [
                    "r191"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year.  Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
                            "label":  "Finite-Lived Intangible Assets, Amortization Expense, Year Five",
                            "verboseLabel":  "2025"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour":  {
                "auth_ref":  [
                    "r191"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year.  Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
                            "label":  "Finite-Lived Intangible Assets, Amortization Expense, Year Four",
                            "verboseLabel":  "2024"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree":  {
                "auth_ref":  [
                    "r191"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year.  Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
                            "label":  "Finite-Lived Intangible Assets, Amortization Expense, Year Three",
                            "verboseLabel":  "2023"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo":  {
                "auth_ref":  [
                    "r191"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year.  Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
                            "label":  "Finite-Lived Intangible Assets, Amortization Expense, Year Two",
                            "verboseLabel":  "2022"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis":  {
                "auth_ref":  [
                    "r184",
                    "r186",
                    "r189",
                    "r193",
                    "r367"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by major type or class of finite-lived intangible assets.",
                            "label":  "Finite-Lived Intangible Assets by Major Class [Axis]",
                            "terseLabel":  "Finite-Lived Intangible Assets by Major Class [Axis]"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsByMajorClassAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofFiniteLivedIntangibleAssetsbyMajorClassDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]",
                            "terseLabel":  "Estimated annual intangible assets amortization expense [Abstract]"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsGross":  {
                "auth_ref":  [
                    "r189",
                    "r367"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofFiniteLivedIntangibleAssetsbyMajorClassDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_IntangibleAssetsNetExcludingGoodwill",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
                            "label":  "Finite-Lived Intangible Assets, Gross",
                            "terseLabel":  "Gross amortizable intangible assets"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsGross",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofFiniteLivedIntangibleAssetsbyMajorClassDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Finite-Lived Intangible Assets [Line Items]",
                            "terseLabel":  "Finite-Lived Intangible Assets [Line Items]"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofFiniteLivedIntangibleAssetsbyMajorClassDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain":  {
                "auth_ref":  [
                    "r184",
                    "r188"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
                            "label":  "Finite-Lived Intangible Assets, Major Class Name [Domain]",
                            "terseLabel":  "Finite-Lived Intangible Assets, Major Class Name [Domain]"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsMajorClassNameDomain",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofFiniteLivedIntangibleAssetsbyMajorClassDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsNet":  {
                "auth_ref":  [
                    "r189"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofFiniteLivedIntangibleAssetsbyMajorClassDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
                            "label":  "Finite-Lived Intangible Assets, Net",
                            "totalLabel":  "Total amortizable intangible assets, net"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsNet",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofFiniteLivedIntangibleAssetsbyMajorClassDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ForeignExchangeForwardMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
                            "label":  "Foreign Exchange Forward [Member]",
                            "terseLabel":  "Foreign currency forwards"
                            }
                        }
                    },
                "localname":  "ForeignExchangeForwardMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/FairvaluemeasurementsDetails",
                    "http://walgreensbootsalliance.com/role/FinancialinstrumentsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ForeignPlanMember":  {
                "auth_ref":  [
                    "r248"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business.  Includes, but is not limited to, defined benefit and defined contribution plans.",
                            "label":  "Foreign Plan [Member]",
                            "terseLabel":  "Foreign Plan"
                            }
                        }
                    },
                "localname":  "ForeignPlanMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/RetirementbenefitsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_GainLossRelatedToLitigationSettlement":  {
                "auth_ref":  [
                    "r217"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/SegmentreportingDetails":  {
                        "order":  7.0,
                        "parentTag":  "us-gaap_OperatingIncomeLoss",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of gain (loss) recognized in settlement of litigation and insurance claims.  Excludes claims within an insurance entity's normal claims settlement process.",
                            "label":  "Gain (Loss) Related to Litigation Settlement",
                            "terseLabel":  "Certain legal and regulatory accruals and settlements"
                            }
                        }
                    },
                "localname":  "GainLossRelatedToLitigationSettlement",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/SegmentreportingDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_Goodwill":  {
                "auth_ref":  [
                    "r174",
                    "r175"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_AssetsNoncurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
                            "label":  "Goodwill",
                            "periodEndLabel":  "Net book value - Ending Period",
                            "periodStartLabel":  "Net book value - Beginning Period",
                            "verboseLabel":  "Goodwill"
                            }
                        }
                    },
                "localname":  "Goodwill",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS",
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofGoodwillDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_GoodwillAcquiredDuringPeriod":  {
                "auth_ref":  [
                    "r176"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
                            "label":  "Goodwill, Acquired During Period",
                            "terseLabel":  "Acquisitions"
                            }
                        }
                    },
                "localname":  "GoodwillAcquiredDuringPeriod",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofGoodwillDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Goodwill and Intangible Assets Disclosure [Abstract]",
                            "terseLabel":  "Goodwill and Intangible Assets Disclosure [Abstract]"
                            }
                        }
                    },
                "localname":  "GoodwillAndIntangibleAssetsDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock":  {
                "auth_ref":  [
                    "r194"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The entire disclosure for goodwill and intangible assets.",
                            "label":  "Goodwill and Intangible Assets Disclosure [Text Block]",
                            "terseLabel":  "Goodwill and other intangible assets"
                            }
                        }
                    },
                "localname":  "GoodwillAndIntangibleAssetsDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/Goodwillandotherintangibleassets"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_GoodwillForeignCurrencyTranslationGainLoss":  {
                "auth_ref":  [
                    "r177"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
                            "label":  "Goodwill, Foreign Currency Translation Gain (Loss)",
                            "terseLabel":  "Currency translation adjustments"
                            }
                        }
                    },
                "localname":  "GoodwillForeignCurrencyTranslationGainLoss",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofGoodwillDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_GoodwillLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Goodwill [Line Items]",
                            "terseLabel":  "Goodwill [Line Items]"
                            }
                        }
                    },
                "localname":  "GoodwillLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsNarrativeDetails",
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofGoodwillDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_GoodwillRollForward":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
                            "label":  "Goodwill [Roll Forward]",
                            "terseLabel":  "Goodwill [Roll Forward]"
                            }
                        }
                    },
                "localname":  "GoodwillRollForward",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofGoodwillDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_GrossProfit":  {
                "auth_ref":  [
                    "r87"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEARNINGS":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_OperatingIncomeLoss",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
                            "label":  "Gross Profit",
                            "totalLabel":  "Gross profit"
                            }
                        }
                    },
                "localname":  "GrossProfit",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEARNINGS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_HedgingDesignationAxis":  {
                "auth_ref":  [
                    "r298",
                    "r310"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by designation of purpose of derivative instrument.",
                            "label":  "Hedging Designation [Axis]",
                            "terseLabel":  "Hedging Designation [Axis]"
                            }
                        }
                    },
                "localname":  "HedgingDesignationAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/FinancialinstrumentsDetails",
                    "http://walgreensbootsalliance.com/role/FinancialinstrumentsTables"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_HedgingDesignationDomain":  {
                "auth_ref":  [
                    "r298"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Designation of purpose of derivative instrument.",
                            "label":  "Hedging Designation [Domain]",
                            "terseLabel":  "Hedging Designation [Domain]"
                            }
                        }
                    },
                "localname":  "HedgingDesignationDomain",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/FinancialinstrumentsDetails",
                    "http://walgreensbootsalliance.com/role/FinancialinstrumentsTables"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse":  {
                "auth_ref":  [
                    "r112",
                    "r195",
                    "r199",
                    "r410"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).",
                            "label":  "Impairment of Long-Lived Assets Held-for-use",
                            "terseLabel":  "Impaired long-lived assets"
                            }
                        }
                    },
                "localname":  "ImpairmentOfLongLivedAssetsHeldForUse",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest":  {
                "auth_ref":  [
                    "r83",
                    "r128",
                    "r368",
                    "r380",
                    "r404"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEARNINGS":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_ProfitLoss",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
                            "label":  "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
                            "totalLabel":  "Earnings before income tax provision"
                            }
                        }
                    },
                "localname":  "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEARNINGS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments":  {
                "auth_ref":  [
                    "r121"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEARNINGS":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
                            "label":  "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
                            "totalLabel":  "Earnings before interest and income tax provision"
                            }
                        }
                    },
                "localname":  "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEARNINGS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare":  {
                "auth_ref":  [
                    "r81",
                    "r86",
                    "r136",
                    "r137",
                    "r138",
                    "r378",
                    "r381",
                    "r383",
                    "r401"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.",
                            "label":  "Income (Loss) from Continuing Operations, Per Basic Share",
                            "terseLabel":  "Basic (in dollars per share)"
                            }
                        }
                    },
                "localname":  "IncomeLossFromContinuingOperationsPerBasicShare",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEARNINGS"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare":  {
                "auth_ref":  [
                    "r81",
                    "r86",
                    "r136",
                    "r137",
                    "r138",
                    "r139",
                    "r383",
                    "r401",
                    "r403"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
                            "label":  "Income (Loss) from Continuing Operations, Per Diluted Share",
                            "terseLabel":  "Diluted (in dollars per share)"
                            }
                        }
                    },
                "localname":  "IncomeLossFromContinuingOperationsPerDilutedShare",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEARNINGS"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_IncomeLossFromEquityMethodInvestments":  {
                "auth_ref":  [
                    "r84",
                    "r112",
                    "r149",
                    "r166",
                    "r379",
                    "r400"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
                            "label":  "Income (Loss) from Equity Method Investments",
                            "negatedLabel":  "Equity (earnings) from equity method investments",
                            "verboseLabel":  "Equity earnings (losses)"
                            }
                        }
                    },
                "localname":  "IncomeLossFromEquityMethodInvestments",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED",
                    "http://walgreensbootsalliance.com/role/EquitymethodinvestmentsNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncomeStatementAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Income Statement [Abstract]",
                            "terseLabel":  "Income Statement [Abstract]"
                            }
                        }
                    },
                "localname":  "IncomeStatementAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncomeStatementLocationAxis":  {
                "auth_ref":  [
                    "r200"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by location in the income statement.",
                            "label":  "Income Statement Location [Axis]",
                            "terseLabel":  "Income Statement Location [Axis]"
                            }
                        }
                    },
                "localname":  "IncomeStatementLocationAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/FinancialinstrumentsDetails",
                    "http://walgreensbootsalliance.com/role/RetirementbenefitsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncomeStatementLocationDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Location in the income statement.",
                            "label":  "Income Statement Location [Domain]",
                            "terseLabel":  "Income Statement Location [Domain]"
                            }
                        }
                    },
                "localname":  "IncomeStatementLocationDomain",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/FinancialinstrumentsDetails",
                    "http://walgreensbootsalliance.com/role/RetirementbenefitsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_IncomeTaxDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Income Tax Disclosure [Abstract]",
                            "terseLabel":  "Income Tax Disclosure [Abstract]"
                            }
                        }
                    },
                "localname":  "IncomeTaxDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncomeTaxDisclosureTextBlock":  {
                "auth_ref":  [
                    "r272"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The entire disclosure for income taxes.  Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
                            "label":  "Income Tax Disclosure [Text Block]",
                            "terseLabel":  "Income taxes"
                            }
                        }
                    },
                "localname":  "IncomeTaxDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/Incometaxes"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_IncomeTaxExpenseBenefit":  {
                "auth_ref":  [
                    "r118",
                    "r150",
                    "r271"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEARNINGS":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_ProfitLoss",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
                            "label":  "Income Tax Expense (Benefit)",
                            "terseLabel":  "Income tax provision"
                            }
                        }
                    },
                "localname":  "IncomeTaxExpenseBenefit",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEARNINGS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncomeTaxesPaid":  {
                "auth_ref":  [
                    "r108",
                    "r115"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
                            "label":  "Income Taxes Paid",
                            "verboseLabel":  "Income taxes paid"
                            }
                        }
                    },
                "localname":  "IncomeTaxesPaid",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/IncometaxesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInAccountsPayableTrade":  {
                "auth_ref":  [
                    "r111"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  10.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.",
                            "label":  "Increase (Decrease) in Accounts Payable, Trade",
                            "terseLabel":  "Trade accounts payable"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInAccountsPayableTrade",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable":  {
                "auth_ref":  [
                    "r111"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  12.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
                            "label":  "Increase (Decrease) in Income Taxes Payable",
                            "terseLabel":  "Income taxes"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInAccruedIncomeTaxesPayable",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInInventories":  {
                "auth_ref":  [
                    "r111"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  8.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
                            "label":  "Increase (Decrease) in Inventories",
                            "negatedLabel":  "Inventories"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInInventories",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Increase (Decrease) in Operating Capital [Abstract]",
                            "terseLabel":  "Changes in operating assets and liabilities:"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInOperatingCapitalAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities":  {
                "auth_ref":  [
                    "r111"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  11.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.",
                            "label":  "Increase (Decrease) in Other Accounts Payable and Accrued Liabilities",
                            "terseLabel":  "Accrued expenses and other liabilities"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities":  {
                "auth_ref":  [
                    "r111"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  13.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) in operating liabilities classified as other.",
                            "label":  "Increase (Decrease) in Other Operating Liabilities",
                            "terseLabel":  "Other non-current assets and liabilities"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInOtherOperatingLiabilities",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets":  {
                "auth_ref":  [
                    "r111"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  9.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
                            "label":  "Increase (Decrease) in Prepaid Expense and Other Assets",
                            "negatedLabel":  "Other current assets"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInReceivables":  {
                "auth_ref":  [
                    "r111"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  7.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.",
                            "label":  "Increase (Decrease) in Receivables",
                            "negatedLabel":  "Accounts receivable, net"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInReceivables",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInRestructuringReserve":  {
                "auth_ref":  [
                    "r111"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the period in the carrying amount (including both current and noncurrent portions of the accrual) of the liability pertaining to the exit from or disposal of business activities or restructuring pursuant to a duly authorized plan, excluding costs or losses pertaining to an entity newly acquired in a business combination and to asset retirement obligations.",
                            "label":  "Increase (Decrease) in Restructuring Reserve",
                            "terseLabel":  "Increase (decrease) in restructuring reserve"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInRestructuringReserve",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
                            "label":  "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
                            "terseLabel":  "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInStockholdersEquityRollForward",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEQUITY"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis":  {
                "auth_ref":  [
                    "r185",
                    "r192"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
                            "label":  "Indefinite-lived Intangible Assets [Axis]",
                            "terseLabel":  "Indefinite-lived Intangible Assets [Axis]"
                            }
                        }
                    },
                "localname":  "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofFiniteLivedIntangibleAssetsbyMajorClassDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill":  {
                "auth_ref":  [
                    "r192"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofFiniteLivedIntangibleAssetsbyMajorClassDetails":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_IntangibleAssetsNetExcludingGoodwill",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
                            "label":  "Indefinite-lived Intangible Assets (Excluding Goodwill)",
                            "terseLabel":  "Indefinite-lived intangible assets"
                            }
                        }
                    },
                "localname":  "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofFiniteLivedIntangibleAssetsbyMajorClassDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain":  {
                "auth_ref":  [
                    "r185",
                    "r192"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill.  A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
                            "label":  "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
                            "terseLabel":  "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
                            }
                        }
                    },
                "localname":  "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofFiniteLivedIntangibleAssetsbyMajorClassDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_IntangibleAssetsNetExcludingGoodwill":  {
                "auth_ref":  [
                    "r182",
                    "r187"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_AssetsNoncurrent",
                        "weight":  1.0
                        },
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofFiniteLivedIntangibleAssetsbyMajorClassDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
                            "label":  "Intangible Assets, Net (Excluding Goodwill)",
                            "terseLabel":  "Intangible assets, net",
                            "totalLabel":  "Total intangible assets, net"
                            }
                        }
                    },
                "localname":  "IntangibleAssetsNetExcludingGoodwill",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS",
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofFiniteLivedIntangibleAssetsbyMajorClassDetails",
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsEffectofLease842AdoptionDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InterestExpense":  {
                "auth_ref":  [
                    "r82",
                    "r147",
                    "r326",
                    "r329",
                    "r384"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEARNINGS":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of the cost of borrowed funds accounted for as interest expense.",
                            "label":  "Interest Expense",
                            "terseLabel":  "Interest expense, net"
                            }
                        }
                    },
                "localname":  "InterestExpense",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEARNINGS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InterestPaidNet":  {
                "auth_ref":  [
                    "r103",
                    "r107",
                    "r115"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity.  Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
                            "label":  "Interest Paid, Excluding Capitalized Interest, Operating Activities",
                            "terseLabel":  "Interest paid"
                            }
                        }
                    },
                "localname":  "InterestPaidNet",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtAdditionalInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InterestRateFairValueHedgesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Interest Rate Fair Value Hedges [Abstract]",
                            "terseLabel":  "Fair Value Hedges [Abstract]"
                            }
                        }
                    },
                "localname":  "InterestRateFairValueHedgesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/FinancialinstrumentsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IntersegmentEliminationMember":  {
                "auth_ref":  [
                    "r155"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Eliminating entries used in operating segment consolidation.",
                            "label":  "Intersegment Eliminations [Member]",
                            "terseLabel":  "Eliminations"
                            }
                        }
                    },
                "localname":  "IntersegmentEliminationMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/SalesDetails",
                    "http://walgreensbootsalliance.com/role/SegmentreportingDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_InventoryLIFOReservePeriodCharge":  {
                "auth_ref":  [
                    "r52",
                    "r53",
                    "r54",
                    "r173"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/SegmentreportingDetails":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_OperatingIncomeLoss",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period.",
                            "label":  "Inventory, LIFO Reserve, Period Charge",
                            "negatedLabel":  "LIFO provision"
                            }
                        }
                    },
                "localname":  "InventoryLIFOReservePeriodCharge",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/SegmentreportingDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InventoryNet":  {
                "auth_ref":  [
                    "r2",
                    "r51",
                    "r172"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
                            "label":  "Inventory, Net",
                            "terseLabel":  "Inventories"
                            }
                        }
                    },
                "localname":  "InventoryNet",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InvestmentsInAndAdvancesToAffiliatesBalanceShares":  {
                "auth_ref":  [
                    "r408"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Number of shares of affiliates held for management investment companies.",
                            "label":  "Investments in and Advances to Affiliates, Balance, Shares",
                            "verboseLabel":  "Outstanding shares owned (in shares)"
                            }
                        }
                    },
                "localname":  "InvestmentsInAndAdvancesToAffiliatesBalanceShares",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/EquitymethodinvestmentsNarrativeDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_LeaseCostTableTextBlock":  {
                "auth_ref":  [
                    "r353"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of lessee's lease cost.  Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
                            "label":  "Lease, Cost [Table Text Block]",
                            "terseLabel":  "Lease, Cost"
                            }
                        }
                    },
                "localname":  "LeaseCostTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_LeasesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Leases [Abstract]",
                            "terseLabel":  "Leases [Abstract]"
                            }
                        }
                    },
                "localname":  "LeasesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LesseeFinanceLeasesTextBlock":  {
                "auth_ref":  [
                    "r356"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The entire disclosure for finance leases of lessee.  Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.",
                            "label":  "Lessee, Finance Leases [Text Block]",
                            "terseLabel":  "Leases"
                            }
                        }
                    },
                "localname":  "LesseeFinanceLeasesTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/Leases"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_LesseeLeaseDescriptionLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Lessee, Lease, Description [Line Items]",
                            "terseLabel":  "Lessee, Lease, Description [Line Items]"
                            }
                        }
                    },
                "localname":  "LesseeLeaseDescriptionLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LesseeLeaseDescriptionTable":  {
                "auth_ref":  [
                    "r343"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Disclosure of information about lessee's leases.",
                            "label":  "Lessee, Lease, Description [Table]",
                            "terseLabel":  "Lessee, Lease, Description [Table]"
                            }
                        }
                    },
                "localname":  "LesseeLeaseDescriptionTable",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock":  {
                "auth_ref":  [
                    "r354"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability.  Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
                            "label":  "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
                            "terseLabel":  "Lessee, Operating Lease, Liability, Maturity"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue":  {
                "auth_ref":  [
                    "r354"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        },
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails_1":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payments for operating lease.",
                            "label":  "Lessee, Operating Lease, Liability, Payments, Due",
                            "totalLabel":  "Total undiscounted minimum lease payments"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseLiabilityPaymentsDue",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive":  {
                "auth_ref":  [
                    "r354"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fifth fiscal year following latest fiscal year.",
                            "label":  "Lessee, Operating Lease, Liability, Payments, Due Year Five",
                            "terseLabel":  "2024"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour":  {
                "auth_ref":  [
                    "r354"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fourth fiscal year following latest fiscal year.",
                            "label":  "Lessee, Operating Lease, Liability, Payments, Due Year Four",
                            "terseLabel":  "2023"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree":  {
                "auth_ref":  [
                    "r354"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in third fiscal year following latest fiscal year.",
                            "label":  "Lessee, Operating Lease, Liability, Payments, Due Year Three",
                            "terseLabel":  "2022"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo":  {
                "auth_ref":  [
                    "r354"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second fiscal year following latest fiscal year.",
                            "label":  "Lessee, Operating Lease, Liability, Payments, Due Year Two",
                            "terseLabel":  "2021"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear":  {
                "auth_ref":  [
                    "r354"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payments for operating lease having an initial or remaining lease term in excess of one year due in remainder of fiscal year following latest fiscal year.",
                            "label":  "Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year",
                            "terseLabel":  "2020 (Remaining period)"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount":  {
                "auth_ref":  [
                    "r354"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails_1":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
                            "label":  "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
                            "negatedLabel":  "Less:  Present value discount"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LesseeOperatingLeaseRenewalTerm":  {
                "auth_ref":  [
                    "r342"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
                            "label":  "Lessee, Operating Lease, Renewal Term",
                            "terseLabel":  "Term of renewal contract"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseRenewalTerm",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsNarrativeDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_LesseeOperatingLeaseTermOfContract":  {
                "auth_ref":  [
                    "r342"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
                            "label":  "Lessee, Operating Lease, Term of Contract",
                            "terseLabel":  "Term of lease"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseTermOfContract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsNarrativeDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_LesseeOperatingLeasesTextBlock":  {
                "auth_ref":  [
                    "r356"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The entire disclosure for operating leases of lessee.  Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
                            "label":  "Lessee, Operating Leases [Text Block]",
                            "terseLabel":  "Leases"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeasesTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/Leases"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_LetterOfCreditMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
                            "label":  "Letter of Credit [Member]",
                            "terseLabel":  "Letter of Credit"
                            }
                        }
                    },
                "localname":  "LetterOfCreditMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_LiabilitiesAndStockholdersEquity":  {
                "auth_ref":  [
                    "r32",
                    "r375",
                    "r395"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
                            "label":  "Liabilities and Equity",
                            "terseLabel":  "Total liabilities and equity",
                            "totalLabel":  "Total liabilities and equity"
                            }
                        }
                    },
                "localname":  "LiabilitiesAndStockholdersEquity",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS",
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsEffectofLease842AdoptionDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LiabilitiesAndStockholdersEquityAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Liabilities and Equity [Abstract]",
                            "terseLabel":  "Liabilities and Shareholders' Equity",
                            "verboseLabel":  "Liabilities and equity"
                            }
                        }
                    },
                "localname":  "LiabilitiesAndStockholdersEquityAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS",
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LiabilitiesCurrent":  {
                "auth_ref":  [
                    "r41"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_LiabilitiesAndStockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
                            "label":  "Liabilities, Current",
                            "terseLabel":  "Total current liabilities",
                            "totalLabel":  "Total current liabilities"
                            }
                        }
                    },
                "localname":  "LiabilitiesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS",
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsEffectofLease842AdoptionDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LiabilitiesCurrentAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Liabilities, Current [Abstract]",
                            "terseLabel":  "Current liabilities:"
                            }
                        }
                    },
                "localname":  "LiabilitiesCurrentAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LiabilitiesFairValueDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Liabilities, Fair Value Disclosure [Abstract]",
                            "terseLabel":  "Liabilities [Abstract]"
                            }
                        }
                    },
                "localname":  "LiabilitiesFairValueDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/FairvaluemeasurementsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LiabilitiesNoncurrent":  {
                "auth_ref":  [
                    "r6",
                    "r7",
                    "r8",
                    "r21",
                    "r22"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_LiabilitiesAndStockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
                            "label":  "Liabilities, Noncurrent",
                            "terseLabel":  "Total non-current liabilities",
                            "totalLabel":  "Total non-current liabilities"
                            }
                        }
                    },
                "localname":  "LiabilitiesNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS",
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsEffectofLease842AdoptionDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LiabilitiesNoncurrentAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Liabilities, Noncurrent [Abstract]",
                            "verboseLabel":  "Non-current liabilities:"
                            }
                        }
                    },
                "localname":  "LiabilitiesNoncurrentAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding":  {
                "auth_ref":  [
                    "r323"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Fair value of the amount outstanding under the credit facility.",
                            "label":  "Line of Credit Facility, Fair Value of Amount Outstanding",
                            "terseLabel":  "Borrowing outstanding"
                            }
                        }
                    },
                "localname":  "LineOfCreditFacilityFairValueOfAmountOutstanding",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtAdditionalInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity":  {
                "auth_ref":  [
                    "r38"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
                            "label":  "Line of Credit Facility, Maximum Borrowing Capacity",
                            "terseLabel":  "Maximum borrowing capacity"
                            }
                        }
                    },
                "localname":  "LineOfCreditFacilityMaximumBorrowingCapacity",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtAdditionalInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LineOfCreditMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
                            "label":  "Line of Credit [Member]",
                            "terseLabel":  "Line of Credit"
                            }
                        }
                    },
                "localname":  "LineOfCreditMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_LoansPayableMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Borrowing supported by a written promise to pay an obligation.",
                            "label":  "Loans Payable [Member]",
                            "terseLabel":  "Term Loan"
                            }
                        }
                    },
                "localname":  "LoansPayableMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_LongTermDebtNoncurrent":  {
                "auth_ref":  [
                    "r43"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_LiabilitiesNoncurrent",
                        "weight":  1.0
                        },
                    "http://walgreensbootsalliance.com/role/DebtShortandLongTermDebtDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer.  Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper.  Excludes capital lease obligations.",
                            "label":  "Long-term Debt, Excluding Current Maturities",
                            "terseLabel":  "Long-term debt",
                            "totalLabel":  "Total long-term debt, less current portion"
                            }
                        }
                    },
                "localname":  "LongTermDebtNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS",
                    "http://walgreensbootsalliance.com/role/DebtShortandLongTermDebtDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LongtermDebtTypeAxis":  {
                "auth_ref":  [
                    "r43"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by type of long-term debt.",
                            "label":  "Long-term Debt, Type [Axis]",
                            "terseLabel":  "Long-term Debt, Type [Axis]"
                            }
                        }
                    },
                "localname":  "LongtermDebtTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtAdditionalInformationDetails",
                    "http://walgreensbootsalliance.com/role/DebtShortandLongTermDebtDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LongtermDebtTypeDomain":  {
                "auth_ref":  [
                    "r43",
                    "r220"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.  These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
                            "label":  "Long-term Debt, Type [Domain]",
                            "terseLabel":  "Long-term Debt, Type [Domain]"
                            }
                        }
                    },
                "localname":  "LongtermDebtTypeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtAdditionalInformationDetails",
                    "http://walgreensbootsalliance.com/role/DebtShortandLongTermDebtDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_MinorityInterest":  {
                "auth_ref":  [
                    "r50",
                    "r374",
                    "r394"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
                            "label":  "Stockholders' Equity Attributable to Noncontrolling Interest",
                            "terseLabel":  "Noncontrolling interests"
                            }
                        }
                    },
                "localname":  "MinorityInterest",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NetCashProvidedByUsedInFinancingActivities":  {
                "auth_ref":  [
                    "r106"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of cash inflow (outflow) from financing activities, including discontinued operations.  Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
                            "label":  "Net Cash Provided by (Used in) Financing Activities",
                            "totalLabel":  "Net cash (used for) provided by financing activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInFinancingActivities",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]",
                            "verboseLabel":  "Cash flows from financing activities:"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NetCashProvidedByUsedInInvestingActivities":  {
                "auth_ref":  [
                    "r106"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of cash inflow (outflow) from investing activities, including discontinued operations.  Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
                            "label":  "Net Cash Provided by (Used in) Investing Activities",
                            "totalLabel":  "Net cash used for investing activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInInvestingActivities",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]",
                            "verboseLabel":  "Cash flows from investing activities:"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NetCashProvidedByUsedInOperatingActivities":  {
                "auth_ref":  [
                    "r106",
                    "r110",
                    "r113"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                        "weight":  1.0
                        }
                    },
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of cash inflow (outflow) from operating activities, including discontinued operations.  Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
                            "label":  "Net Cash Provided by (Used in) Operating Activities",
                            "totalLabel":  "Net cash provided by operating activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInOperatingActivities",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]",
                            "terseLabel":  "Cash flows from operating activities:"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NetIncomeLoss":  {
                "auth_ref":  [
                    "r74",
                    "r77",
                    "r85",
                    "r113",
                    "r141",
                    "r382",
                    "r402"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEARNINGS":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
                            "label":  "Net Income (Loss) Attributable to Parent",
                            "totalLabel":  "Net earnings attributable to Walgreens Boots Alliance, Inc."
                            }
                        }
                    },
                "localname":  "NetIncomeLoss",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEARNINGS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NetIncomeLossAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Net Income (Loss) Attributable to Parent [Abstract]",
                            "terseLabel":  "Comprehensive income:"
                            }
                        }
                    },
                "localname":  "NetIncomeLossAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest":  {
                "auth_ref":  [
                    "r74",
                    "r77",
                    "r285",
                    "r290"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEARNINGS":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_NetIncomeLoss",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of Net Income (Loss) attributable to noncontrolling interest.",
                            "label":  "Net Income (Loss) Attributable to Noncontrolling Interest",
                            "terseLabel":  "Net loss attributable to noncontrolling interests"
                            }
                        }
                    },
                "localname":  "NetIncomeLossAttributableToNoncontrollingInterest",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEARNINGS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]",
                            "terseLabel":  "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]"
                            }
                        }
                    },
                "localname":  "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
                            "terseLabel":  "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
                            }
                        }
                    },
                "localname":  "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsEffectofLease842AdoptionDetails",
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable":  {
                "auth_ref":  [
                    "r127",
                    "r129"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
                            "label":  "New Accounting Pronouncements or Change in Accounting Principle [Table]",
                            "terseLabel":  "New Accounting Pronouncements or Change in Accounting Principle [Table]"
                            }
                        }
                    },
                "localname":  "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsEffectofLease842AdoptionDetails",
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting.  Includes, but is not limited to, quantification of the expected or actual impact.",
                            "label":  "New Accounting Pronouncements, Policy [Policy Text Block]",
                            "terseLabel":  "Adoption of new accounting pronouncements; New accounting pronouncements not yet adopted"
                            }
                        }
                    },
                "localname":  "NewAccountingPronouncementsPolicyPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/AccountingpoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_NoncontrollingInterestMember":  {
                "auth_ref":  [
                    "r279"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent.  A noncontrolling interest is sometimes called a minority interest.",
                            "label":  "Noncontrolling Interest [Member]",
                            "terseLabel":  "Noncontrolling interests"
                            }
                        }
                    },
                "localname":  "NoncontrollingInterestMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEQUITY"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_NondesignatedMember":  {
                "auth_ref":  [
                    "r298"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
                            "label":  "Not Designated as Hedging Instrument [Member]",
                            "terseLabel":  "Not Designated as Hedging Instrument"
                            }
                        }
                    },
                "localname":  "NondesignatedMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/FinancialinstrumentsDetails",
                    "http://walgreensbootsalliance.com/role/FinancialinstrumentsTables"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_NotesPayableToBanksMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "A written promise to pay a note to a bank.",
                            "label":  "Notes Payable to Banks [Member]",
                            "terseLabel":  "Notes payable to banks"
                            }
                        }
                    },
                "localname":  "NotesPayableToBanksMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtShortandLongTermDebtDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_NumberOfReportableSegments":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Number of segments reported by the entity.  A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
                            "label":  "Number of Reportable Segments",
                            "terseLabel":  "Number of reportable segments"
                            }
                        }
                    },
                "localname":  "NumberOfReportableSegments",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/SegmentreportingDetails"
                    ],
                "xbrltype":  "integerItemType"
                },
            "us-gaap_OperatingIncomeLoss":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEARNINGS":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
                        "weight":  1.0
                        },
                    "http://walgreensbootsalliance.com/role/SegmentreportingDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The net result for the period of deducting operating expenses from operating revenues.",
                            "label":  "Operating Income (Loss)",
                            "totalLabel":  "Operating income"
                            }
                        }
                    },
                "localname":  "OperatingIncomeLoss",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEARNINGS",
                    "http://walgreensbootsalliance.com/role/SegmentreportingDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeaseCost":  {
                "auth_ref":  [
                    "r345",
                    "r355"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term.  Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
                            "label":  "Operating Lease, Cost",
                            "terseLabel":  "Fixed"
                            }
                        }
                    },
                "localname":  "OperatingLeaseCost",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesComponentsofLeaseCostDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Lessee, Operating Lease, Liability, Payment, Due [Abstract]",
                            "terseLabel":  "Operating lease"
                            }
                        }
                    },
                "localname":  "OperatingLeaseLiabilitiesPaymentsDueAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OperatingLeaseLiability":  {
                "auth_ref":  [
                    "r337"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails_1":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        },
                    "http://walgreensbootsalliance.com/role/LeasesSupplementalBalanceSheetInformationDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Present value of lessee's discounted obligation for lease payments from operating lease.",
                            "label":  "Operating Lease, Liability",
                            "terseLabel":  "Operating lease liability",
                            "totalLabel":  "Total operating lease obligations"
                            }
                        }
                    },
                "localname":  "OperatingLeaseLiability",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails",
                    "http://walgreensbootsalliance.com/role/LeasesSupplementalBalanceSheetInformationDetails",
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeaseLiabilityCurrent":  {
                "auth_ref":  [
                    "r337"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        },
                    "http://walgreensbootsalliance.com/role/LeasesSupplementalBalanceSheetInformationDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_OperatingLeaseLiability",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
                            "label":  "Operating Lease, Liability, Current",
                            "terseLabel":  "Operating lease obligation"
                            }
                        }
                    },
                "localname":  "OperatingLeaseLiabilityCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS",
                    "http://walgreensbootsalliance.com/role/LeasesSupplementalBalanceSheetInformationDetails",
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsEffectofLease842AdoptionDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeaseLiabilityNoncurrent":  {
                "auth_ref":  [
                    "r337"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_LiabilitiesNoncurrent",
                        "weight":  1.0
                        },
                    "http://walgreensbootsalliance.com/role/LeasesSupplementalBalanceSheetInformationDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_OperatingLeaseLiability",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
                            "label":  "Operating Lease, Liability, Noncurrent",
                            "terseLabel":  "Operating lease obligation"
                            }
                        }
                    },
                "localname":  "OperatingLeaseLiabilityNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS",
                    "http://walgreensbootsalliance.com/role/LeasesSupplementalBalanceSheetInformationDetails",
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsEffectofLease842AdoptionDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeasePayments":  {
                "auth_ref":  [
                    "r341",
                    "r349"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/LeasesSupplementalCashFlowInformationDetails":  {
                        "order":  1.0,
                        "parentTag":  "wba_LeasesPayments",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
                            "label":  "Operating Lease, Payments",
                            "terseLabel":  "Operating cash flows from operating leases"
                            }
                        }
                    },
                "localname":  "OperatingLeasePayments",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesSupplementalCashFlowInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeaseRightOfUseAsset":  {
                "auth_ref":  [
                    "r336"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_AssetsNoncurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of lessee's right to use underlying asset under operating lease.",
                            "label":  "Operating Lease, Right-of-Use Asset",
                            "terseLabel":  "Operating lease right-of-use assets"
                            }
                        }
                    },
                "localname":  "OperatingLeaseRightOfUseAsset",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS",
                    "http://walgreensbootsalliance.com/role/LeasesSupplementalBalanceSheetInformationDetails",
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsEffectofLease842AdoptionDetails",
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent":  {
                "auth_ref":  [
                    "r352",
                    "r355"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Weighted average discount rate for operating lease calculated at point in time.",
                            "label":  "Operating Lease, Weighted Average Discount Rate, Percent",
                            "terseLabel":  "Operating leases"
                            }
                        }
                    },
                "localname":  "OperatingLeaseWeightedAverageDiscountRatePercent",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesAverageLeaseTermsAndDiscountsDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1":  {
                "auth_ref":  [
                    "r351",
                    "r355"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
                            "label":  "Operating Lease, Weighted Average Remaining Lease Term",
                            "terseLabel":  "Operating leases"
                            }
                        }
                    },
                "localname":  "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesAverageLeaseTermsAndDiscountsDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_OperatingSegmentsMember":  {
                "auth_ref":  [
                    "r146",
                    "r157"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
                            "label":  "Operating Segments [Member]",
                            "terseLabel":  "Reportable Segments"
                            }
                        }
                    },
                "localname":  "OperatingSegmentsMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringCostsDetails",
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofGoodwillDetails",
                    "http://walgreensbootsalliance.com/role/SalesDetails",
                    "http://walgreensbootsalliance.com/role/SegmentreportingDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_OtherAssetsCurrent":  {
                "auth_ref":  [
                    "r55"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of current assets classified as other.",
                            "label":  "Other Assets, Current",
                            "terseLabel":  "Other current assets"
                            }
                        }
                    },
                "localname":  "OtherAssetsCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS",
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsEffectofLease842AdoptionDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherAssetsNoncurrent":  {
                "auth_ref":  [
                    "r36"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_AssetsNoncurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of noncurrent assets classified as other.",
                            "label":  "Other Assets, Noncurrent",
                            "terseLabel":  "Other non-current assets"
                            }
                        }
                    },
                "localname":  "OtherAssetsNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax":  {
                "auth_ref":  [
                    "r71"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/AccumulatedothercomprehensiveincomelossDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount before tax and reclassification adjustments of other comprehensive income (loss).",
                            "label":  "Other Comprehensive Income (Loss), before Reclassifications, before Tax",
                            "terseLabel":  "Other comprehensive income (loss) before reclassification adjustments"
                            }
                        }
                    },
                "localname":  "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/AccumulatedothercomprehensiveincomelossDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax":  {
                "auth_ref":  [
                    "r64",
                    "r68"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
                            "label":  "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
                            "terseLabel":  "Unrealized gain (loss) on cash flow hedges"
                            }
                        }
                    },
                "localname":  "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax":  {
                "auth_ref":  [
                    "r62",
                    "r325"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
                            "label":  "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
                            "terseLabel":  "Currency translation adjustments"
                            }
                        }
                    },
                "localname":  "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherComprehensiveIncomeLossNetOfTax":  {
                "auth_ref":  [
                    "r75",
                    "r78",
                    "r80",
                    "r223"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/AccumulatedothercomprehensiveincomelossDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        },
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
                            "label":  "Other Comprehensive Income (Loss), Net of Tax",
                            "terseLabel":  "Other comprehensive income (loss), net of tax",
                            "totalLabel":  "Total other comprehensive income (loss)"
                            }
                        }
                    },
                "localname":  "OtherComprehensiveIncomeLossNetOfTax",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/AccumulatedothercomprehensiveincomelossDetails",
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME",
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEQUITY"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
                            "terseLabel":  "Other comprehensive income (loss), net of tax:"
                            }
                        }
                    },
                "localname":  "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax":  {
                "auth_ref":  [
                    "r66",
                    "r68"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
                            "label":  "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
                            "negatedLabel":  "Pension/postretirement obligations"
                            }
                        }
                    },
                "localname":  "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherCurrentAssetsMember":  {
                "auth_ref":  [
                    "r300",
                    "r313"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Primary financial statement caption encompassing other current assets.",
                            "label":  "Other Current Assets [Member]",
                            "terseLabel":  "Other current assets"
                            }
                        }
                    },
                "localname":  "OtherCurrentAssetsMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/FinancialinstrumentsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_OtherCurrentLiabilitiesMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Primary financial statement caption encompassing other current liabilities.",
                            "label":  "Other Current Liabilities [Member]",
                            "terseLabel":  "Other current liabilities"
                            }
                        }
                    },
                "localname":  "OtherCurrentLiabilitiesMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/FinancialinstrumentsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_OtherLiabilitiesNoncurrent":  {
                "auth_ref":  [
                    "r44"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_LiabilitiesNoncurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
                            "label":  "Other Liabilities, Noncurrent",
                            "terseLabel":  "Other non-current liabilities"
                            }
                        }
                    },
                "localname":  "OtherLiabilitiesNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS",
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsEffectofLease842AdoptionDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherLongTermDebt":  {
                "auth_ref":  [
                    "r21",
                    "r373",
                    "r391"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/DebtShortandLongTermDebtDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_LongTermDebtNoncurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of long-term debt classified as other.",
                            "label":  "Other Long-term Debt",
                            "terseLabel":  "Other"
                            }
                        }
                    },
                "localname":  "OtherLongTermDebt",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtShortandLongTermDebtDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherNoncashIncomeExpense":  {
                "auth_ref":  [
                    "r113"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
                            "label":  "Other Noncash Income (Expense)",
                            "negatedLabel":  "Other"
                            }
                        }
                    },
                "localname":  "OtherNoncashIncomeExpense",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherNoncurrentAssetsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Primary financial statement caption encompassing other noncurrent assets.",
                            "label":  "Other Noncurrent Assets [Member]",
                            "terseLabel":  "Other non-current assets"
                            }
                        }
                    },
                "localname":  "OtherNoncurrentAssetsMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/FinancialinstrumentsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_OtherNoncurrentLiabilitiesMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Primary financial statement caption encompassing other noncurrent liabilities.",
                            "label":  "Other Noncurrent Liabilities [Member]",
                            "terseLabel":  "Other non-current liabilities"
                            }
                        }
                    },
                "localname":  "OtherNoncurrentLiabilitiesMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/FinancialinstrumentsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_OtherNonoperatingIncomeExpense":  {
                "auth_ref":  [
                    "r90"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEARNINGS":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of income (expense) related to nonoperating activities, classified as other.",
                            "label":  "Other Nonoperating Income (Expense)",
                            "terseLabel":  "Other income"
                            }
                        }
                    },
                "localname":  "OtherNonoperatingIncomeExpense",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEARNINGS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherNonoperatingIncomeExpenseMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Primary financial statement caption encompassing other nonoperating income (expense).",
                            "label":  "Other Nonoperating Income (Expense) [Member]",
                            "terseLabel":  "Other income (expense)"
                            }
                        }
                    },
                "localname":  "OtherNonoperatingIncomeExpenseMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/RetirementbenefitsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_PaymentsForLegalSettlements":  {
                "auth_ref":  [
                    "r109"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The amount of cash paid for the settlement of litigation or for other legal issues during the period.",
                            "label":  "Payments for Legal Settlements",
                            "terseLabel":  "Payments for legal settlements"
                            }
                        }
                    },
                "localname":  "PaymentsForLegalSettlements",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CommitmentsandcontingenciesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PaymentsForProceedsFromOtherInvestingActivities":  {
                "auth_ref":  [
                    "r93",
                    "r96",
                    "r125"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInInvestingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of cash (inflow) outflow from investing activities classified as other.",
                            "label":  "Payments for (Proceeds from) Other Investing Activities",
                            "negatedLabel":  "Other"
                            }
                        }
                    },
                "localname":  "PaymentsForProceedsFromOtherInvestingActivities",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PaymentsForRepurchaseOfCommonStock":  {
                "auth_ref":  [
                    "r100"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The cash outflow to reacquire common stock during the period.",
                            "label":  "Payments for Repurchase of Common Stock",
                            "negatedLabel":  "Stock purchases"
                            }
                        }
                    },
                "localname":  "PaymentsForRepurchaseOfCommonStock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PaymentsForRestructuring":  {
                "auth_ref":  [
                    "r104",
                    "r204"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of cash payments made as the result of exit or disposal activities.  Excludes payments associated with a discontinued operation or an asset retirement obligation.",
                            "label":  "Payments for Restructuring",
                            "negatedTerseLabel":  "Payments"
                            }
                        }
                    },
                "localname":  "PaymentsForRestructuring",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringReserveActivityDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PaymentsOfDividends":  {
                "auth_ref":  [
                    "r100"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
                            "label":  "Payments of Dividends",
                            "negatedLabel":  "Cash dividends paid"
                            }
                        }
                    },
                "localname":  "PaymentsOfDividends",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PaymentsToAcquireBusinessesGross":  {
                "auth_ref":  [
                    "r94",
                    "r277"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The cash outflow associated with the acquisition of business during the period.  The cash portion only of the acquisition price.",
                            "label":  "Payments to Acquire Businesses, Gross",
                            "terseLabel":  "Payments to acquire business"
                            }
                        }
                    },
                "localname":  "PaymentsToAcquireBusinessesGross",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/AcquisitionsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment":  {
                "auth_ref":  [
                    "r95"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInInvestingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
                            "label":  "Payments to Acquire Property, Plant, and Equipment",
                            "negatedLabel":  "Additions to property, plant and equipment"
                            }
                        }
                    },
                "localname":  "PaymentsToAcquirePropertyPlantAndEquipment",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PostemploymentBenefitsDisclosureTextBlock":  {
                "auth_ref":  [
                    "r237"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The entire disclosure for postemployment benefits,  which may include supplemental unemployment benefits, obligations recognized for all types of benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement.  Disclosure may also include discussion that an obligation for postemployment benefits is not accrued in accordance with regulation only because the amount cannot be reasonably estimated.",
                            "label":  "Postemployment Benefits Disclosure [Text Block]",
                            "verboseLabel":  "Retirement benefits"
                            }
                        }
                    },
                "localname":  "PostemploymentBenefitsDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/Retirementbenefits"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_PreferredStockParOrStatedValuePerShare":  {
                "auth_ref":  [
                    "r24"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
                            "label":  "Preferred Stock, Par or Stated Value Per Share",
                            "terseLabel":  "Preferred stock, par value (in dollars per share)"
                            }
                        }
                    },
                "localname":  "PreferredStockParOrStatedValuePerShare",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_PreferredStockSharesAuthorized":  {
                "auth_ref":  [
                    "r24"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
                            "label":  "Preferred Stock, Shares Authorized",
                            "terseLabel":  "Preferred stock, authorized (in shares)"
                            }
                        }
                    },
                "localname":  "PreferredStockSharesAuthorized",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_PreferredStockSharesIssued":  {
                "auth_ref":  [
                    "r24"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury).  May be all or portion of the number of preferred shares authorized.  Excludes preferred shares that are classified as debt.",
                            "label":  "Preferred Stock, Shares Issued",
                            "terseLabel":  "Preferred stock, issued (in shares)"
                            }
                        }
                    },
                "localname":  "PreferredStockSharesIssued",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_PreferredStockValue":  {
                "auth_ref":  [
                    "r24"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer).  This item includes treasury stock repurchased by the entity.  Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
                            "label":  "Preferred Stock, Value, Issued",
                            "terseLabel":  "Preferred stock $.01 par value; authorized 32 million shares, none issued"
                            }
                        }
                    },
                "localname":  "PreferredStockValue",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromIssuanceOfLongTermDebt":  {
                "auth_ref":  [
                    "r98"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  7.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
                            "label":  "Proceeds from Issuance of Long-term Debt",
                            "terseLabel":  "Proceeds from debt"
                            }
                        }
                    },
                "localname":  "ProceedsFromIssuanceOfLongTermDebt",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities":  {
                "auth_ref":  [
                    "r99",
                    "r102",
                    "r125"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of cash inflow (outflow) from financing activities classified as other.",
                            "label":  "Proceeds from (Payments for) Other Financing Activities",
                            "terseLabel":  "Other"
                            }
                        }
                    },
                "localname":  "ProceedsFromPaymentsForOtherFinancingActivities",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromRepaymentsOfShortTermDebt":  {
                "auth_ref":  [
                    "r125"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
                            "label":  "Proceeds from (Repayments of) Short-term Debt",
                            "terseLabel":  "Net change in short-term debt with maturities of 3 months or less"
                            }
                        }
                    },
                "localname":  "ProceedsFromRepaymentsOfShortTermDebt",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities":  {
                "auth_ref":  [
                    "r93"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInInvestingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of cash inflow from the sale of other assets recognized in investing activities.",
                            "label":  "Proceeds from Sale of Other Assets, Investing Activities",
                            "terseLabel":  "Proceeds from sale of other assets"
                            }
                        }
                    },
                "localname":  "ProceedsFromSaleOfOtherAssetsInvestingActivities",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromStockPlans":  {
                "auth_ref":  [
                    "r97"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The cash inflow associated with the amount received from the stock plan during the period.",
                            "label":  "Proceeds from Stock Plans",
                            "terseLabel":  "Proceeds related to employee stock plans"
                            }
                        }
                    },
                "localname":  "ProceedsFromStockPlans",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProfitLoss":  {
                "auth_ref":  [
                    "r74",
                    "r77",
                    "r105",
                    "r151",
                    "r158",
                    "r281",
                    "r284",
                    "r286",
                    "r290",
                    "r291"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        },
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
                        "weight":  1.0
                        },
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEARNINGS":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NetIncomeLoss",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
                            "label":  "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
                            "terseLabel":  "Net earnings",
                            "totalLabel":  "Net earnings",
                            "verboseLabel":  "Net earnings (loss)"
                            }
                        }
                    },
                "localname":  "ProfitLoss",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED",
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME",
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEARNINGS",
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEQUITY"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentNet":  {
                "auth_ref":  [
                    "r13",
                    "r14",
                    "r198",
                    "r397"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_AssetsNoncurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale.  Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
                            "label":  "Property, Plant and Equipment, Net",
                            "terseLabel":  "Property, plant and equipment, net"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentNet",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS",
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsEffectofLease842AdoptionDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RatioOfIndebtednessToNetCapital1":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Indebtedness divided by net capital.",
                            "label":  "Ratio of Indebtedness to Net Capital",
                            "terseLabel":  "Debt to total capitalization ratio"
                            }
                        }
                    },
                "localname":  "RatioOfIndebtednessToNetCapital1",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtAdditionalInformationDetails"
                    ],
                "xbrltype":  "pureItemType"
                },
            "us-gaap_ReceivableTypeDomain":  {
                "auth_ref":  [
                    "r49"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates.",
                            "label":  "Receivable [Domain]",
                            "terseLabel":  "Receivable [Domain]"
                            }
                        }
                    },
                "localname":  "ReceivableTypeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/SupplementalinformationNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax":  {
                "auth_ref":  [
                    "r71",
                    "r73"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/AccumulatedothercomprehensiveincomelossDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount before tax of reclassification adjustments of other comprehensive income (loss).",
                            "label":  "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax",
                            "negatedTerseLabel":  "Amounts reclassified from AOCI"
                            }
                        }
                    },
                "localname":  "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/AccumulatedothercomprehensiveincomelossDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ReclassificationFromAociCurrentPeriodTax":  {
                "auth_ref":  [
                    "r69",
                    "r72",
                    "r270"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/AccumulatedothercomprehensiveincomelossDetails":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).",
                            "label":  "Reclassification from AOCI, Current Period, Tax",
                            "negatedLabel":  "Tax benefit (provision)"
                            }
                        }
                    },
                "localname":  "ReclassificationFromAociCurrentPeriodTax",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/AccumulatedothercomprehensiveincomelossDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock":  {
                "auth_ref":  [
                    "r154",
                    "r156"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations.  Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
                            "label":  "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
                            "terseLabel":  "Reconciliation of Operating Income (Loss) from Segments to Consolidated"
                            }
                        }
                    },
                "localname":  "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/SegmentreportingTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
                            "label":  "Related Party Transaction, Purchases from Related Party",
                            "terseLabel":  "Purchases, net"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionPurchasesFromRelatedParty",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/RelatedpartiesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RelatedPartyTransactionsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Related Party Transactions [Abstract]",
                            "terseLabel":  "Related Party Transactions [Abstract]"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RelatedPartyTransactionsDisclosureTextBlock":  {
                "auth_ref":  [
                    "r361"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The entire disclosure for related party transactions.  Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
                            "label":  "Related Party Transactions Disclosure [Text Block]",
                            "terseLabel":  "Related parties"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionsDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/Relatedparties"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_RepaymentsOfLongTermDebt":  {
                "auth_ref":  [
                    "r101"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
                            "label":  "Repayments of Long-term Debt",
                            "negatedLabel":  "Payments of debt"
                            }
                        }
                    },
                "localname":  "RepaymentsOfLongTermDebt",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ReportingUnitAxis":  {
                "auth_ref":  [
                    "r179",
                    "r180"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by reporting unit.",
                            "label":  "Reporting Unit [Axis]",
                            "terseLabel":  "Reporting Unit [Axis]"
                            }
                        }
                    },
                "localname":  "ReportingUnitAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ReportingUnitDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Level of reporting at which goodwill is tested for impairment.",
                            "label":  "Reporting Unit [Domain]",
                            "terseLabel":  "Reporting Unit [Domain]"
                            }
                        }
                    },
                "localname":  "ReportingUnitDomain",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Percentage of fair value of reporting unit in excess of carrying amount.",
                            "label":  "Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount",
                            "terseLabel":  "Reporting unit fair value in excess of carrying amount (as a percent)"
                            }
                        }
                    },
                "localname":  "ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsNarrativeDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_RestrictedCashAndCashEquivalents":  {
                "auth_ref":  [
                    "r9",
                    "r114",
                    "r117",
                    "r369",
                    "r392"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/SupplementalinformationSummaryofCashCashEquivalentsandRestrictedCashDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of cash and cash equivalents restricted as to withdrawal or usage.  Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.  Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
                            "label":  "Restricted Cash and Cash Equivalents",
                            "terseLabel":  "Restricted cash (included in other current assets)"
                            }
                        }
                    },
                "localname":  "RestrictedCashAndCashEquivalents",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/SupplementalinformationNarrativeDetails",
                    "http://walgreensbootsalliance.com/role/SupplementalinformationSummaryofCashCashEquivalentsandRestrictedCashDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RestructuringAndRelatedActivitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Restructuring and Related Activities [Abstract]",
                            "terseLabel":  "Restructuring and Related Activities [Abstract]"
                            }
                        }
                    },
                "localname":  "RestructuringAndRelatedActivitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock":  {
                "auth_ref":  [
                    "r215"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The entire disclosure for restructuring and related activities.  Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
                            "label":  "Restructuring and Related Activities Disclosure [Text Block]",
                            "terseLabel":  "Exit and disposal activities"
                            }
                        }
                    },
                "localname":  "RestructuringAndRelatedActivitiesDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/Exitanddisposalactivities"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_RestructuringAndRelatedCostCostIncurredToDate1":  {
                "auth_ref":  [
                    "r203",
                    "r205",
                    "r211",
                    "r214"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of costs incurred to date for the specified restructuring cost.",
                            "label":  "Restructuring and Related Cost, Cost Incurred to Date",
                            "terseLabel":  "Costs incurred"
                            }
                        }
                    },
                "localname":  "RestructuringAndRelatedCostCostIncurredToDate1",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RestructuringAndRelatedCostExpectedCost1":  {
                "auth_ref":  [
                    "r203",
                    "r205",
                    "r211",
                    "r214"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount expected to be recognized in earnings for the specified restructuring cost.",
                            "label":  "Restructuring and Related Cost, Expected Cost",
                            "terseLabel":  "Expected cost"
                            }
                        }
                    },
                "localname":  "RestructuringAndRelatedCostExpectedCost1",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RestructuringAndRelatedCostIncurredCost":  {
                "auth_ref":  [
                    "r203",
                    "r205",
                    "r211",
                    "r214"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/SegmentreportingDetails":  {
                        "order":  8.0,
                        "parentTag":  "us-gaap_OperatingIncomeLoss",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.",
                            "label":  "Restructuring and Related Cost, Incurred Cost",
                            "negatedLabel":  "Store optimization"
                            }
                        }
                    },
                "localname":  "RestructuringAndRelatedCostIncurredCost",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/SegmentreportingDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RestructuringCharges":  {
                "auth_ref":  [
                    "r112",
                    "r202",
                    "r208",
                    "r213"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan.  Excludes expenses related to a discontinued operation or an asset retirement obligation.",
                            "label":  "Restructuring Charges",
                            "terseLabel":  "Costs"
                            }
                        }
                    },
                "localname":  "RestructuringCharges",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringReserveActivityDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RestructuringCostAndReserveAxis":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by type of restructuring cost.",
                            "label":  "Restructuring Type [Axis]",
                            "terseLabel":  "Restructuring Type [Axis]",
                            "verboseLabel":  "Restructuring Type [Axis]"
                            }
                        }
                    },
                "localname":  "RestructuringCostAndReserveAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesNarrativeDetails",
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringCostsDetails",
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringReserveActivityDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RestructuringCostAndReserveLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Restructuring Cost and Reserve [Line Items]",
                            "terseLabel":  "Restructuring Cost and Reserve [Line Items]"
                            }
                        }
                    },
                "localname":  "RestructuringCostAndReserveLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesNarrativeDetails",
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringReserveActivityDetails",
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesTables"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RestructuringCosts":  {
                "auth_ref":  [
                    "r112"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan.  Excludes expenses related to a discontinued operation or an asset retirement obligation.",
                            "label":  "Restructuring Costs",
                            "terseLabel":  "Total pre-tax exit and disposal charges"
                            }
                        }
                    },
                "localname":  "RestructuringCosts",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringCostsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RestructuringPlanAxis":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by individual restructuring plan.",
                            "label":  "Restructuring Plan [Axis]",
                            "terseLabel":  "Restructuring Plan [Axis]"
                            }
                        }
                    },
                "localname":  "RestructuringPlanAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesNarrativeDetails",
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringCostsDetails",
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringReserveActivityDetails",
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesTables"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RestructuringPlanDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Identification of the individual restructuring plans.",
                            "label":  "Restructuring Plan [Domain]",
                            "terseLabel":  "Restructuring Plan [Domain]"
                            }
                        }
                    },
                "localname":  "RestructuringPlanDomain",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesNarrativeDetails",
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringCostsDetails",
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringReserveActivityDetails",
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesTables"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_RestructuringReserve":  {
                "auth_ref":  [
                    "r204",
                    "r209"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
                            "label":  "Restructuring Reserve",
                            "periodEndLabel":  "Ending balance",
                            "periodStartLabel":  "Beginning balance"
                            }
                        }
                    },
                "localname":  "RestructuringReserve",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringReserveActivityDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RestructuringReserveLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Restructuring Reserve Disclosures [Abstract]",
                            "terseLabel":  "Restructuring Reserve Disclosures [Abstract]"
                            }
                        }
                    },
                "localname":  "RestructuringReserveLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringCostsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RestructuringReserveRollForward":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
                            "label":  "Restructuring Reserve [Roll Forward]",
                            "terseLabel":  "Restructuring Reserve [Roll Forward]"
                            }
                        }
                    },
                "localname":  "RestructuringReserveRollForward",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringReserveActivityDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RestructuringReserveTranslationAdjustment":  {
                "auth_ref":  [
                    "r204",
                    "r212"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of foreign currency translation gain (loss) which decreases (increases) the restructuring reserve.",
                            "label":  "Restructuring Reserve, Foreign Currency Translation Gain (Loss)",
                            "terseLabel":  "Currency translation adjustments"
                            }
                        }
                    },
                "localname":  "RestructuringReserveTranslationAdjustment",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringReserveActivityDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RetailMember":  {
                "auth_ref":  [
                    "r234"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Sale of product directly to consumer.",
                            "label":  "Retail [Member]",
                            "terseLabel":  "Retail"
                            }
                        }
                    },
                "localname":  "RetailMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/SalesDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_RetainedEarningsAccumulatedDeficit":  {
                "auth_ref":  [
                    "r29",
                    "r228",
                    "r393"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
                            "label":  "Retained Earnings (Accumulated Deficit)",
                            "terseLabel":  "Retained earnings"
                            }
                        }
                    },
                "localname":  "RetainedEarningsAccumulatedDeficit",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS",
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsEffectofLease842AdoptionDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RetainedEarningsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
                            "label":  "Retained Earnings [Member]",
                            "terseLabel":  "Retained earnings"
                            }
                        }
                    },
                "localname":  "RetainedEarningsMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEQUITY",
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesNarrativeDetails",
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_RetirementPlanSponsorLocationAxis":  {
                "auth_ref":  [
                    "r248",
                    "r250"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by location of employer sponsoring plan designed to provide retirement benefits.  Includes, but is not limited to, defined benefit and defined contribution plans.",
                            "label":  "Retirement Plan Sponsor Location [Axis]",
                            "terseLabel":  "Retirement Plan Sponsor Location [Axis]"
                            }
                        }
                    },
                "localname":  "RetirementPlanSponsorLocationAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/RetirementbenefitsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RetirementPlanSponsorLocationDomain":  {
                "auth_ref":  [
                    "r248",
                    "r250"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Location of employer sponsoring plan designed to provide retirement benefits.  Includes, but is not limited to, defined benefit and defined contribution plans.",
                            "label":  "Retirement Plan Sponsor Location [Domain]",
                            "terseLabel":  "Retirement Plan Sponsor Location [Domain]"
                            }
                        }
                    },
                "localname":  "RetirementPlanSponsorLocationDomain",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/RetirementbenefitsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_RevenueFromContractWithCustomerAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Revenue from Contract with Customer [Abstract]",
                            "terseLabel":  "Revenue from Contract with Customer [Abstract]"
                            }
                        }
                    },
                "localname":  "RevenueFromContractWithCustomerAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax":  {
                "auth_ref":  [
                    "r231",
                    "r232"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEARNINGS":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_GrossProfit",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer.  Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
                            "label":  "Revenue from Contract with Customer, Excluding Assessed Tax",
                            "terseLabel":  "Sales"
                            }
                        }
                    },
                "localname":  "RevenueFromContractWithCustomerExcludingAssessedTax",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEARNINGS",
                    "http://walgreensbootsalliance.com/role/SalesDetails",
                    "http://walgreensbootsalliance.com/role/SegmentreportingDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RevenueFromContractWithCustomerTextBlock":  {
                "auth_ref":  [
                    "r236"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset.  Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer.  Excludes insurance and lease contracts.",
                            "label":  "Revenue from Contract with Customer [Text Block]",
                            "terseLabel":  "Sales"
                            }
                        }
                    },
                "localname":  "RevenueFromContractWithCustomerTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/Sales"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_RevolvingCreditFacilityMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
                            "label":  "Revolving Credit Facility [Member]",
                            "terseLabel":  "Credit facilities"
                            }
                        }
                    },
                "localname":  "RevolvingCreditFacilityMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtAdditionalInformationDetails",
                    "http://walgreensbootsalliance.com/role/DebtShortandLongTermDebtDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability":  {
                "auth_ref":  [
                    "r350",
                    "r355"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
                            "label":  "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
                            "terseLabel":  "Operating leases"
                            }
                        }
                    },
                "localname":  "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesSupplementalCashFlowInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_SaleAndLeasebackTransactionGainLossNet":  {
                "auth_ref":  [
                    "r348",
                    "r355",
                    "r357"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of gain (loss) on sale and leaseback transaction from transfer of asset accounted for as sale.",
                            "label":  "Sale and Leaseback Transaction, Gain (Loss), Net",
                            "terseLabel":  "Gains on sale-leaseback transactions1"
                            }
                        }
                    },
                "localname":  "SaleAndLeasebackTransactionGainLossNet",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesSupplementalCashFlowInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_SaleLeasebackTransactionDeferredGainGross":  {
                "auth_ref":  [
                    "r331"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The amount of the gain recorded in connection with the transaction involving the sale of property to another party and the lease of the property back to the seller to be recognized in future periods.",
                            "label":  "Sale Leaseback Transaction, Deferred Gain, Gross",
                            "terseLabel":  "De-recognition of deferred gains on historical sale and leaseback transactions"
                            }
                        }
                    },
                "localname":  "SaleLeasebackTransactionDeferredGainGross",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_SaleLeasebackTransactionGrossProceedsInvestingActivities":  {
                "auth_ref":  [
                    "r332",
                    "r333",
                    "r334"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInInvestingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of cash inflow before closing and debt issuance costs received by a seller-lessee in a sale-leaseback recognized in investing activities.",
                            "label":  "Sale Leaseback Transaction, Gross Proceeds, Investing Activities",
                            "terseLabel":  "Proceeds from sale-leaseback transactions"
                            }
                        }
                    },
                "localname":  "SaleLeasebackTransactionGrossProceedsInvestingActivities",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable":  {
                "auth_ref":  [
                    "r49"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date.  Presentation is categorized by current, noncurrent and unclassified receivables.",
                            "label":  "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]",
                            "terseLabel":  "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/SupplementalinformationNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock":  {
                "auth_ref":  [
                    "r71"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
                            "label":  "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
                            "terseLabel":  "Components of Accumulated Other Comprehensive Income (Loss)"
                            }
                        }
                    },
                "localname":  "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/AccumulatedothercomprehensiveincomelossTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable":  {
                "auth_ref":  [
                    "r274",
                    "r275"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
                            "label":  "Schedule of Business Acquisitions, by Acquisition [Table]",
                            "terseLabel":  "Schedule of Business Acquisitions, by Acquisition [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/AcquisitionsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the components of cash and cash equivalents.",
                            "label":  "Schedule of Cash and Cash Equivalents [Table Text Block]",
                            "terseLabel":  "Schedule of Cash and Cash Equivalents"
                            }
                        }
                    },
                "localname":  "ScheduleOfCashAndCashEquivalentsTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/SupplementalinformationTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfDebtInstrumentsTextBlock":  {
                "auth_ref":  [
                    "r43",
                    "r120",
                    "r224",
                    "r225",
                    "r226",
                    "r227",
                    "r327",
                    "r328",
                    "r330",
                    "r385"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation.  These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
                            "label":  "Schedule of Long-term Debt Instruments [Table Text Block]",
                            "verboseLabel":  "Long-Term Debt"
                            }
                        }
                    },
                "localname":  "ScheduleOfDebtInstrumentsTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable":  {
                "auth_ref":  [
                    "r247",
                    "r248",
                    "r249",
                    "r250",
                    "r256"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan.  It may be appropriate to group certain similar plans.  Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
                            "label":  "Schedule of Defined Benefit Plans Disclosures [Table]",
                            "terseLabel":  "Schedule of Defined Benefit Plans Disclosures [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfDefinedBenefitPlansDisclosuresTable",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/RetirementbenefitsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock":  {
                "auth_ref":  [
                    "r302"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of derivative instruments (including nonderivative instruments that are designated and qualify as hedging instruments) of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.",
                            "label":  "Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block]",
                            "terseLabel":  "Gains and (Losses) due to Changes in Fair Value Recognized in Earnings"
                            }
                        }
                    },
                "localname":  "ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/FinancialinstrumentsTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfDividendsPayableTextBlock":  {
                "auth_ref":  [
                    "r116"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of all or some of the information related to dividends declared, but not paid, as of the financial reporting date.",
                            "label":  "Schedule of Dividends Payable [Table Text Block]",
                            "terseLabel":  "Schedule of Dividends Payable"
                            }
                        }
                    },
                "localname":  "ScheduleOfDividendsPayableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/SupplementalinformationTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Schedule of Equity Method Investments [Line Items]",
                            "terseLabel":  "Schedule of Equity Method Investments [Line Items]"
                            }
                        }
                    },
                "localname":  "ScheduleOfEquityMethodInvestmentsLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/EquitymethodinvestmentsNarrativeDetails",
                    "http://walgreensbootsalliance.com/role/EquitymethodinvestmentsScheduleofEquityMethodInvestmentsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfEquityMethodInvestmentsTable":  {
                "auth_ref":  [
                    "r168"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Summarization of information required and determined to be disclosed concerning equity method investments in common stock.  The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.",
                            "label":  "Schedule of Equity Method Investments [Table]",
                            "terseLabel":  "Schedule of Equity Method Investments [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfEquityMethodInvestmentsTable",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/EquitymethodinvestmentsNarrativeDetails",
                    "http://walgreensbootsalliance.com/role/EquitymethodinvestmentsScheduleofEquityMethodInvestmentsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock":  {
                "auth_ref":  [
                    "r317",
                    "r318"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis.  The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
                            "label":  "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
                            "terseLabel":  "Assets and Liabilities Measured at Fair Value on a Recurring Basis"
                            }
                        }
                    },
                "localname":  "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/FairvaluemeasurementsTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock":  {
                "auth_ref":  [
                    "r184",
                    "r188"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
                            "label":  "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
                            "terseLabel":  "Schedule of Finite-Lived Intangible Assets by Major Class"
                            }
                        }
                    },
                "localname":  "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfGoodwillTable":  {
                "auth_ref":  [
                    "r178",
                    "r181"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
                            "label":  "Schedule of Goodwill [Table]",
                            "terseLabel":  "Schedule of Goodwill [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfGoodwillTable",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsNarrativeDetails",
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofGoodwillDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfGoodwillTextBlock":  {
                "auth_ref":  [
                    "r178",
                    "r181"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
                            "label":  "Schedule of Goodwill [Table Text Block]",
                            "terseLabel":  "Schedule of Goodwill"
                            }
                        }
                    },
                "localname":  "ScheduleOfGoodwillTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock":  {
                "auth_ref":  [
                    "r242"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
                            "label":  "Schedule of Net Benefit Costs [Table Text Block]",
                            "terseLabel":  "Components of Net Periodic Benefit Cost"
                            }
                        }
                    },
                "localname":  "ScheduleOfNetBenefitCostsTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/RetirementbenefitsTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock":  {
                "auth_ref":  [
                    "r127",
                    "r129",
                    "r142",
                    "r143",
                    "r144"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.",
                            "label":  "Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block]",
                            "terseLabel":  "Schedule of New Accounting Pronouncements and Changes in Accounting Principles"
                            }
                        }
                    },
                "localname":  "ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsNewaccountingpronouncementsTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock":  {
                "auth_ref":  [
                    "r295"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the notional amounts of outstanding derivative positions.",
                            "label":  "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]",
                            "terseLabel":  "Notional Amounts, Fair Value and Balance Sheet Presentation of Derivative Instruments Outstanding"
                            }
                        }
                    },
                "localname":  "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/FinancialinstrumentsTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of related party transactions.  Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.",
                            "label":  "Schedule of Related Party Transactions [Table Text Block]",
                            "terseLabel":  "Schedule of Related Party Transactions"
                            }
                        }
                    },
                "localname":  "ScheduleOfRelatedPartyTransactionsTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/RelatedpartiesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock":  {
                "auth_ref":  [
                    "r9",
                    "r117",
                    "r369",
                    "r392"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.",
                            "label":  "Restrictions on Cash and Cash Equivalents [Table Text Block]",
                            "terseLabel":  "Restrictions on Cash and Cash Equivalents"
                            }
                        }
                    },
                "localname":  "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/SupplementalinformationTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable":  {
                "auth_ref":  [
                    "r206",
                    "r207",
                    "r210"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
                            "label":  "Schedule of Restructuring and Related Costs [Table]",
                            "terseLabel":  "Schedule of Restructuring and Related Costs [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfRestructuringAndRelatedCostsTable",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesNarrativeDetails",
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringCostsDetails",
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringReserveActivityDetails",
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesTables"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock":  {
                "auth_ref":  [
                    "r206",
                    "r207",
                    "r210"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
                            "label":  "Restructuring and Related Costs [Table Text Block]",
                            "terseLabel":  "Restructuring and Related Costs"
                            }
                        }
                    },
                "localname":  "ScheduleOfRestructuringAndRelatedCostsTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock":  {
                "auth_ref":  [
                    "r204",
                    "r212"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost.  This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities.  This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
                            "label":  "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
                            "terseLabel":  "Change in Restructuring Liabilities"
                            }
                        }
                    },
                "localname":  "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable":  {
                "auth_ref":  [
                    "r145",
                    "r151",
                    "r153",
                    "r155",
                    "r178"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "A table disclosing the profit or loss and total assets for each reportable segment of the entity.  An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
                            "label":  "Schedule of Segment Reporting Information, by Segment [Table]",
                            "terseLabel":  "Schedule of Segment Reporting Information, by Segment [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfSegmentReportingInformationBySegmentTable",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/SegmentreportingDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfShortTermDebtTextBlock":  {
                "auth_ref":  [
                    "r39"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
                            "label":  "Schedule of Short-term Debt [Table Text Block]",
                            "terseLabel":  "Short-Term Borrowings"
                            }
                        }
                    },
                "localname":  "ScheduleOfShortTermDebtTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock":  {
                "auth_ref":  [
                    "r188"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
                            "label":  "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
                            "terseLabel":  "Schedule of Future Amortization Expense"
                            }
                        }
                    },
                "localname":  "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_SegmentDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
                            "label":  "Segments [Domain]",
                            "terseLabel":  "Segments [Domain]"
                            }
                        }
                    },
                "localname":  "SegmentDomain",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringCostsDetails",
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofGoodwillDetails",
                    "http://walgreensbootsalliance.com/role/SalesDetails",
                    "http://walgreensbootsalliance.com/role/SegmentreportingDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_SegmentReportingAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Segment Reporting [Abstract]",
                            "terseLabel":  "Segment Reporting [Abstract]"
                            }
                        }
                    },
                "localname":  "SegmentReportingAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SegmentReportingDisclosureTextBlock":  {
                "auth_ref":  [
                    "r161"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The entire disclosure for reporting segments including data and tables.  Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
                            "label":  "Segment Reporting Disclosure [Text Block]",
                            "terseLabel":  "Segment reporting"
                            }
                        }
                    },
                "localname":  "SegmentReportingDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/Segmentreporting"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_SegmentReportingInformationLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Segment Reporting Information [Line Items]",
                            "terseLabel":  "Segment Reporting Information [Line Items]"
                            }
                        }
                    },
                "localname":  "SegmentReportingInformationLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/SegmentreportingDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SellingGeneralAndAdministrativeExpense":  {
                "auth_ref":  [
                    "r89",
                    "r171"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEARNINGS":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_OperatingIncomeLoss",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses.  Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products.  Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges.  General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
                            "label":  "Selling, General and Administrative Expense",
                            "terseLabel":  "Selling, general and administrative expenses"
                            }
                        }
                    },
                "localname":  "SellingGeneralAndAdministrativeExpense",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEARNINGS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_SellingGeneralAndAdministrativeExpensesMember":  {
                "auth_ref":  [
                    "r91"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Primary financial statement caption encompassing selling, general and administrative expense.",
                            "label":  "Selling, General and Administrative Expenses [Member]",
                            "terseLabel":  "Selling, general and administrative (expenses) income"
                            }
                        }
                    },
                "localname":  "SellingGeneralAndAdministrativeExpensesMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/FinancialinstrumentsDetails",
                    "http://walgreensbootsalliance.com/role/RetirementbenefitsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ShareBasedCompensation":  {
                "auth_ref":  [
                    "r111"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of noncash expense for share-based payment arrangement.",
                            "label":  "Share-based Payment Arrangement, Noncash Expense",
                            "terseLabel":  "Stock compensation expense"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensation",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ShortTermBorrowings":  {
                "auth_ref":  [
                    "r18",
                    "r371",
                    "r390"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
                            "label":  "Short-term Debt",
                            "terseLabel":  "Total short-term debt",
                            "verboseLabel":  "Short-term debt"
                            }
                        }
                    },
                "localname":  "ShortTermBorrowings",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS",
                    "http://walgreensbootsalliance.com/role/DebtShortandLongTermDebtDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ShortTermDebtTypeAxis":  {
                "auth_ref":  [
                    "r39"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by type of short-term debt arrangement.",
                            "label":  "Short-term Debt, Type [Axis]",
                            "terseLabel":  "Short-term Debt, Type [Axis]"
                            }
                        }
                    },
                "localname":  "ShortTermDebtTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtAdditionalInformationDetails",
                    "http://walgreensbootsalliance.com/role/DebtShortandLongTermDebtDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ShortTermDebtTypeDomain":  {
                "auth_ref":  [
                    "r37"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
                            "label":  "Short-term Debt, Type [Domain]",
                            "terseLabel":  "Short-term Debt, Type [Domain]"
                            }
                        }
                    },
                "localname":  "ShortTermDebtTypeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtAdditionalInformationDetails",
                    "http://walgreensbootsalliance.com/role/DebtShortandLongTermDebtDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ShortTermDebtWeightedAverageInterestRateOverTime":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Weighted average interest rate of short-term debt outstanding calculated over time.",
                            "label":  "Short-term Debt, Weighted Average Interest Rate, over Time",
                            "terseLabel":  "Weighted average interest rate"
                            }
                        }
                    },
                "localname":  "ShortTermDebtWeightedAverageInterestRateOverTime",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtAdditionalInformationDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_ShorttermDebtAverageOutstandingAmount":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "For the form of debt having an initial term of less than one year or less than the normal operating cycle, if longer, average borrowings during the period.",
                            "label":  "Short-term Debt, Average Outstanding Amount",
                            "terseLabel":  "Average daily short-term borrowings"
                            }
                        }
                    },
                "localname":  "ShorttermDebtAverageOutstandingAmount",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtAdditionalInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_SignificantAccountingPoliciesTextBlock":  {
                "auth_ref":  [
                    "r126"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The entire disclosure for all significant accounting policies of the reporting entity.",
                            "label":  "Significant Accounting Policies [Text Block]",
                            "terseLabel":  "Accounting policies"
                            }
                        }
                    },
                "localname":  "SignificantAccountingPoliciesTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/Accountingpolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_StatementBusinessSegmentsAxis":  {
                "auth_ref":  [
                    "r0",
                    "r151",
                    "r178",
                    "r201",
                    "r205",
                    "r214",
                    "r405"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by business segments.",
                            "label":  "Segments [Axis]",
                            "terseLabel":  "Segments [Axis]"
                            }
                        }
                    },
                "localname":  "StatementBusinessSegmentsAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringCostsDetails",
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofGoodwillDetails",
                    "http://walgreensbootsalliance.com/role/SalesDetails",
                    "http://walgreensbootsalliance.com/role/SegmentreportingDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementClassOfStockAxis":  {
                "auth_ref":  [
                    "r23",
                    "r24",
                    "r25",
                    "r223"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by the different classes of stock of the entity.",
                            "label":  "Class of Stock [Axis]",
                            "terseLabel":  "Class of Stock [Axis]"
                            }
                        }
                    },
                "localname":  "StatementClassOfStockAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CoverPage"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementEquityComponentsAxis":  {
                "auth_ref":  [
                    "r47",
                    "r223"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information by component of equity.",
                            "label":  "Equity Components [Axis]",
                            "terseLabel":  "Equity Components [Axis]"
                            }
                        }
                    },
                "localname":  "StatementEquityComponentsAxis",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/AccumulatedothercomprehensiveincomelossDetails",
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEQUITY",
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesNarrativeDetails",
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsNarrativeDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Statement [Line Items]",
                            "terseLabel":  "Statement [Line Items]"
                            }
                        }
                    },
                "localname":  "StatementLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEQUITY"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementOfCashFlowsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Statement of Cash Flows [Abstract]",
                            "terseLabel":  "Statement of Cash Flows [Abstract]"
                            }
                        }
                    },
                "localname":  "StatementOfCashFlowsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementOfFinancialPositionAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Statement of Financial Position [Abstract]",
                            "terseLabel":  "Statement of Financial Position [Abstract]"
                            }
                        }
                    },
                "localname":  "StatementOfFinancialPositionAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Statement of Comprehensive Income [Abstract]",
                            "terseLabel":  "Statement of Comprehensive Income [Abstract]"
                            }
                        }
                    },
                "localname":  "StatementOfIncomeAndComprehensiveIncomeAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementOfStockholdersEquityAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Statement of Stockholders' Equity [Abstract]",
                            "terseLabel":  "Statement of Stockholders' Equity [Abstract]"
                            }
                        }
                    },
                "localname":  "StatementOfStockholdersEquityAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementTable":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
                            "label":  "Statement [Table]",
                            "terseLabel":  "Statement [Table]"
                            }
                        }
                    },
                "localname":  "StatementTable",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEQUITY"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation":  {
                "auth_ref":  [
                    "r24",
                    "r25",
                    "r223",
                    "r228"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Number, after forfeiture, of shares or units issued under share-based payment arrangement.  Excludes shares or units issued under employee stock ownership plan (ESOP).",
                            "label":  "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
                            "verboseLabel":  "Employee stock purchase and option plans (in shares)"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesShareBasedCompensation",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEQUITY"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation":  {
                "auth_ref":  [
                    "r24",
                    "r25",
                    "r228",
                    "r260",
                    "r261"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Value, after forfeiture, of shares issued under share-based payment arrangement.  Excludes employee stock ownership plan (ESOP).",
                            "label":  "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
                            "verboseLabel":  "Employee stock purchase and option plans"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodValueShareBasedCompensation",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEQUITY"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockholdersEquity":  {
                "auth_ref":  [
                    "r25",
                    "r30",
                    "r31",
                    "r164"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent.  The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest).  This excludes temporary equity and is sometimes called permanent equity.",
                            "label":  "Stockholders' Equity Attributable to Parent",
                            "totalLabel":  "Total Walgreens Boots Alliance, Inc. shareholders\u2019 equity"
                            }
                        }
                    },
                "localname":  "StockholdersEquity",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest":  {
                "auth_ref":  [
                    "r279",
                    "r280",
                    "r289"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_LiabilitiesAndStockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests.  Amount excludes temporary equity.  Alternate caption for the concept is permanent equity.",
                            "label":  "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
                            "periodEndLabel":  "Ending Balance",
                            "periodStartLabel":  "Beginning Balance",
                            "totalLabel":  "Total equity"
                            }
                        }
                    },
                "localname":  "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/AccumulatedothercomprehensiveincomelossDetails",
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS",
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEQUITY"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
                            "terseLabel":  "Equity:",
                            "verboseLabel":  "Equity:"
                            }
                        }
                    },
                "localname":  "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS",
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SubleaseIncome":  {
                "auth_ref":  [
                    "r347",
                    "r355"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of sublease income excluding finance and operating lease expense.",
                            "label":  "Sublease Income",
                            "negatedLabel":  "Sublease income"
                            }
                        }
                    },
                "localname":  "SubleaseIncome",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesComponentsofLeaseCostDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock":  {
                "auth_ref":  [
                    "r61"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.",
                            "label":  "Supplemental Balance Sheet Disclosures [Text Block]",
                            "terseLabel":  "Supplemental information"
                            }
                        }
                    },
                "localname":  "SupplementalBalanceSheetDisclosuresTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/Supplementalinformation"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_SupplementalCashFlowElementsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "label":  "Supplemental Cash Flow Elements [Abstract]",
                            "terseLabel":  "Supplemental Cash Flow Elements [Abstract]"
                            }
                        }
                    },
                "localname":  "SupplementalCashFlowElementsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_TradeAccountsReceivableMember":  {
                "auth_ref":  [
                    "r48"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount due from customers or clients for goods or services  that have been delivered or sold in the normal course of business.",
                            "label":  "Trade Accounts Receivable [Member]",
                            "terseLabel":  "Trade Accounts Receivable"
                            }
                        }
                    },
                "localname":  "TradeAccountsReceivableMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/SupplementalinformationNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_TrademarksAndTradeNamesMember":  {
                "auth_ref":  [
                    "r276"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.",
                            "label":  "Trademarks and Trade Names [Member]",
                            "terseLabel":  "Trade names and trademarks",
                            "verboseLabel":  "Trade names and trademarks"
                            }
                        }
                    },
                "localname":  "TrademarksAndTradeNamesMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofFiniteLivedIntangibleAssetsbyMajorClassDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_TreasuryStockMember":  {
                "auth_ref":  [
                    "r46",
                    "r229"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Shares of an entity that have been repurchased by the entity.  This stock has no voting rights and receives no dividends.  Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital.  Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer.  Classified within temporary equity if redemption is outside the control of the issuer.",
                            "label":  "Treasury Stock [Member]",
                            "terseLabel":  "Treasury stock amount"
                            }
                        }
                    },
                "localname":  "TreasuryStockMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEQUITY"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_TreasuryStockShares":  {
                "auth_ref":  [
                    "r46",
                    "r229"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date.  This stock has no voting rights and receives no dividends.",
                            "label":  "Treasury Stock, Shares",
                            "terseLabel":  "Treasury stock, at cost (in shares)"
                            }
                        }
                    },
                "localname":  "TreasuryStockShares",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_TreasuryStockSharesAcquired":  {
                "auth_ref":  [
                    "r25",
                    "r223",
                    "r228"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Number of shares that have been repurchased during the period and are being held in treasury.",
                            "label":  "Treasury Stock, Shares, Acquired",
                            "negatedLabel":  "Treasury stock purchases (in shares)"
                            }
                        }
                    },
                "localname":  "TreasuryStockSharesAcquired",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEQUITY"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_TreasuryStockValue":  {
                "auth_ref":  [
                    "r46",
                    "r229",
                    "r230"
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The amount allocated to treasury stock.  Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
                            "label":  "Treasury Stock, Value",
                            "negatedLabel":  "Treasury stock, at cost; 284,423,873 shares at November 30, 2019 and 277,126,116 shares at August 31, 2019"
                            }
                        }
                    },
                "localname":  "TreasuryStockValue",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_TreasuryStockValueAcquiredCostMethod":  {
                "auth_ref":  [
                    "r223",
                    "r228",
                    "r229"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Equity impact of the cost of common and preferred stock that were repurchased during the period.  Recorded using the cost method.",
                            "label":  "Treasury Stock, Value, Acquired, Cost Method",
                            "negatedLabel":  "Treasury stock purchases"
                            }
                        }
                    },
                "localname":  "TreasuryStockValueAcquiredCostMethod",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEQUITY"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_TypeOfAdoptionMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Adoption and early adoption of sources of change to generally accepted accounting principles (GAAP) in the United States.  The FASB released the FASB Accounting Standards Codification as the authoritative source of literature effective for interim and annual periods ending after September 15, 2009.  As part of the Codification process, the FASB issues Accounting Standards Updates to amend the Codification but otherwise the Accounting Standards Updates are not authoritative in their own right.  All previous accounting standards (such as FASB Statements of Financial Accounting Standards, FASB Interpretations, FASB Staff Positions, Emerging Issues Task Force Consensuses, other pronouncements of the FASB or other designated bodies, or other forms of GAAP are considered accounting pronouncements) were superseded upon the adoption of the Codification.  For an interim period, references to the superseded standards are included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.",
                            "label":  "Type of Adoption [Domain]",
                            "terseLabel":  "Type of Adoption [Domain]"
                            }
                        }
                    },
                "localname":  "TypeOfAdoptionMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/NewaccountingpronouncementsNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_TypeOfRestructuringDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Identification of the types of restructuring costs.",
                            "label":  "Type of Restructuring [Domain]",
                            "terseLabel":  "Type of Restructuring [Domain]"
                            }
                        }
                    },
                "localname":  "TypeOfRestructuringDomain",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesNarrativeDetails",
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringCostsDetails",
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringReserveActivityDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_UnsecuredDebtMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets.",
                            "label":  "Unsecured Debt [Member]",
                            "terseLabel":  "Unsecured Notes",
                            "verboseLabel":  "Unsecured Debt"
                            }
                        }
                    },
                "localname":  "UnsecuredDebtMember",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtAdditionalInformationDetails",
                    "http://walgreensbootsalliance.com/role/DebtShortandLongTermDebtDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_VariableLeaseCost":  {
                "auth_ref":  [
                    "r346",
                    "r355"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
                            "label":  "Variable Lease, Cost",
                            "terseLabel":  "Variable"
                            }
                        }
                    },
                "localname":  "VariableLeaseCost",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesComponentsofLeaseCostDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding":  {
                "auth_ref":  [
                    "r135",
                    "r139"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
                            "label":  "Weighted Average Number of Shares Outstanding, Diluted",
                            "terseLabel":  "Diluted (in shares)"
                            }
                        }
                    },
                "localname":  "WeightedAverageNumberOfDilutedSharesOutstanding",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEARNINGS"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic":  {
                "auth_ref":  [
                    "r134",
                    "r139"
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
                            "label":  "Weighted Average Number of Shares Outstanding, Basic",
                            "terseLabel":  "Basic (in shares)"
                            }
                        }
                    },
                "localname":  "WeightedAverageNumberOfSharesOutstandingBasic",
                "nsuri":  "http://fasb.org/us-gaap/2019-01-31",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEARNINGS"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "wba_A2125NotesPayableDue2026Member":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "A written promise to pay a note to a third party.",
                            "label":  "2.125% Notes Payable Due 2026 [Member]",
                            "terseLabel":  "2.125% unsecured Euro notes due 2026"
                            }
                        }
                    },
                "localname":  "A2125NotesPayableDue2026Member",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtShortandLongTermDebtDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_A2700NotesPayableDue2019Member":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "A written promise to pay a note to a third party.",
                            "label":  "2.700% Notes Payable Due 2019 [Member]",
                            "terseLabel":  "2.700% unsecured notes due 2019"
                            }
                        }
                    },
                "localname":  "A2700NotesPayableDue2019Member",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtShortandLongTermDebtDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_A2875NotesPayableDue2020Member":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "A written promise to pay a note to a third party.",
                            "label":  "2.875% Notes Payable, Due 2020 [Member]",
                            "terseLabel":  "2.875% unsecured Pound sterling notes due 2020",
                            "verboseLabel":  "2.875% Walgreens Boots Alliance, Inc. notes due 2020"
                            }
                        }
                    },
                "localname":  "A2875NotesPayableDue2020Member",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CoverPage",
                    "http://walgreensbootsalliance.com/role/DebtShortandLongTermDebtDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_A3100NotesPayableDue2022Member":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "A written promise to pay a note to a third party.",
                            "label":  "3.100% Notes Payable, Due 2022 [Member]",
                            "terseLabel":  "3.100% unsecured notes due 2022"
                            }
                        }
                    },
                "localname":  "A3100NotesPayableDue2022Member",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtShortandLongTermDebtDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_A3300NotesPayableDue2021Member":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "A written promise to pay a note to a third party.",
                            "label":  "3.300% Notes Payable Due 2021 [Member]",
                            "terseLabel":  "3.300% unsecured notes due 2021"
                            }
                        }
                    },
                "localname":  "A3300NotesPayableDue2021Member",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtShortandLongTermDebtDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_A3450NotesPayableDue2026Member":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "A written promise to pay a note to a third party.",
                            "label":  "3.450% Notes Payable, Due 2026 [Member]",
                            "terseLabel":  "3.450% unsecured notes due 2026",
                            "verboseLabel":  "2.125% Walgreens Boots Alliance, Inc. notes due 2026"
                            }
                        }
                    },
                "localname":  "A3450NotesPayableDue2026Member",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CoverPage",
                    "http://walgreensbootsalliance.com/role/DebtShortandLongTermDebtDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_A3600NotesPayableDue2025Member":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "A written promise to pay a note to a third party.",
                            "label":  "3.600% Notes Payable, Due 2025 [Member]",
                            "terseLabel":  "3.600% unsecured Pound sterling notes due 2025",
                            "verboseLabel":  "3.600% Walgreens Boots Alliance, Inc. notes due 2025"
                            }
                        }
                    },
                "localname":  "A3600NotesPayableDue2025Member",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CoverPage",
                    "http://walgreensbootsalliance.com/role/DebtShortandLongTermDebtDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_A3800NotesPayableDue2024Member":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "A written promise to pay a note to a third party.",
                            "label":  "3.800% Notes Payable, Due 2024 [Member]",
                            "terseLabel":  "3.800% unsecured notes due 2024"
                            }
                        }
                    },
                "localname":  "A3800NotesPayableDue2024Member",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtShortandLongTermDebtDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_A4400NotesPayableDue2042Member":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "A written promise to pay a note to a third party.",
                            "label":  "4.400% Notes Payable, Due 2042 [Member]",
                            "terseLabel":  "4.400% unsecured notes due 2042"
                            }
                        }
                    },
                "localname":  "A4400NotesPayableDue2042Member",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtShortandLongTermDebtDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_A4500NotesPayableDue2034Member":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "A written promise to pay a note to a third party.",
                            "label":  "4.500% Notes Payable, Due 2034 [Member]",
                            "terseLabel":  "4.500% unsecured notes due 2034"
                            }
                        }
                    },
                "localname":  "A4500NotesPayableDue2034Member",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtShortandLongTermDebtDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_A4650NotesPayableDue2046Member":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "A written promise to pay a note to a third party.",
                            "label":  "4.650% Notes Payable Due 2046 [Member]",
                            "terseLabel":  "4.650% unsecured notes due 2046"
                            }
                        }
                    },
                "localname":  "A4650NotesPayableDue2046Member",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtShortandLongTermDebtDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_A4800NotesPayableDue2044Member":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "A written promise to pay a note to a third party.",
                            "label":  "4.800% Notes Payable, Due 2044 [Member]",
                            "terseLabel":  "4.800% unsecured notes due 2044"
                            }
                        }
                    },
                "localname":  "A4800NotesPayableDue2044Member",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtShortandLongTermDebtDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_AOCINetInvestmentHedgesParentMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "AOCI, Net Investment Hedges, Parent",
                            "label":  "AOCI, Net Investment Hedges, Parent [Member]",
                            "terseLabel":  "Net investment hedges"
                            }
                        }
                    },
                "localname":  "AOCINetInvestmentHedgesParentMember",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/AccumulatedothercomprehensiveincomelossDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_AccumulatedOtherComprehensiveIncomeofEquityMethodInvestmentsAttributableToParentMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Accumulated Other Comprehensive Income of Equity Method Investments, Attributable To Parent [Member]",
                            "label":  "Accumulated Other Comprehensive Income of Equity Method Investments, Attributable To Parent [Member]",
                            "terseLabel":  "Share of OCI of equity method investments"
                            }
                        }
                    },
                "localname":  "AccumulatedOtherComprehensiveIncomeofEquityMethodInvestmentsAttributableToParentMember",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/AccumulatedothercomprehensiveincomelossDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_AdjustedOperatingIncome":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/SegmentreportingDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_OperatingIncomeLoss",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The total amount of adjusted operating income, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operation.",
                            "label":  "Adjusted Operating Income",
                            "terseLabel":  "Adjusted operating income"
                            }
                        }
                    },
                "localname":  "AdjustedOperatingIncome",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/SegmentreportingDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "wba_AdjustmentsToEquityEarningsInEquityInvestmentOne":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/SegmentreportingDetails":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_OperatingIncomeLoss",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Adjustments To Equity Earnings In Equity Investment One",
                            "label":  "Adjustments To Equity Earnings In Equity Investment One",
                            "terseLabel":  "Adjustments to equity earnings in AmerisourceBergen"
                            }
                        }
                    },
                "localname":  "AdjustmentsToEquityEarningsInEquityInvestmentOne",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/SegmentreportingDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "wba_AmerisourceBergenAndOtherEquityMethodInvestmentsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The aggregate of all equity method investments.",
                            "label":  "AmerisourceBergen And Other Equity Method Investments [Member]",
                            "terseLabel":  "Total"
                            }
                        }
                    },
                "localname":  "AmerisourceBergenAndOtherEquityMethodInvestmentsMember",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/EquitymethodinvestmentsScheduleofEquityMethodInvestmentsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_AmerisourceBergenCorporationMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "An equity method investee of the company.",
                            "label":  "AmerisourceBergen Corporation [Member]",
                            "verboseLabel":  "AmerisourceBergen"
                            }
                        }
                    },
                "localname":  "AmerisourceBergenCorporationMember",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/EquitymethodinvestmentsNarrativeDetails",
                    "http://walgreensbootsalliance.com/role/EquitymethodinvestmentsScheduleofEquityMethodInvestmentsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_AssetImpairmentRestructuringChargesMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Asset Impairment Restructuring Charges",
                            "label":  "Asset Impairment Restructuring Charges [Member]",
                            "terseLabel":  "Asset impairment"
                            }
                        }
                    },
                "localname":  "AssetImpairmentRestructuringChargesMember",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesNarrativeDetails",
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringCostsDetails",
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringReserveActivityDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_AssetPurchaseAgreementNumberofDistributionCentersExpectedToBeAcquired":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Asset Purchase Agreement, Number of Distribution Centers Expected To Be Acquired",
                            "label":  "Asset Purchase Agreement, Number of Distribution Centers Expected To Be Acquired",
                            "terseLabel":  "Number of distribution centers expected to be acquired"
                            }
                        }
                    },
                "localname":  "AssetPurchaseAgreementNumberofDistributionCentersExpectedToBeAcquired",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/AcquisitionsDetails"
                    ],
                "xbrltype":  "integerItemType"
                },
            "wba_AssetsAndLiabilitiesLesseeTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Assets And Liabilities, Lessee",
                            "label":  "Assets And Liabilities, Lessee [Table Text Block]",
                            "terseLabel":  "Assets And Liabilities, Lessee"
                            }
                        }
                    },
                "localname":  "AssetsAndLiabilitiesLesseeTableTextBlock",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "wba_August2018RevolvingCreditAgreementMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "August 2018 Revolving Credit Agreement [Member]",
                            "label":  "August 2018 Revolving Credit Agreement [Member]",
                            "terseLabel":  "August 2018 Revolving Credit Agreement"
                            }
                        }
                    },
                "localname":  "August2018RevolvingCreditAgreementMember",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_August2019RevolvingCreditAgreementsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "August 2019 Revolving Credit Agreements",
                            "label":  "August 2019 Revolving Credit Agreements [Member]",
                            "terseLabel":  "August 2019 Revolving Credit Agreements"
                            }
                        }
                    },
                "localname":  "August2019RevolvingCreditAgreementsMember",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_BootsReportingUnitMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Boots Reporting Unit",
                            "label":  "Boots Reporting Unit [Member]",
                            "terseLabel":  "Boots Reporting Unit"
                            }
                        }
                    },
                "localname":  "BootsReportingUnitMember",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_BusinessInvestmentandAssetAcquisitionsNetofCashAcquired":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInInvestingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.  This item also includes the cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
                            "label":  "Business, Investment and Asset Acquisitions, Net of Cash Acquired",
                            "terseLabel":  "Business, investment and asset acquisitions, net of cash acquired"
                            }
                        }
                    },
                "localname":  "BusinessInvestmentandAssetAcquisitionsNetofCashAcquired",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWSUNAUDITED"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "wba_CashFlowLesseeAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Cash Flow, Lessee",
                            "label":  "Cash Flow, Lessee [Abstract]",
                            "terseLabel":  "Cash paid for amounts included in the measurement of lease obligations"
                            }
                        }
                    },
                "localname":  "CashFlowLesseeAbstract",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesSupplementalCashFlowInformationDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "wba_CostTransformationRestructuringProgramMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Cost transformation program is a restructuring plan to reduce costs and increase operating efficiencies.",
                            "label":  "Cost Transformation restructuring Program [Member]",
                            "terseLabel":  "Cost Transformation Program"
                            }
                        }
                    },
                "localname":  "CostTransformationRestructuringProgramMember",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesNarrativeDetails",
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesTables"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_CustomerRelationshipsAndLoyaltyCardHoldersMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Refers to customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships and loyalty card, similar to a credit card, debit card, or digital card that identifies the card holder as a member in a loyalty program.",
                            "label":  "Customer Relationships and Loyalty Card Holders [Member]",
                            "terseLabel":  "Customer relationships and loyalty card holders1"
                            }
                        }
                    },
                "localname":  "CustomerRelationshipsAndLoyaltyCardHoldersMember",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofFiniteLivedIntangibleAssetsbyMajorClassDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_DebtIssuanceNoteFiveMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "This element details information about the total 700 million pounds debt issuance.",
                            "label":  "Debt Issuance Note Five [Member]",
                            "terseLabel":  "Total 700 million pounds debt issuance"
                            }
                        }
                    },
                "localname":  "DebtIssuanceNoteFiveMember",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtNoteIssuancesDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_DebtIssuanceNoteFourMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "This element details information about the total $6.0 billion debt issuance.",
                            "label":  "Debt Issuance Note Four [Member]",
                            "terseLabel":  "Total $6.0 billion debt issuance"
                            }
                        }
                    },
                "localname":  "DebtIssuanceNoteFourMember",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtNoteIssuancesDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_DebtIssuanceNoteOneMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "This element details information about the total $8.0 billion debt issuance.",
                            "label":  "Debt Issuance Note One [Member]",
                            "terseLabel":  "Total $8.0 billion debt issuance"
                            }
                        }
                    },
                "localname":  "DebtIssuanceNoteOneMember",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtNoteIssuancesDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_DebtIssuanceNoteSixMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "This element details information about the total 750 million Euros debt issuance.",
                            "label":  "Debt Issuance Note Six [Member]",
                            "terseLabel":  "Total 750 million euros debt issuance"
                            }
                        }
                    },
                "localname":  "DebtIssuanceNoteSixMember",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtNoteIssuancesDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_DebtIssuanceNoteTwoMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "This element details information about the total $4.0 billion debt issuance.",
                            "label":  "Debt Issuance Note Two [Member]",
                            "terseLabel":  "Total $4.0 billion debt issuance"
                            }
                        }
                    },
                "localname":  "DebtIssuanceNoteTwoMember",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtNoteIssuancesDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_December2018RevolvingCreditAgreementMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "December 2018 Revolving Credit Agreement",
                            "label":  "December 2018 Revolving Credit Agreement [Member]",
                            "terseLabel":  "December 2018 Revolving Credit Agreement"
                            }
                        }
                    },
                "localname":  "December2018RevolvingCreditAgreementMember",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_December2018TermLoanCreditAgreementMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "December 2018 Term Loan Credit Agreement",
                            "label":  "December 2018 Term Loan Credit Agreement [Member]",
                            "terseLabel":  "December 2018 Term Loan Credit Agreement"
                            }
                        }
                    },
                "localname":  "December2018TermLoanCreditAgreementMember",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_DefinedContributionPlanProfitSharingProvisionBenefitExpenseAmount":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The amount of the cost recognized during the period for defined contribution plans profit sharing provision benefit expense amount.",
                            "label":  "Defined Contribution Plan Profit Sharing Provision Benefit Expense Amount",
                            "terseLabel":  "Profit sharing provision expense"
                            }
                        }
                    },
                "localname":  "DefinedContributionPlanProfitSharingProvisionBenefitExpenseAmount",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/RetirementbenefitsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "wba_EmployeeSeveranceAndBusinessTransitionCostsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Employee Severance And Business Transition Costs",
                            "label":  "Employee Severance And Business Transition Costs [Member]",
                            "terseLabel":  "Employee severance and business transition costs"
                            }
                        }
                    },
                "localname":  "EmployeeSeveranceAndBusinessTransitionCostsMember",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesNarrativeDetails",
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringCostsDetails",
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringReserveActivityDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_EmployeeSeveranceAndOtherExitCostsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Employee Severance And Other Exit Costs",
                            "label":  "Employee Severance And Other Exit Costs [Member]",
                            "terseLabel":  "Employee severance and other exit costs"
                            }
                        }
                    },
                "localname":  "EmployeeSeveranceAndOtherExitCostsMember",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesNarrativeDetails",
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringCostsDetails",
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringReserveActivityDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_EquityInvestmentExceededItsProportionateShareOfNetAssets":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "This item represents the carrying amount exceeded its proportionate share of the net assets of an equity method investee.",
                            "label":  "Equity Investment, Exceeded its Proportionate Share of Net Assets",
                            "terseLabel":  "Equity investment, exceeded its proportionate share of net assets"
                            }
                        }
                    },
                "localname":  "EquityInvestmentExceededItsProportionateShareOfNetAssets",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/EquitymethodinvestmentsNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "wba_ExitAndDisposalCostsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Exit And Disposal Costs",
                            "label":  "Exit And Disposal Costs [Member]",
                            "terseLabel":  "Exit and disposal costs"
                            }
                        }
                    },
                "localname":  "ExitAndDisposalCostsMember",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesNarrativeDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_FavorableLeaseInterestsAndNonCompeteAgreementsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Refers to contractual agreement that stipulates the lessee pay the lessor for use of an asset and agreement in which one party agrees not to pursue a similar trade in competition with another party.",
                            "label":  "Favorable Lease Interests and Non-compete Agreements [Member]",
                            "terseLabel":  "Favorable lease interests and non-compete agreements2"
                            }
                        }
                    },
                "localname":  "FavorableLeaseInterestsAndNonCompeteAgreementsMember",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofFiniteLivedIntangibleAssetsbyMajorClassDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Finance Lease, Assets And Liabilities, Lessee",
                            "label":  "Finance Lease, Assets And Liabilities, Lessee [Abstract]",
                            "terseLabel":  "Finance Leases:"
                            }
                        }
                    },
                "localname":  "FinanceLeaseAssetsAndLiabilitiesLesseeAbstract",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesSupplementalBalanceSheetInformationDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "wba_FinanceLeaseLiabilityAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Finance Lease, Liability",
                            "label":  "Finance Lease, Liability [Abstract]",
                            "terseLabel":  "Lease obligations included in:"
                            }
                        }
                    },
                "localname":  "FinanceLeaseLiabilityAbstract",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesSupplementalBalanceSheetInformationDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "wba_FinanceLeaseLiabilityPaymentsDueAfterYearSix":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails_1":  {
                        "order":  7.0,
                        "parentTag":  "us-gaap_FinanceLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Finance Lease, Liability, Payments, Due After Year Six",
                            "label":  "Finance Lease, Liability, Payments, Due After Year Six",
                            "terseLabel":  "Later"
                            }
                        }
                    },
                "localname":  "FinanceLeaseLiabilityPaymentsDueAfterYearSix",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "wba_FinanceLeaseLiabilityPaymentsDueYearSix":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails_1":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_FinanceLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Finance Lease, Liability, Payments, Due Year Six",
                            "label":  "Finance Lease, Liability, Payments, Due Year Six",
                            "terseLabel":  "2025"
                            }
                        }
                    },
                "localname":  "FinanceLeaseLiabilityPaymentsDueYearSix",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "wba_IncomeLossFromEquityMethodInvestmentOne":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEARNINGS":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_OperatingIncomeLoss",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Income (Loss) From Equity Method Investment One",
                            "label":  "Income (Loss) From Equity Method Investment One",
                            "terseLabel":  "Equity earnings in AmerisourceBergen"
                            }
                        }
                    },
                "localname":  "IncomeLossFromEquityMethodInvestmentOne",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEARNINGS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "wba_IncomeLossfromOtherEquityMethodInvestments":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEARNINGS":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_ProfitLoss",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Income (Loss) from Other Equity Method Investments",
                            "label":  "Income (Loss) from Other Equity Method Investments",
                            "terseLabel":  "Post tax earnings (loss) from other equity method investments"
                            }
                        }
                    },
                "localname":  "IncomeLossfromOtherEquityMethodInvestments",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFEARNINGS"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "wba_InformationTechnologyTransformationAndOtherExitCostsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Information Technology Transformation And Other Exit Costs",
                            "label":  "Information Technology Transformation And Other Exit Costs [Member]",
                            "terseLabel":  "Information technology transformation and other exit costs"
                            }
                        }
                    },
                "localname":  "InformationTechnologyTransformationAndOtherExitCostsMember",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesNarrativeDetails",
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringCostsDetails",
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringReserveActivityDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_January2019364DayRevolvingCreditAgreementMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "January 2019 364-Day Revolving Credit Agreement",
                            "label":  "January 2019 364-Day Revolving Credit Agreement [Member]",
                            "terseLabel":  "January 2019 364-Day Revolving Credit Agreement"
                            }
                        }
                    },
                "localname":  "January2019364DayRevolvingCreditAgreementMember",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_LeaseObligationsandOtherRealEstateCostsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Lease Obligations and Other Real Estate Costs [Member]",
                            "label":  "Lease Obligations and Other Real Estate Costs [Member]",
                            "terseLabel":  "Lease obligations and other real estate costs"
                            }
                        }
                    },
                "localname":  "LeaseObligationsandOtherRealEstateCostsMember",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesNarrativeDetails",
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringCostsDetails",
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringReserveActivityDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_LeasesPayments":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/LeasesSupplementalCashFlowInformationDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Leases, Payments",
                            "label":  "Leases, Payments",
                            "totalLabel":  "Total"
                            }
                        }
                    },
                "localname":  "LeasesPayments",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesSupplementalCashFlowInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "wba_LeasesWeightedAverageDiscountRateAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Leases, Weighted Average Discount Rate",
                            "label":  "Leases, Weighted Average Discount Rate [Abstract]",
                            "terseLabel":  "Weighted average discount rate"
                            }
                        }
                    },
                "localname":  "LeasesWeightedAverageDiscountRateAbstract",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesAverageLeaseTermsAndDiscountsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "wba_LesseeFinanceLeaseCostAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Lessee, Finance Lease, Cost",
                            "label":  "Lessee, Finance Lease, Cost [Abstract]",
                            "terseLabel":  "Finance lease cost"
                            }
                        }
                    },
                "localname":  "LesseeFinanceLeaseCostAbstract",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesComponentsofLeaseCostDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "wba_LesseeLeaseRenewalTerm":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Lessee, Lease, Renewal Term",
                            "label":  "Lessee, Lease, Renewal Term",
                            "terseLabel":  "Renewal term"
                            }
                        }
                    },
                "localname":  "LesseeLeaseRenewalTerm",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesNarrativeDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "wba_LesseeLeaseTermOfContract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Lessee, Lease, Term Of Contract",
                            "label":  "Lessee, Lease, Term Of Contract",
                            "terseLabel":  "Term of contract"
                            }
                        }
                    },
                "localname":  "LesseeLeaseTermOfContract",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesNarrativeDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "wba_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Lessee, Operating Lease, Liability, Payments, Due After Year Six",
                            "label":  "Lessee, Operating Lease, Liability, Payments, Due After Year Six",
                            "terseLabel":  "Later"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "wba_LesseeOperatingLeaseLiabilityPaymentsDueYearSix":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails":  {
                        "order":  7.0,
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Lessee, Operating Lease, Liability, Payments, Due Year Six",
                            "label":  "Lessee, Operating Lease, Liability, Payments, Due Year Six",
                            "terseLabel":  "2025"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseLiabilityPaymentsDueYearSix",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesFutureLeasePaymentsforOperatingandFinanceLeasesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "wba_LongTermDebtNetDiscountAndFairMarketValueAdjustments":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/DebtShortandLongTermDebtDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_LongTermDebtNoncurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Including current and noncurrent portions, aggregate carrying amount of long-term borrowings as of the balance sheet date.  May include notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt, which had initial maturities beyond one year or beyond the normal operating cycle, if longer, and after deducting unamortized discount or premiums and unamortized fair market value adjustments, if any.",
                            "label":  "Long Term Debt Net Discount And Fair Market Value Adjustments",
                            "verboseLabel":  "Carrying value of notes, net of unamortized discount and interest rate swap FMV adjustment"
                            }
                        }
                    },
                "localname":  "LongTermDebtNetDiscountAndFairMarketValueAdjustments",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtShortandLongTermDebtDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "wba_November2018CreditAgreementMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "November 2018 Credit Agreement [Member]",
                            "label":  "November 2018 Credit Agreement [Member]",
                            "terseLabel":  "November 2018 Credit Agreement"
                            }
                        }
                    },
                "localname":  "November2018CreditAgreementMember",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_NumberOfCreditAgreements":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Number Of Credit Agreements",
                            "label":  "Number Of Credit Agreements",
                            "terseLabel":  "Number of credit agreements"
                            }
                        }
                    },
                "localname":  "NumberOfCreditAgreements",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtAdditionalInformationDetails"
                    ],
                "xbrltype":  "integerItemType"
                },
            "wba_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Operating Lease, Assets And Liabilities, Lessee",
                            "label":  "Operating Lease, Assets And Liabilities, Lessee [Abstract]",
                            "terseLabel":  "Operating Leases:"
                            }
                        }
                    },
                "localname":  "OperatingLeaseAssetsAndLiabilitiesLesseeAbstract",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesSupplementalBalanceSheetInformationDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "wba_OperatingLeaseCostAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Operating Lease, Cost",
                            "label":  "Operating Lease, Cost [Abstract]",
                            "terseLabel":  "Operating lease cost"
                            }
                        }
                    },
                "localname":  "OperatingLeaseCostAbstract",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesComponentsofLeaseCostDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "wba_OtherComprehensiveIncomeLossNetInvestmentHedgesAfterTax":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Other Comprehensive Income (Loss), Net Investment Hedges, After Tax",
                            "label":  "Other Comprehensive Income (Loss), Net Investment Hedges, After Tax",
                            "negatedLabel":  "Net investment hedges"
                            }
                        }
                    },
                "localname":  "OtherComprehensiveIncomeLossNetInvestmentHedgesAfterTax",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "wba_OtherComprehensiveIncomeLossShareOfOtherComprehensiveIncomeLossOfEquityMethodInvestmentsAfterTax":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Other Comprehensive Income (Loss), Share Of Other Comprehensive Income (Loss) Of Equity Method Investments, After Tax",
                            "label":  "Other Comprehensive Income (Loss), Share Of Other Comprehensive Income (Loss) Of Equity Method Investments, After Tax",
                            "negatedLabel":  "Share of other comprehensive income (loss) of equity method investments"
                            }
                        }
                    },
                "localname":  "OtherComprehensiveIncomeLossShareOfOtherComprehensiveIncomeLossOfEquityMethodInvestmentsAfterTax",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "wba_OtherEquityMethodInvestmentsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "The aggregate of all other equity method investments not separately disclosed in the taxonomy.",
                            "label":  "Other equity method investments [Member]",
                            "terseLabel":  "Others",
                            "verboseLabel":  "Other Investments"
                            }
                        }
                    },
                "localname":  "OtherEquityMethodInvestmentsMember",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/EquitymethodinvestmentsNarrativeDetails",
                    "http://walgreensbootsalliance.com/role/EquitymethodinvestmentsScheduleofEquityMethodInvestmentsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_OtherIncomeExpensesMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Primary financial statement caption encompassing other expense and revenues.",
                            "label":  "Other income/(expenses) [Member]",
                            "terseLabel":  "Other income"
                            }
                        }
                    },
                "localname":  "OtherIncomeExpensesMember",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/FinancialinstrumentsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_OtherShortTermDebtMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Represents other types of short-term debt arrangements not previously listed in the taxonomy.",
                            "label":  "Other Short Term Debt [Member]",
                            "terseLabel":  "Other"
                            }
                        }
                    },
                "localname":  "OtherShortTermDebtMember",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/DebtShortandLongTermDebtDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_PharmaceuticalWholesaleMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Identifies division of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
                            "label":  "Pharmaceutical Wholesale [Member]",
                            "terseLabel":  "Pharmaceutical Wholesale",
                            "verboseLabel":  "Pharmaceutical Wholesale"
                            }
                        }
                    },
                "localname":  "PharmaceuticalWholesaleMember",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringCostsDetails",
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofGoodwillDetails",
                    "http://walgreensbootsalliance.com/role/SalesDetails",
                    "http://walgreensbootsalliance.com/role/SegmentreportingDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_PharmacyLicensesMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Pharmacy Licenses given to the company.",
                            "label":  "Pharmacy Licenses [Member]",
                            "terseLabel":  "Pharmacy licenses"
                            }
                        }
                    },
                "localname":  "PharmacyLicensesMember",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofFiniteLivedIntangibleAssetsbyMajorClassDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_PharmacyMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Pharmacy [Member]",
                            "label":  "Pharmacy [Member]",
                            "terseLabel":  "Pharmacy"
                            }
                        }
                    },
                "localname":  "PharmacyMember",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/SalesDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_PurchasingAndPayerContractsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "An asset acquired in a business combination representing an entity's purchasing and payer contract.",
                            "label":  "Purchasing and Payer Contracts [Member]",
                            "terseLabel":  "Purchasing and payer contracts"
                            }
                        }
                    },
                "localname":  "PurchasingAndPayerContractsMember",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofFiniteLivedIntangibleAssetsbyMajorClassDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_RestructuringAndRelatedCostExpectedAnnualCostSavingsOfRestructuringPlan":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Restructuring and Related Cost, Expected Annual Cost Savings Of Restructuring Plan",
                            "label":  "Restructuring and Related Cost, Expected Annual Cost Savings Of Restructuring Plan",
                            "terseLabel":  "Expected annual cost savings of restructuring plan"
                            }
                        }
                    },
                "localname":  "RestructuringAndRelatedCostExpectedAnnualCostSavingsOfRestructuringPlan",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesNarrativeDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "wba_RestructuringAndRelatedCostNumberOfStoresExpectedToClose":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Restructuring and Related Cost, Number of Stores Expected To Close",
                            "label":  "Restructuring and Related Cost, Number of Stores Expected To Close",
                            "terseLabel":  "Number of stores expected to close"
                            }
                        }
                    },
                "localname":  "RestructuringAndRelatedCostNumberOfStoresExpectedToClose",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesNarrativeDetails"
                    ],
                "xbrltype":  "integerItemType"
                },
            "wba_RestructuringReserveAccountingPronouncementAdjustments":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Restructuring Reserve, Accounting Pronouncement Adjustments",
                            "label":  "Restructuring Reserve, Accounting Pronouncement Adjustments",
                            "terseLabel":  "ASC 842 Leases adoption"
                            }
                        }
                    },
                "localname":  "RestructuringReserveAccountingPronouncementAdjustments",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringReserveActivityDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "wba_RestructuringReserveOtherNonCash":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Restructuring Reserve, Other, Non-Cash",
                            "label":  "Restructuring Reserve, Other, Non-Cash",
                            "terseLabel":  "Other - non cash"
                            }
                        }
                    },
                "localname":  "RestructuringReserveOtherNonCash",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringReserveActivityDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "wba_RetailPharmacyInternationalMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Identifies division of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
                            "label":  "Retail Pharmacy International [Member]",
                            "terseLabel":  "Retail Pharmacy International"
                            }
                        }
                    },
                "localname":  "RetailPharmacyInternationalMember",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringCostsDetails",
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofGoodwillDetails",
                    "http://walgreensbootsalliance.com/role/SalesDetails",
                    "http://walgreensbootsalliance.com/role/SegmentreportingDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_RetailPharmacyUSAMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Identifies division of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
                            "label":  "Retail Pharmacy USA [Member]",
                            "terseLabel":  "Retail Pharmacy USA"
                            }
                        }
                    },
                "localname":  "RetailPharmacyUSAMember",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringCostsDetails",
                    "http://walgreensbootsalliance.com/role/GoodwillandotherintangibleassetsScheduleofGoodwillDetails",
                    "http://walgreensbootsalliance.com/role/SalesDetails",
                    "http://walgreensbootsalliance.com/role/SegmentreportingDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Right-Of-Use Asset Obtained In Exchange For Lease Liability",
                            "label":  "Right-Of-Use Asset Obtained In Exchange For Lease Liability [Abstract]",
                            "terseLabel":  "Right-of-use assets obtained in exchange for new lease obligations:"
                            }
                        }
                    },
                "localname":  "RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesSupplementalCashFlowInformationDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "wba_RiteAidCorporationFirstDistributionCenterMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Rite Aid Corporation - First Distribution Center [Member]",
                            "label":  "Rite Aid Corporation - First Distribution Center [Member]",
                            "terseLabel":  "Rite Aid Corporation - First Distribution Center"
                            }
                        }
                    },
                "localname":  "RiteAidCorporationFirstDistributionCenterMember",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/AcquisitionsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_RiteAidCorporationMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Rite Aid Corporation [Member]",
                            "label":  "Rite Aid Corporation [Member]",
                            "terseLabel":  "Rite Aid Corporation"
                            }
                        }
                    },
                "localname":  "RiteAidCorporationMember",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/AcquisitionsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_ScheduleofDepreciationandAmortizationExpenseTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Schedule of Depreciation and Amortization Expense [Table Text Block]",
                            "label":  "Schedule of Depreciation and Amortization Expense [Table Text Block]",
                            "terseLabel":  "Schedule of Depreciation and Amortization Expense"
                            }
                        }
                    },
                "localname":  "ScheduleofDepreciationandAmortizationExpenseTableTextBlock",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/SupplementalinformationTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "wba_StoreOptimizationProgramMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Store Optimization Program [Member]",
                            "label":  "Store Optimization Program [Member]",
                            "terseLabel":  "Store Optimization Program"
                            }
                        }
                    },
                "localname":  "StoreOptimizationProgramMember",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesNarrativeDetails",
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringCostsDetails",
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringReserveActivityDetails",
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesTables"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_TimePeriodOfReportingLag":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Period of reporting lag for availability of financial information.",
                            "label":  "Time period of reporting lag",
                            "terseLabel":  "Period of reporting lag"
                            }
                        }
                    },
                "localname":  "TimePeriodOfReportingLag",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/EquitymethodinvestmentsNarrativeDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "wba_TransformationalCostManagement":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://walgreensbootsalliance.com/role/SegmentreportingDetails":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_OperatingIncomeLoss",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Transformational Cost Management",
                            "label":  "Transformational Cost Management",
                            "negatedLabel":  "Transformational cost management"
                            }
                        }
                    },
                "localname":  "TransformationalCostManagement",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/SegmentreportingDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "wba_TransformationalCostManagementProgramMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Transformational Cost Management Program",
                            "label":  "Transformational Cost Management Program [Member]",
                            "terseLabel":  "Transformational Cost Management Program"
                            }
                        }
                    },
                "localname":  "TransformationalCostManagementProgramMember",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesNarrativeDetails",
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringCostsDetails",
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesRestructuringReserveActivityDetails",
                    "http://walgreensbootsalliance.com/role/ExitanddisposalactivitiesTables"
                    ],
                "xbrltype":  "domainItemType"
                },
            "wba_WeightedAverageRemainingLeaseTermAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-US":  {
                        "role":  {
                            "documentation":  "Weighted Average Remaining Lease Term",
                            "label":  "Weighted Average Remaining Lease Term [Abstract]",
                            "terseLabel":  "Weighted average remaining lease term in years:"
                            }
                        }
                    },
                "localname":  "WeightedAverageRemainingLeaseTermAbstract",
                "nsuri":  "http://walgreensbootsalliance.com/20191130",
                "presentation":  [
                    "http://walgreensbootsalliance.com/role/LeasesAverageLeaseTermsAndDiscountsDetails"
                    ],
                "xbrltype":  "stringItemType"
                }
            },
        "unitCount":  10
        }
    },
"std_ref":  {
    "r0":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)",
        "Topic":  "205",
        "URI":  "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
        },
    "r1":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
        },
    "r10":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(10))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r100":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585"
        },
    "r101":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585"
        },
    "r102":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585"
        },
    "r103":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "17",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3367-108585"
        },
    "r104":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "17",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(f)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3367-108585"
        },
    "r105":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3000-108585"
        },
    "r106":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "24",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585"
        },
    "r107":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585"
        },
    "r108":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(f)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585"
        },
    "r109":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(g)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585"
        },
    "r11":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(11))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r110":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585"
        },
    "r111":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
        },
    "r112":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
        },
    "r113":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
        },
    "r114":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3044-108585"
        },
    "r115":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4297-108586"
        },
    "r116":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4304-108586"
        },
    "r117":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=98513485&loc=SL98516268-108586"
        },
    "r118":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(h))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
        },
    "r119":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(k)(1))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
        },
    "r12":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(12))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r120":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08.(e),(f))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
        },
    "r121":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08.(h)(1)(i))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
        },
    "r122":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08.(h)(2))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
        },
    "r123":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08.(k)(1))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
        },
    "r124":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08.(n)(2))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
        },
    "r125":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.12-04(a))",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690"
        },
    "r126":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "235",
        "URI":  "http://asc.fasb.org/topic&trid=2122369"
        },
    "r127":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
        },
    "r128":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
        },
    "r129":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
        },
    "r13":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(13))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r130":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
        },
    "r131":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
        },
    "r132":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
        },
    "r133":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "250",
        "URI":  "http://asc.fasb.org/topic&trid=2122394"
        },
    "r134":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1448-109256"
        },
    "r135":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "16",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1505-109256"
        },
    "r136":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1252-109256"
        },
    "r137":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "60B",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256"
        },
    "r138":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256"
        },
    "r139":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
        },
    "r14":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(14))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r140":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
        },
    "r141":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
        },
    "r142":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "270",
        "URI":  "http://asc.fasb.org/extlink&oid=116846552&loc=d3e725-108305"
        },
    "r143":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "270",
        "URI":  "http://asc.fasb.org/extlink&oid=116846552&loc=d3e765-108305"
        },
    "r144":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.10-01.(b)(6))",
        "Topic":  "270",
        "URI":  "http://asc.fasb.org/extlink&oid=27015980&loc=d3e46468-122699"
        },
    "r145":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "21",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8721-108599"
        },
    "r146":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
        },
    "r147":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
        },
    "r148":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
        },
    "r149":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(g)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
        },
    "r15":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(15))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r150":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(h)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
        },
    "r151":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
        },
    "r152":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599"
        },
    "r153":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599"
        },
    "r154":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "30",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599"
        },
    "r155":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "30",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599"
        },
    "r156":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "31",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8924-108599"
        },
    "r157":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599"
        },
    "r158":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599"
        },
    "r159":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "40",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9031-108599"
        },
    "r16":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(16))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r160":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "41",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599"
        },
    "r161":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "280",
        "URI":  "http://asc.fasb.org/topic&trid=2134510"
        },
    "r162":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "310",
        "URI":  "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4428-111522"
        },
    "r163":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "310",
        "URI":  "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4531-111522"
        },
    "r164":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 4.E)",
        "Topic":  "310",
        "URI":  "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
        },
    "r165":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "25",
        "SubTopic":  "10",
        "Topic":  "323",
        "URI":  "http://asc.fasb.org/extlink&oid=117311354&loc=d3e32014-111567"
        },
    "r166":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "323",
        "URI":  "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
        },
    "r167":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(1)",
        "Topic":  "323",
        "URI":  "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
        },
    "r168":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(b)",
        "Topic":  "323",
        "URI":  "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
        },
    "r169":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "323",
        "URI":  "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
        },
    "r17":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(17))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r170":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "323",
        "URI":  "http://asc.fasb.org/topic&trid=2196965"
        },
    "r171":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "30",
        "SubTopic":  "10",
        "Topic":  "330",
        "URI":  "http://asc.fasb.org/extlink&oid=68048583&loc=d3e3636-108311"
        },
    "r172":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "35",
        "SubTopic":  "10",
        "Topic":  "330",
        "URI":  "http://asc.fasb.org/extlink&oid=116846819&loc=d3e3927-108312"
        },
    "r173":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 5.L)",
        "Topic":  "330",
        "URI":  "http://asc.fasb.org/extlink&oid=27011343&loc=d3e99989-122729"
        },
    "r174":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
        },
    "r175":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=77989000&loc=SL49117168-202975"
        },
    "r176":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267"
        },
    "r177":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(f)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267"
        },
    "r178":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267"
        },
    "r179":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=108376223&loc=SL108378252-109267"
        },
    "r18":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(19)(a))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r180":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13854-109267"
        },
    "r181":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13854-109267"
        },
    "r182":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
        },
    "r183":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
        },
    "r184":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
        },
    "r185":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(b)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
        },
    "r186":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(d)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
        },
    "r187":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "((a)(1),(b))",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
        },
    "r188":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
        },
    "r189":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)(1)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
        },
    "r19":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(19))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r190":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)(2)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
        },
    "r191":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)(3)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
        },
    "r192":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(b)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
        },
    "r193":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(d)",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
        },
    "r194":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "350",
        "URI":  "http://asc.fasb.org/topic&trid=2144416"
        },
    "r195":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "360",
        "URI":  "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2420-110228"
        },
    "r196":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "360",
        "URI":  "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
        },
    "r197":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "360",
        "URI":  "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
        },
    "r198":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "360",
        "URI":  "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
        },
    "r199":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "360",
        "URI":  "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230"
        },
    "r2":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
        },
    "r20":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(20))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r200":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "360",
        "URI":  "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
        },
    "r201":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)",
        "Topic":  "360",
        "URI":  "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
        },
    "r202":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "420",
        "URI":  "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
        },
    "r203":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)(1)",
        "Topic":  "420",
        "URI":  "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
        },
    "r204":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)(2)",
        "Topic":  "420",
        "URI":  "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
        },
    "r205":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "420",
        "URI":  "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
        },
    "r206":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "420",
        "URI":  "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
        },
    "r207":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB TOPIC 5.P.3)",
        "Topic":  "420",
        "URI":  "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
        },
    "r208":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 5.P.3)",
        "Topic":  "420",
        "URI":  "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
        },
    "r209":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB TOPIC 5.P.4(b))",
        "Topic":  "420",
        "URI":  "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
        },
    "r21":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(22))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r210":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB TOPIC 5.P.4)",
        "Topic":  "420",
        "URI":  "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
        },
    "r211":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 5.P.4(b)(1))",
        "Topic":  "420",
        "URI":  "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
        },
    "r212":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 5.P.4(b)(2))",
        "Topic":  "420",
        "URI":  "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
        },
    "r213":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 5.P.4(b))",
        "Topic":  "420",
        "URI":  "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
        },
    "r214":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 5.P.4(d))",
        "Topic":  "420",
        "URI":  "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
        },
    "r215":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "420",
        "URI":  "http://asc.fasb.org/topic&trid=2175745"
        },
    "r216":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "440",
        "URI":  "http://asc.fasb.org/topic&trid=2144648"
        },
    "r217":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "450",
        "URI":  "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14326-108349"
        },
    "r218":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "450",
        "URI":  "http://asc.fasb.org/topic&trid=2127136"
        },
    "r219":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
        },
    "r22":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(23))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r220":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
        },
    "r221":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(1)",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870"
        },
    "r222":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "470",
        "URI":  "http://asc.fasb.org/topic&trid=2208564"
        },
    "r223":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
        },
    "r224":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
        },
    "r225":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
        },
    "r226":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
        },
    "r227":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
        },
    "r228":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.3-04)",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770"
        },
    "r229":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
        },
    "r23":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(27))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r230":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Topic":  "505",
        "URI":  "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
        },
    "r231":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130543-203045"
        },
    "r232":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045"
        },
    "r233":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045"
        },
    "r234":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "91",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046"
        },
    "r235":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "91",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046"
        },
    "r236":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "606",
        "URI":  "http://asc.fasb.org/topic&trid=49130388"
        },
    "r237":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "712",
        "URI":  "http://asc.fasb.org/topic&trid=2197446"
        },
    "r238":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)(1)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
        },
    "r239":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)(2)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
        },
    "r24":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(28))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r240":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)(ii)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
        },
    "r241":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)(iv)(01)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
        },
    "r242":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(h)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
        },
    "r243":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(h)(1)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
        },
    "r244":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(h)(2)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
        },
    "r245":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(h)(3)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
        },
    "r246":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(j)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
        },
    "r247":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
        },
    "r248":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2410-114920"
        },
    "r249":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
        },
    "r25":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(29))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r250":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2439-114920"
        },
    "r251":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
        },
    "r252":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)(1)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
        },
    "r253":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)(2)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
        },
    "r254":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)(3)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
        },
    "r255":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
        },
    "r256":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "17",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
        },
    "r257":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "70",
        "Topic":  "715",
        "URI":  "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
        },
    "r258":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "35",
        "SubTopic":  "10",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116855982&loc=d3e4534-113899"
        },
    "r259":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901"
        },
    "r26":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(3)(a)(2))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r260":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901"
        },
    "r261":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)(1)",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
        },
    "r262":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=118258462&loc=d3e11149-113907"
        },
    "r263":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "718",
        "URI":  "http://asc.fasb.org/extlink&oid=118258462&loc=d3e11178-113907"
        },
    "r264":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=116821951&loc=d3e31931-109318"
        },
    "r265":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
        },
    "r266":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319"
        },
    "r267":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
        },
    "r268":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
        },
    "r269":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 6.I.7)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
        },
    "r27":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(3))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r270":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=109238882&loc=d3e39076-109324"
        },
    "r271":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324"
        },
    "r272":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "740",
        "URI":  "http://asc.fasb.org/topic&trid=2144680"
        },
    "r273":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "23",
        "Publisher":  "FASB",
        "Section":  "25",
        "SubTopic":  "10",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=116868678&loc=d3e1043-128460"
        },
    "r274":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
        },
    "r275":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
        },
    "r276":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5263-128473"
        },
    "r277":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(b)(1)",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479"
        },
    "r278":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "805",
        "URI":  "http://asc.fasb.org/topic&trid=2303972"
        },
    "r279":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
        },
    "r28":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(30)(a)(1))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r280":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "16",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
        },
    "r281":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "19",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
        },
    "r282":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
        },
    "r283":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "21",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613674-111683"
        },
    "r284":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(1)",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
        },
    "r285":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(2)",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
        },
    "r286":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
        },
    "r287":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(3)",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
        },
    "r288":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c),(3)",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
        },
    "r289":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4I",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=116874947&loc=SL4590271-111686"
        },
    "r29":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(30)(a)(3))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r290":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4J",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=116874947&loc=SL4591551-111686"
        },
    "r291":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4K",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=116874947&loc=SL4591552-111686"
        },
    "r292":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.3A-04)",
        "Topic":  "810",
        "URI":  "http://asc.fasb.org/extlink&oid=116822174&loc=d3e355119-122828"
        },
    "r293":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579240-113959"
        },
    "r294":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959"
        },
    "r295":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959"
        },
    "r296":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959"
        },
    "r297":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=109980867&loc=SL5580258-113959"
        },
    "r298":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959"
        },
    "r299":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41638-113959"
        },
    "r3":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
        },
    "r30":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(30))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r300":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959"
        },
    "r301":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959"
        },
    "r302":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959"
        },
    "r303":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a),(c)",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
        },
    "r304":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
        },
    "r305":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
        },
    "r306":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
        },
    "r307":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4C",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959"
        },
    "r308":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4D",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(6)",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959"
        },
    "r309":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4D",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959"
        },
    "r31":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(31))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r310":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4E",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624181-113959"
        },
    "r311":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41641-113959"
        },
    "r312":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41678-113959"
        },
    "r313":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "182",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=116861445&loc=SL5629052-113961"
        },
    "r314":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "25",
        "Subparagraph":  "(a)(1)",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=109977999&loc=d3e76258-113986"
        },
    "r315":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "25",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/extlink&oid=109977999&loc=d3e76258-113986"
        },
    "r316":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "815",
        "URI":  "http://asc.fasb.org/topic&trid=2229140"
        },
    "r317":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "820",
        "URI":  "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
        },
    "r318":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "820",
        "URI":  "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
        },
    "r319":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(bb)",
        "Topic":  "820",
        "URI":  "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
        },
    "r32":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(32))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r320":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "820",
        "URI":  "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
        },
    "r321":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "820",
        "URI":  "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
        },
    "r322":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "825",
        "URI":  "http://asc.fasb.org/extlink&oid=99377092&loc=SL75136599-209740"
        },
    "r323":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "825",
        "URI":  "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13433-108611"
        },
    "r324":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "230",
        "Topic":  "830",
        "URI":  "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
        },
    "r325":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Subparagraph":  "(b,c)",
        "Topic":  "830",
        "URI":  "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
        },
    "r326":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "835",
        "URI":  "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
        },
    "r327":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "835",
        "URI":  "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399"
        },
    "r328":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "835",
        "URI":  "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399"
        },
    "r329":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "835",
        "URI":  "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28555-108399"
        },
    "r33":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.1)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r330":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "30",
        "Topic":  "835",
        "URI":  "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
        },
    "r331":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "25",
        "SubTopic":  "40",
        "Topic":  "840",
        "URI":  "http://asc.fasb.org/extlink&oid=77913853&loc=d3e49567-112750"
        },
    "r332":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "50",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "40",
        "Topic":  "840",
        "URI":  "http://asc.fasb.org/extlink&oid=82846721&loc=d3e51831-112757"
        },
    "r333":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "51",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "40",
        "Topic":  "840",
        "URI":  "http://asc.fasb.org/extlink&oid=82846721&loc=d3e51840-112757"
        },
    "r334":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "52",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "40",
        "Topic":  "840",
        "URI":  "http://asc.fasb.org/extlink&oid=82846721&loc=d3e51843-112757"
        },
    "r335":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=119364159&loc=SL77916155-209984"
        },
    "r336":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977"
        },
    "r337":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977"
        },
    "r338":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918638-209977"
        },
    "r339":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918643-209977"
        },
    "r34":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.12)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r340":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918643-209977"
        },
    "r341":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Subparagraph":  "(c)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918643-209977"
        },
    "r342":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)(3)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918673-209980"
        },
    "r343":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918673-209980"
        },
    "r344":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
        },
    "r345":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
        },
    "r346":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
        },
    "r347":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(e)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
        },
    "r348":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(f)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
        },
    "r349":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(g)(1)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
        },
    "r35":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.14)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r350":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(g)(2)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
        },
    "r351":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(g)(3)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
        },
    "r352":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(g)(4)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
        },
    "r353":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
        },
    "r354":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980"
        },
    "r355":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "53",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=77888399&loc=SL77918982-209971"
        },
    "r356":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "SubTopic":  "20",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/subtopic&trid=77888251"
        },
    "r357":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "40",
        "Subparagraph":  "(b)",
        "Topic":  "842",
        "URI":  "http://asc.fasb.org/extlink&oid=77888430&loc=SL77919786-209982"
        },
    "r358":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "850",
        "URI":  "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
        },
    "r359":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "850",
        "URI":  "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
        },
    "r36":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.17)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r360":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "850",
        "URI":  "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864"
        },
    "r361":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "850",
        "URI":  "http://asc.fasb.org/topic&trid=2122745"
        },
    "r362":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(bb)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
        },
    "r363":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(bb)(1)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
        },
    "r364":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(bb)(2)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
        },
    "r365":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(bb)(3)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
        },
    "r366":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4D",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)(2)",
        "Topic":  "860",
        "URI":  "http://asc.fasb.org/extlink&oid=118948506&loc=SL51823488-111719"
        },
    "r367":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "340",
        "Topic":  "928",
        "URI":  "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
        },
    "r368":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "25",
        "SubTopic":  "20",
        "Topic":  "940",
        "URI":  "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953"
        },
    "r369":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(1)(a))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
        },
    "r37":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.19(a))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r370":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(11))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
        },
    "r371":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(13))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
        },
    "r372":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(15)(1))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
        },
    "r373":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(16))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
        },
    "r374":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(22))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
        },
    "r375":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(23))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
        },
    "r376":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03.15(5))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
        },
    "r377":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03.17)",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
        },
    "r378":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(19))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
        },
    "r379":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.9-04(13)(f))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
        },
    "r38":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.19(b),22(b))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r380":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.9-04(15))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
        },
    "r381":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.9-04(20))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
        },
    "r382":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.9-04(22))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
        },
    "r383":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.9-04(23))",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
        },
    "r384":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.9-04.9)",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
        },
    "r385":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "470",
        "Topic":  "942",
        "URI":  "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
        },
    "r386":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(16))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
        },
    "r387":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(5))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
        },
    "r388":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(12))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
        },
    "r389":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(15)(b)(1))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
        },
    "r39":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.19)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r390":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(16)(a)(1))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
        },
    "r391":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(16))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
        },
    "r392":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(2))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
        },
    "r393":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(23)(a)(4))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
        },
    "r394":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(24))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
        },
    "r395":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(25))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
        },
    "r396":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(3))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
        },
    "r397":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(8))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
        },
    "r398":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03.(a),19)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
        },
    "r399":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03.17)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
        },
    "r4":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
        },
    "r40":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.20)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r400":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(10))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263"
        },
    "r401":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(11))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263"
        },
    "r402":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(18))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263"
        },
    "r403":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(19))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263"
        },
    "r404":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(8))",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263"
        },
    "r405":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4H",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "40",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
        },
    "r406":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13H",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "40",
        "Subparagraph":  "(a)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441"
        },
    "r407":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13H",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "40",
        "Subparagraph":  "(b)",
        "Topic":  "944",
        "URI":  "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441"
        },
    "r408":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "320",
        "Subparagraph":  "(SX 210.12-14.Column B)",
        "Topic":  "946",
        "URI":  "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611322-123010"
        },
    "r409":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "310",
        "Subparagraph":  "(SX 210.12-29(Footnote 4))",
        "Topic":  "948",
        "URI":  "http://asc.fasb.org/extlink&oid=6589523&loc=d3e617274-123014"
        },
    "r41":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.21)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r410":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "220",
        "Subparagraph":  "(a)",
        "Topic":  "958",
        "URI":  "http://asc.fasb.org/extlink&oid=114873921&loc=SL114875236-224282"
        },
    "r411":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "360",
        "Subparagraph":  "(SX 210.12-28(Footnote 2))",
        "Topic":  "970",
        "URI":  "http://asc.fasb.org/extlink&oid=6590653&loc=d3e638233-123024"
        },
    "r412":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12",
        "Subsection":  "b"
        },
    "r413":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12",
        "Subsection":  "d1-1"
        },
    "r414":  {
        "Name":  "Form 10-Q",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "13",
        "Subsection":  "a-13"
        },
    "r415":  {
        "Name":  "Forms 10-K, 10-Q, 20-F",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "13",
        "Subsection":  "a-1-"
        },
    "r416":  {
        "Name":  "Regulation 12B",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12",
        "Subsection":  "b-2"
        },
    "r417":  {
        "Name":  "Regulation S-T",
        "Number":  "232",
        "Publisher":  "SEC",
        "Section":  "405"
        },
    "r42":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.22(a)(1))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r43":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.22)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r44":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.24)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r45":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.25)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r46":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.29,30)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r47":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.29-31)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r48":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.3(a)(1),(4))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r49":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.3,4)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r5":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6801-107765"
        },
    "r50":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.31)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r51":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.6(a))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r52":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.6a)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r53":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.6b)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r54":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.6c)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r55":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.8)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r56":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.9)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r57":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
        },
    "r58":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
        },
    "r59":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
        },
    "r6":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 201.5-02(24))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r60":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
        },
    "r61":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/topic&trid=2122208"
        },
    "r62":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
        },
    "r63":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a),(b),(c)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
        },
    "r64":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
        },
    "r65":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(i),(j),(k)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
        },
    "r66":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(i-k)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
        },
    "r67":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
        },
    "r68":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=118930883&loc=d3e637-108580"
        },
    "r69":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=118930883&loc=d3e640-108580"
        },
    "r7":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 201.5-02(25))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r70":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=118930883&loc=d3e681-108580"
        },
    "r71":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669686-108580"
        },
    "r72":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "17A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=118930883&loc=SL34724391-108580"
        },
    "r73":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "17B",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=118930883&loc=SL34724394-108580"
        },
    "r74":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
        },
    "r75":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
        },
    "r76":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
        },
    "r77":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580"
        },
    "r78":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580"
        },
    "r79":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=118930883&loc=d3e557-108580"
        },
    "r8":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 201.5-02(26))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r80":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=118951672&loc=d3e1436-108581"
        },
    "r81":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(13))",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868656-224227"
        },
    "r82":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(210.5-03(11))",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
        },
    "r83":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(10))",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
        },
    "r84":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(12))",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
        },
    "r85":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(20))",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
        },
    "r86":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(21))",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
        },
    "r87":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03.1,2)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
        },
    "r88":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03.2(a),(d))",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
        },
    "r89":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03.4)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
        },
    "r9":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(1))",
        "Topic":  "210",
        "URI":  "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
        },
    "r90":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03.9)",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
        },
    "r91":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
        },
    "r92":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "220",
        "URI":  "http://asc.fasb.org/topic&trid=2134417"
        },
    "r93":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585"
        },
    "r94":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585"
        },
    "r95":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585"
        },
    "r96":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585"
        },
    "r97":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585"
        },
    "r98":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585"
        },
    "r99":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585"
        }
    },
"version":  "2.1"
}

↑Top

Filing Submission 0001618921-20-000008 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Walgreens Boots Alliance, Inc. – ‘10-Q’ for 11/30/19 – ‘JSON’

On: Wednesday, 1/8/20, at 4:14pm ET · For: 11/30/19 · Accession #: 1618921-20-8 · File #: 1-36759

Previous ‘10-Q’: ‘10-Q’ on 6/27/19 for 5/31/19 · Next: ‘10-Q’ on 4/2/20 for 2/29/20 · Latest: ‘10-Q’ on 3/28/24 for 2/29/24

Quarterly Report — Form 10-Q — Sect. 13 / 15(d) – SEA’34Filing Table of Contents

‘JSON’ — XBRL Instance as JSON Data — MetaLinks

This File is an XBRL Instance as JavaScript Object Notation (JSON) Data.

Quarterly Report — Form 10-Q — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents